Page last updated: 2024-08-17

medroxyprogesterone acetate and Breast Neoplasms

medroxyprogesterone acetate has been researched along with Breast Neoplasms in 582 studies

Research

Studies (582)

Timeframe	Studies, this research(%)	All Research%
pre-1990	166 (28.52)	18.7374
1990's	181 (31.10)	18.2507
2000's	148 (25.43)	29.6817
2010's	73 (12.54)	24.3611
2020's	14 (2.41)	2.80

Authors

Authors	Studies
Jones, TK; Mais, DE; Marschke, KB; Tegley, CM; Zhi, L	1
Fensome, A; Terefenko, EA; Winneker, R; Wrobel, J; Zhang, P; Zhang, Z	1
Cohen, J; Fensome, A; Koko, M; Lundeen, S; Rudnick, K; Winneker, R; Wrobel, J; Zhang, P; Zhang, Z; Zhu, Y	1
Edwards, JP; Jones, TK; Mais, DE; Marschke, KB; Motamedi, M; Pio, B; Risek, B; Schrader, WT; Tegley, CM; Zhi, L	1
Africander, D; Jackson, H; Louw-du Toit, R; Perkins, MS; Simons, M	1
Deng, Y; Huang, H; Jin, H; Shi, J	1
Anan, K; Aogi, K; Fujisawa, T; Hasegawa, Y; Hattori, M; Kawaguchi, H; Masuda, N; Morita, S; Nakamura, S; Nakayama, T; Ohno, S; Ohtani, S; Saji, S; Sato, N; Takano, T; Toi, M; Tokunaga, E; Yamaguchi, M; Yamamoto, Y; Yamashita, T; Yotsumoto, D	1
Africander, D; Cartwright, M; Jackson, H; Janse van Vuuren, M; Louw-du Toit, R	1
Bluming, AZ; Hodis, HN; Langer, RD	1
Anderson, KS; Ernst, BJ; Ertz-Archambault, NM; Gray, RJ; Kosiorek, HE; Northfelt, DW; Pockaj, BA; Rogoff, LB	1
Ebrahimie, E; Hanson, AR; Hickey, TE; Moore, NL; Tilley, WD	1
Anderson, GL; Aragaki, AK; Chlebowski, RT; Prentice, RL	1
Benson, JR; Dumitru, D; Jatoi, I	1
Anderson, GL; Aragaki, AK; Barrington, W; Cauley, JA; Chlebowski, RT; Gass, MLS; Johnson, KC; Kuller, LH; Lane, D; Manson, JE; Pan, K; Paskett, ED; Prentice, RL; Rohan, TE; Sattari, M; Simon, MS; Stefanick, ML	1
Lundström, E; Söderqvist, G; Virijevic, I	1
Bispo, D; Fabris, V; Gil, AM; Helguero, LA; Lamb, CA; Lanari, C	1
Agnes, JP; Báfica, A; Bishop, AJR; Bruxel, MA; Casagrande, T; Cassali, GD; das Neves, RN; Delgobo, M; Falchetti, M; Garcia, APV; Gelain, DP; Gonçalves, RM; Mendes, DAGB; Moreira, JCF; Rafacho, A; Somensi, N; Vieira, TC; Zanotto-Filho, A	1
Bloy, N; Buqué, A; Galluzzi, L; Humeau, J; Kroemer, G; Perez-Lanzón, M; Petroni, G; Sato, A; Yamazaki, T	1
Boyd, NF; Byrne, C; Chlebowski, RT; Cole, EB; Heiss, G; Kim, E; Lane, DS; Manson, JE; Martin, CF; McTiernan, A; Peck, JD; Pisano, ED; Ursin, G; Wactawski-Wende, J; Yaffe, MD; Zeng, D	1
Allen, AM; Alorro, M; Chand, AL; Clyne, CD; Connelly, AA; Coulson, R; Deb, S; Ernst, M; George, AJ; Hannan, NJ; Harrison, CA; Kumar, B; Lazarus, KA; Liew, SH; Morrow, RJ; O'Toole, SA; Parslow, AC; Poh, A; Putoczki, T; Vargas, AC; Walton, KL; Yeap, EFW; Yee, NS	1
Chen, Y; Lin, SQ; Ran, SY; Yu, Q	1
Archer, DF; Hodis, HN; Langer, RD; Lobo, RA; Pickar, JH; Pines, A; Sarrel, PM; Simon, JA; Utian, WH	1
Anderson, GL; Barnabei, VM; Brinton, LA; Cauley, JA; Chen, C; Chlebowski, RT; Coburn, SB; Falk, RT; Manson, JE; Pfeiffer, RM; Reding, KW; Rohan, TE; Sarto, GE; Trabert, B; Wentzensen, N; Xu, X	1
Hodis, HN; Sarrel, PM	1
Cahill, MA; Fehm, T; Hyder, SM; Liang, Y; Mafuvadze, B; Mueck, AO; Neubauer, H; Ruan, X; Schneck, H; Seeger, H	1
Bing, S; Lijuan, D; Santai, S; Shaohua, Z; Shikai, W; Tao, W; Xiangying, M; Xin, Z; Yan, M; Yue, W; Zefei, J	1
Cahill, MA; Chen, R; Fehm, T; Mueck, AO; Neubauer, H; Seeger, H; Yu, Q; Zhou, J	1
Fehm, T; Mueck, AO; Neubauer, H; Ruan, X; Seeger, H	1
Carmona-Sánchez, E; Cuadros Celorrio, ÁM; Cuadros López, JL; Fernández Alonso, AM; González Ramírez, AR; Pérez-Roncero, G	1
Chen, FP; Chen, HY; Chien, MH; Huang, TS; Ng, YT	1
Nabel, EG	1
Anderson, G; Aragaki, AK; Beresford, SA; Cauley, JA; Chlebowski, RT; Eaton, CB; Gass, M; Howard, BV; Hsia, J; Jackson, RD; Johnson, KC; Kooperberg, C; Kuller, LH; LaCroix, AZ; Lewis, CE; Limacher, M; Liu, S; Manson, JE; Margolis, KL; Martin, LW; O'Sullivan, MJ; Ockene, JK; Powell, LH; Prentice, RL; Rossouw, JE; Simon, MS; Stefanick, ML; Thomson, CA; Van Horn, L; Vitolins, MZ; Wactawski-Wende, J; Wallace, RB; Wassertheil-Smoller, S	1
Avila, DE; Battistone, MA; Dalotto-Moreno, T; Domaica, CI; Fuertes, MB; Rabinovich, GA; Raffo Iraolagoitia, XL; Rossi, LE; Salatino, M; Spallanzani, RG; Ziblat, A; Zwirner, NW	1
Besch-Williford, CL; Cook, M; Hyder, SM; Mafuvadze, B; Xu, Z	1
Davis, SR	1
Gurney, EP; Nachtigall, LE; Nachtigall, MJ; Naftolin, F	1
Bhavnani, BR; Stanczyk, FZ	1
Béguelin, W; Charreau, EH; Díaz Flaqué, MC; Elizalde, PV; Galigniana, NM; Guzmán, P; Maronna, E; Mercogliano, M; Muñoz, S; Pineda, V; Proietti, CJ; Rivas, MA; Roa, JC; Russo, R; Schillaci, R; Tkach, M; Vicario, R; Yankilevich, P	1
Simon, JA	1
Warren, MP	1
Bunce, C; Chong, MG; Davies, N; Drayson, M; Farmer, R; Gunther, U; Hayden, R; Khanim, F; Pararasa, C; Ride, J; Rigoreau, L; Trivier, E; Veerapen, N; Veliça, P; Winn, P	1
Hodis, HN; Neves-e-Castro, M	1
Anderson, GL; Beresford, SA; Chlebowski, RT; Gass, M; Kuller, LH; Lane, DS; Lavasani, S; Manson, JE; Patterson, R; Prentice, RL; Rohan, TE; Rossouw, JE; Zhao, S	1
Barlow, WE; Cook, LS; Li, CI; Newcomb, PA; Pocobelli, G; Weiss, NS	1
Aughenbaugh, J; Futia, GL; Gibson, EA; Potcoava, MC; Schlaepfer, IR	1
Scarabin, PY	1
Blanco, MA; Bronson, RT; Chakrabarti, R; Chekmareva, M; Guo, F; Haffty, BG; Hua, Y; Kang, Y; Lu, X; Shen, M; Smith, HA; Wan, L; Wei, Y; Wu, H; Xing, Y; Yuan, M; Yuan, S	1
Althouse, SK; Carey, L; Jones, DR; Kimmick, G; Merino, MJ; Miller, KD; Nabell, L; Rugo, H; Steeg, PS	1
Fan, P; Jordan, VC; Sweeney, EE	1
Prentice, RL	1
Archer, DF	1
Iwase, H	1
Iwase, H; Yamamoto, Y	1
Aedo, S; Barriga, P; Blümel, JE; Brantes, S; Campodónico, Í; Cavada, G; Chedraui, P; Fica, J; Irribarra, C; Vallejo, M	1
Abderrahman, B; Curpan, RF; Fan, P; Jordan, VC; Maximov, PY	1
Goodwin, PJ; Joshi, PA; Khokha, R	2
Adams-Campbell, LL; Aragaki, AK; Chlebowski, RT; Johnson, KC; Kaunitz, A; Lessin, LS; Manson, JE; Nassir, R; O'Sullivan, MJ; Prentice, RL; Rohan, TE; Simon, MS; Stefanick, ML; Wactawski-Wende, J	1
Fan, P; Jordan, VC; Maximov, PY	1
Gompel, A; Plu-Bureau, G	1
Amaya, F; Fukazawa, K; Harada, A; Hatano, T; Hosokawa, T; Kwon, C; Nakasone, A; Okada, M; Okamoto, A; Onishi, K; Taguchi, T; Taniguchi, A; Ueno, H; Yamashiro, A	1
Mejía, A; Palacios, S	1
Makris, A; Miles, D; Sutherland, S	1
Bianco-Miotto, T; Birrell, SN; Butler, LM; Clarke, CL; Cops, EJ; Moore, NL; Tilley, WD	1
Baldacci, C; Flamini, MI; Fu, XD; Garibaldi, S; Genazzani, AR; Giretti, MS; Goglia, L; Sanchez, AM; Simoncini, T; Sitruk-Ware, R	1
Baldacci, C; Flamini, M; Fu, XD; Gadducci, A; Garibaldi, S; Genazzani, AR; Giretti, MS; Sanchez, AM; Simoncini, T	1
Jonsson, H; Kemetli, L; Lenner, P; Nyström, L; Rutqvist, LE; Törnberg, S	1
Shapiro, S	3
Mueck, AO; Seeger, H; Wallwiener, D	3
Jinta, E; Sakurai, T; Shimizu, S; Suzuma, T; Umemura, T; Yoshimura, G	1
Anderson, G; Aragaki, AK; Chlebowski, RT; Gass, M; Hendrix, SL; Kuller, LH; Lane, DS; Manson, JE; Ockene, JK; Prentice, RL; Rajkovic, A; Ravdin, PM; Rohan, TE; Sarto, GE; Schenken, R; Stefanick, ML; Yasmeen, S	1
Langer, RD	1
Lee, JH; Marshall, JC; Steeg, PS	1
Allison, M; Anderson, GL; Brzyski, R; Jackson, RD; Johnson, KC; Kuller, LH; Lane, DS; Langer, RD; Manson, JE; Ockene, J; Pettinger, M; Prentice, RL; Rossouw, JE; Sarto, G; Wactawski-Wende, J	1
Hasegawa, N; Iimura, Y; Kaneko, H; Kawabata, M; Konishi, K; Shoji, Y	1
Anderson, G; Aragaki, AK; Cauley, JA; Chlebowski, RT; Cochrane, BB; Crandall, CJ; Hendrix, SL; Kuller, LH; McTiernan, A	1
Tanne, JH	1
Hernán, MA; Hernández-Díaz, S; Logan, R; Robins, JM; Toh, S	1
Béguelin, W; Cayrol, F; Charreau, EH; Díaz Flaqué, MC; Elizalde, PV; Proietti, CJ; Rivas, MA; Rosemblit, C; Schillaci, R; Tkach, M; Tocci, JM	1
Branstetter, D; Dougall, WC; Erwert, R; Gonzalez-Suarez, E; Jacob, AP; Jones, J; Miller, R; Pinkas, J; Roudier-Meyer, MP	1
Anderson, GL; Aragaki, AK; Chlebowski, RT; Gass, M; Hendrix, SL; Johnson, KC; Kuller, LH; Lane, DS; Manson, JE; Ockene, J; Prentice, RL; Rajkovic, A; Ravdin, PM; Rohan, TE; Sarto, GE; Schenken, R; Stefanick, ML; Wactawski-Wende, J; Yasmeen, S	1
Bach, PB	1
Beliard, A; Conner, P; Leifland, K; Lundström, E; Murkes, D; Söderqvist, G; Tani, E	1
Hermsmeyer, RK; Kaski, JC; Thompson, TL	1
Baber, R	1
Chaouat, M; Cimino, D; Communal, L; Courtin, A; de Bortoli, M; Faussat, AM; Forgez, P; Gompel, A; Mourra, N; Taverna, D; Vilasco, M	1
Davidge Pitts, CJ; Kearns, AE	1
Aogi, K; Hara, F; Kiyoto, S; Ohsumi, S; Takabatake, D; Takahashi, M; Takashima, S	1
Cerliani, JP; Giulianelli, S; Guillardoy, T; Gutkind, JS; Lamb, CA; Lanari, C; Martins, R; Vanzulli, SI; Vaque, JP; Zeitlin, E	1
Cahill, MA; Fehm, T; Mueck, AO; Neubauer, H; Ruan, X; Seeger, H; Tong, X; Yang, Y	1
Stanczyk, FZ	1
Kahan, BC; Morris, TP	1
Cahill, MA; Fehm, T; Mueck, AO; Neubauer, H; Ruan, X; Schneck, H; Schultz, S; Seeger, H; Yang, Y	1
Beaber, EF; Daling, JR; Li, CI; Malone, KE; Porter, PL; Tang, MT	1
Giulianelli, S; Gutkind, JS; Helguero, LA; Lamb, CA; Lanari, C; Martins, R; Molinolo, AA; Soldati, R; Vanzulli, SI; Vaqué, JP; Wargon, V; Zeitlin, E	1
Barnhart, KT; Chen, TJ; Chen, YC; Hwang, WT; Liu, Z; Su, IH; Su, TP; Yang, YX	1
Besch-Williford, C; Hyder, SM; Liang, Y; Mafuvadze, B; Zhang, X	1
Wallis, L	1
Lalitkumar, PG; Leifland, K; Lundström, E; Murkes, D; Söderqvist, G	1
Giulianelli, S; Gutkind, JS; Helguero, L; Lamb, C; Lanari, C; Martins, R; Molinolo, AA; Soldati, R; Vanzulli, SI; Vaqué, JP; Wargon, V; Zeitlin, E	1
Kusama, M	1
Bergman, BC; Eckel, RH; Gijón, MA; Hitz, CA; Jacobsen, BM; Schlaepfer, IR	1
Cahill, MA; Fehm, T; Mueck, AO; Neubauer, H; Ruan, X; Schneck, H; Seeger, H	1
Beguelin, W; Deza, EG; Díaz Flaqué, MC; Elizalde, PV; Gercovich, FG; Guzmán, P; Maronna, E; Mercogliano, MF; Proietti, CJ; Rivas, MA; Rosemblit, C; Schillaci, R; Tkach, M	1
Anderson, GL; Beresford, SA; Howard, BV; Jackson, RD; Johnson, KC; Kooperberg, C; Kotchen, JM; LaCroix, AZ; Ockene, J; Prentice, RL; Rossouw, JE; Stefanick, ML	1
Colditz, GA; Fletcher, SW	1
Bergaglio, M; Bertelli, G; Biglia, N; Costantini, M; Del Mastro, L; Porcile, G; Pronzato, P; Rosso, R; Sismondi, P; Venturini, M; Venturini, S	1
Enserink, M	1
Hara, A; Harada, T; Iwamoto, S; Izumi, N; Matsubara, C; Satake, K; Tsunematsu, I	1
Wren, LM	1
Ahola, TM; Alkio, N; Manninen, T; Ylikomi, T	2
Thacker, HL	1
Pike, MC; Spicer, DV; Ursin, G	1
Castegnaro, E; Lenaz, GR; Martoni, A; Pannuti, F; Piana, E; Sala, G	1
London, RS	1
Greenspan, A	1
Chandran, R	1
Kaunitz, AM	3
Ahola, TM; Aksenov, N; Pennanen, P; Purmonen, S; Tuohimaa, P; Ylikomi, T; Zhuang, YH	1
Lemay, A	1
Bhavnani, B	1
Reid, RL	1
Blake, JM; Christilaw, J; Collins, JA; Cooper, J; Fedorkow, DM; Fortier, M; Fortin, C; Jolly, EE; Lalonde, AB; Lemay, A; Maxted, JM; O'Grady, K; O'Grady, T; Reid, RL; Smith, TE; Turek, MA	1
Batur, P; Moore, HC; Thacker, HL	1
Randal, J	1
Greendale, GA; Pike, MC; Reboussin, BA; Slone, S; Ursin, G; Wasilauskas, C	1
Breckwoldt, M	1
Fukushima, M; Ono, Y; Sawada, M	1
Caubel, P; Chetrite, GS; Friedman, AJ; Pasqualini, JR; Philippe, JC	1
Fabris, V; Helguero, LA; Lamb, CA; Lanari, C; Lucas, C; Molinolo, AA	1
Lynge, E; Ottesen, B; Pederson, AT; Stahlberg, C	1
Stjernquist, M	1
Chlebowski, RT; Cyr, MG; Gass, M; Gilligan, MA; Hendrix, SL; Khandekar, J; Lane, D; Langer, RD; McTiernan, A; Petrovitch, H; Rodabough, RJ; Stefanick, ML; Thomson, CA	1
Gann, PH; Morrow, M	1
Mio, H	1
Alvarez-Vasquez, RB; Axelrod, D; Bradlow, HL; Frenkel, K; Newman, MC; Sepkovic, DW; Zumoff, B	1
Irahara, M; Takikawa, M; Uemura, H; Yasui, T	1
HELMREICH, ML; HUSEBY, RA	1
Halverson, D; Ouatas, T; Steeg, PS	1
Kotchen, TA; Mansour, AJ; Mansour, G	1
Kocjan, T; Prelevic, GM	1
Heinemann, V; Parhofer, K	1
Appt, SE; Clarkson, TB	1
Kato, H; Kondo, S; Sekishita, Y; Shiono, T; Suzuki, O	1
Lech, MM	1
Jassem, J; Senkus-Konefka, E	1
Beauduin, M; Canon, JL; Cusumano, G; Focan, C; Focan-Henrard, D; Lobelle, JP; Majois, F	1
Danby, FW	1
Kuhl, H	1
Meyer, VF	1
Abbà, C; Ambroggio, S; Campagnoli, C; Peris, C	1
Kerlikowske, K; Miglioretti, DL	1
Perlroth, FA	1
Cooper, MH	1
Jassem, J; Sosińska-Mielcarek, K; Zaucha, R	1
Merz, WE	1
Bottino, MC; Efeyan, A; Fabris, V; Gorostiaga, MA; Helguero, LA; Lamb, CA; Lanari, C; Molinolo, A; Sanjuan, N; Simian, M; Soldati, R	1
Okazaki, Y; Yamada, T; Yuyama, Y	1
Boerstoel-Streefland, M; Hendricks, PT; Wierik, EJ	1
Brandt, S; Hyder, SM; Wu, J	1
Hashiguchi, H; Hirooka, Y; Kamasako, A; Nozaka, K; Ohgami, Y; Otani, S; Takebayashi, M; Tanida, O; Toyota, N; Wakatsuki, T	1
Suda, T	1
Rutqvist, LE; von Schoultz, E	1
Hyder, SM; Liang, Y	1
Arima, T; Horino, K; Inoue, M; Kaneda, H; Kimura, M; Kuhara, H; Kume, S; Nakano, M; Nishimura, T; Uemura, K	1
Beier, HM; Classen-Linke, I; Krusche, CA; Mrusek, S; Vloet, A	1
Jordan, VC	1
Berrigan, D; Figg, WD; Halverson, DO; Hollingshead, M; Horak, CE; Hursting, S; Johnson, J; Merino, MJ; Ouatas, T; Palmieri, D; Salerno, M; Steeg, PS; Steinberg, SM	1
Birkhaeuser, MH	1
Kihara, M; Kontani, K; Yamauchi, A; Yokomise, H	1
Hirakawa, K; Ishikawa, T; Kato, Y; Nakata, B; Ogawa, Y; Onoda, N; Takagaki, K; Takashima, T	1
Carnevale, R; Charreau, EH; Elizalde, PV; Frahm, I; Kornblihtt, AR; Molinolo, AA; Pecci, A; Proietti, C; Rosemblit, C; Salatino, M; Schillaci, R	1
Bazzocchi, M; Della Martina, M; Driul, L; Fabiani, G; Ianni, A; Marchesoni, D; Zuiani, C	1
Gorbunova, VA; Howell, A; Lichinitser, MR; Pienkowski, T; Robertson, JF; Watanabe, T	1
Chambers, AF	1
Doshida, M; Du, B; Igarashi, H; Kawagoe, J; Kurachi, H; Mori-Abe, A; Ohmichi, M; Ohta, T; Saitoh, M; Takahashi, K; Takahashi, T; Tsutsumi, S	1
Mueck, AO; Rakov, V; Seeger, H	1
Eronen, H; Miettinen, S; Sarvilinna, N; Vienonen, A; Ylikomi, T	1
Bray, JA; Bray, JD; Brown, EL; Ghatge, R; Horwitz, KB; Jacobsen, BM; Jelinsky, S; Lyttle, CR; Richer, JK; Saraf, K; Tunkey, C; Winneker, RC	1
Bentel, JM; Bianco-Miotto, T; Birrell, SN; Buchanan, G; Butler, LM; Cops, EJ; Harris, JM; Horsfall, DJ; Moore, NL; Peters, AA; Ramsay, K; Ricciardelli, C; Simila, HA; Tilley, WD; Yang, M	1
Aragaki, AK; Brunner, RL; Chlebowski, RT; Hulka, BS; Johnson, KC; Kotchen, JM; Lewis, CE; Manson, JE; Martin, CF; McTiernan, A; Peck, JD; Pisano, ED; Wang, CY	1
Harvell, DM; Horwitz, KB; Sartorius, CA; Shen, T	1
Franke, HR; Vermes, I; Werner, HM	1
Ghatge, RP; Horwitz, KB; Jacobsen, BM; Schittone, SA	1
Lehr, J; Manders, P; Span, PN; Sweep, FC; Tjan-Heijnen, VC; van Tienoven, D	1
Cheung, KL; Owers, R; Robertson, JF	1
Aggerwal, A; Allan Hubbell, F; Anderson, GL; Chlebowski, RT; David Curb, J; Hendrix, SL; Khandekar, J; Lane, DS; Lasser, N; Lopez, AM; Margolis, KL; McTiernan, A; Potter, J; Ritenbaugh, C; Rodabough, RJ; Rossouw, JE	1
Chen, H; Cline, JM; Kimrey, S; Lees, CJ; Register, TC; Wood, CE	1
Heikkinen, J; Timonen, U; Vaheri, R	1
Honjo, H; Ishihara, H; Kitaoka, Y; Kitawaki, J; Kiyomizu, M; Koshiba, H; Teramoto, M; Xu, B	1
Eigeliene, N; Erkkola, R; Härkönen, P	2
Baila, L; Beex, L; Estape, J; Gorlia, T; Jassem, J; Lardenoije, S; Mouridsen, H; Nooij, M; Paridaens, R; Piccart, M; Rose, C	1
Murase, JE; Weinstein, GD; Wu, JJ	1
Abdallah, MA; Abdullah, HI; Gercel-Taylor, C; Kang, S; Nakajima, ST; Taylor, DD	1
Cortés-Prieto, J; Juez-Martel, P	1
Bernhardt, G; Bosland, M; Dai, J; Frenkel, K; Huang, X; Jian, J	1
Abeshima, S; Hasegawa, N; Ichimura, T; Kaneko, H; Kawabata, M; Konishi, K; Nakayama, T	1
Besch-Williford, C; Brekken, RA; Hyder, SM; Liang, Y	1
Twombly, R	1
Anderson, G; Chen, C; Chlebowski, RT; Gillian, MA; Gilligan, MA; Lane, D; Langer, RD; McTiernan, A; Pettinger, M; Walsh, BW	1
Anderson, GL; Chlebowski, RT; Hendrix, SL; Hubbell, FA; Jo O'Sullivan, M; Kooperberg, C; Kuller, LH; Lane, DS; Manson, JE; McTiernan, A; Pettinger, M; Prentice, RL; Rossouw, JE; Stefanick, ML	1
Kurebayashi, J	1
Manninen, T; Pennanen, P; Purmonen, S; Ylikomi, T	1
Blossey, HC; Koebberling, J; Nagel, GA; Wander, HE	1
Amato, G; Capuano, F; Carella, C; Figlia, A; Papaleo, C; Zito, GA	1
Kaufman, R; Kinne, D; Kraybill, WG	1
De Lena, M; Di Fronzo, G; Villa, S	1
Beaufort, F; Gölles, M	1
Bartsch, HH; Blossey, HC; Kanne, D; Koebberling, J; Nagel, GA	1
Battaglia, A; Bernardo, G; Brunner, K; Cavalli, F; Ganzina, F; Goldhirsch, A; Isetta, AM; Robustelli della Cuna, G; Sacchetti, G; Tamassia, V	1
Blossey, HC; Kleeberg, U; Köbberling, J; Nagel, GA; Wander, HE	2
Blossey, HC; Nagel, GA; Wander, HE	1
Endo, K; Iino, Y; Izuo, M	1
Ausilli-Cefaro, GP; Minotti, G; Saccheri, S; Trodella, L; Turriziani, A; Venturo, I	1
Bartsch, HH; Blossey, HC; Nagel, GA	1
Bastert, G; Michel, RT	1
Bleichner, F; Mende, S; Meuret, G; Stoeter, P	1
Beaufort, F; Fereberger, W	1
Abe, O; Enomoto, K; Izuo, M; Kubo, K; Nomura, Y; Takatani, O; Tominaga, T	1
Blossey, C; Köbberling, J; Nagel, GA; Wander, HE	1
Ghobrial, HK; Hayden, DW; Johnson, KH	1
Falkson, G; Falkson, HC	2
Mattsson, W	1
Fraser, IS	1
Fereberger, W; Schenk, H	1
Ingle, JN	1
Chalbos, D; Rochefort, H	1
Barduagni, A; Barduagni, M; Di Lauro, L; Lopez, M; Papaldo, P; Perno, CF	1
Blumenschein, GR	1
Battelli, T; Ginnetti, A; Guistini, L; Manocchi, P; Mattioli, R	1
Alberto, P; Cavalli, F; Goldhirsch, A; Jungi, F; Martz, G	1
Priestman, TJ	1
Fotherby, K; Johnson, JR; Kelly, KA; Priestman, SG; Priestman, TJ	1
Carlström, K; Döberl, A; Pousette, A; Rannevik, G; Wilking, N	1
Kauppila, A	1
Coates, A; Dalgleish, A; Fox, R; Hedley, D; Raghavan, D; Tattersall, MH	1
Arai, T; Endo, K; Hoshino, K; Iino, Y; Ishida, T; Ishikawa, H; Ogawa, T; Takahashi, T; Yamazaki, K; Yokoe, T	1
Garbrecht, M; Kleeberg, UR; Müllerleile, U; Pompecki, R; Treidler, J	1
Baroni, M; Farris, A; Grieco, A; Martoni, A; Pannuti, F; Piana, E; Saccani, F; Tomasi, L	1
Carli, A; D'Aniello, C; De Stefano, A; Guarnieri, A; Mariani, L; Nardi, P; Tucci, E	1
Houwerzijl, J; Pratt, JJ; Roding, TJ; Sleijfer, DT; Tjabbes, T; Van Veelen, H; Vermeer, RJ; Willemse, PH	1
Graziottin, A; Marchetti, M; Onnis, A	1
Tominaga, T	3
Gitsch, E; Salzer, H	1
Doorenbos, H; Pratt, JJ; Sleijfer, DT; Sluiter, WJ; van Veelen, H; Willemse, PH	1
Asselain, B; Bretaudeau, B; Giralt, E; Jouve, M; Magdelenat, H; Merle, S; Palangie, T; Pouillart, P; Zajdela, A	1
Fraser, IS; Weisberg, E	1
Belnome, N; Calbo, L; Di Mauro, S; Melita, P; Navarra, S	1
Di Marco, AR; Fruet, F; Martoni, A; Pannuti, F; Strocchi, E	1
McGoldrick, IA	1
Clinton, O; Earl, H; Moore, A; Murray, A; Price, M	1
Coutts, A; Murphy, LC; Murphy, LJ	1
Furukawa, J; Kinuta, M; Maruyama, H; Okamura, J; Ooi, H; Sekimoto, M; Tateishi, H; Yayoi, E	1
Bentel, JM; Birrell, SN; Horsfall, DJ; Roder, DM; Tilley, WD	1
Gallagher, JC; Larson, EB; Laya, MB; Schreiman, JS; Watson, P; Weinstein, L	1
Jiang, Z; Li, J; Song, S	1
Beex, L; Bron, H; de Jong, J; Fickers, M; Hupperets, P; Jager, J; Schouten, H; Schouten, L; Volovics, L; Wils, J	1
Espié, M	2
Kiyono, T; Kurebayashi, J; Ohta, K; Shimozuma, K; Sonoo, H	1
Asaishi, K; Hirata, K; Masuoka, H; Narimatsu, E; Okazaki, A; Okazaki, M; Okazaki, Y; Toda, K; Yamada, T	1
Hayashi, K; Taniguchi, T; Toi, M; Tominaga, T	1
Meirik, O; Noonan, EA; Paul, C; Skegg, DC; Spears, GF; Thomas, DB	1
Gundersen, S; Hannisdal, E; Lundgren, S; Wist, E	1
Aoyagi, H	1
Iacopino, F; Marchetti, P; Marini, L; Robustelli della Cuna, G; Sica, G	1
Hagiwara, S; Hirose, K; Iwai, K; Kimura, M; Shimokawa, Y; Uemura, K	1
Asaumi, S; Iino, Y; Ishikawa, H; Iwanami, K; Kawashima, K; Kobayashi, J; Kubota, K; Matsumoto, H; Morishita, Y; Yokoe, T	1
Abe, O; Abe, R; Enomoto, K; Hayasaka, H; Izuo, M; Ohshima, A; Takatani, O; Tominaga, T; Uchino, J; Watanabe, H	1
Ayme, Y; Carton, M; Daban, A; Delozier, T; Fargeot, P; Ferri, L; Fumoleau, P; Garcia-Giralt, E; Gorins, A; Omodei Zorini, C	1
Alkhalaf, M; Coutts, A; Dotzlaw, H; Haddad-Alkhalaf, B; Murphy, LC	1
Atkins, CD	1
Inaji, H; Koyama, H; Motomura, K; Noguchi, S	1
Gomi, K; Horiuchi, R; Ishida, H; Mikami, K; Naito, M; Okabe, M; Tsuruo, T	1
Atkins, JN; Bearden, JD; Case, LD; Cooper, MR; Cruz, JM; Jackson, DV; Muss, HB; O'Rourke, MA; Pavy, MD; Powell, BL	1
Ebihara, Y; Hirota, T; Koyanagi, Y; Kusama, M; Matsunaga, T; Nakamura, Y; Sekine, M; Serizawa, H	1
Akedo, H; Mukai, M; Shinkai, K; Yoshioka, K	1
Etienne, MC; Milano, G; Namer, M	1
Chilvers, C	1
Hirata, S; Ikeda, K; Kubo, Y; Maeda, T; Nakajima, S; Sasajima, T; Yamazaki, K	1
Brunner, K; Castiglione-Gertsch, M; Cavalli, F; Goldhirsch, A; Metzger, U; Pampallona, S; Senn, HJ; Varini, M	1
Brockerhoff, P; Hofmann, M; Holzer, A; Rathgen, GH	1
Andoh, T; Iijima, T; Iino, Y; Inoue, T; Izumi, M; Kobayashi, I; Morishita, Y; Yamada, T; Yokoe, T; Yokota, T	1
Filmer, A; Hackenberg, R; Hawighorst, T; Nia, AH; Schulz, KD	1
Couture, P; Labrie, F; Simard, J; Thériault, C	1
Pike, A; Pike, MC; Richardson, J; Rude, R; Shoupe, D; Spicer, DV	1
Lynch, M; Martin, JH; van den Berg, HW	1
Falkson, CB; Falkson, CI; Falkson, G; Falkson, HC	2
Dohi, K; Gotoh, T; Kataoka, T; Nishiki, M; Okamoto, T; Sadamoto, S	1
Ahern, J; Iveson, TJ; Smith, IE	1
Beck, T; Crombach, G; Kreienberg, R; Möbus, V; Paula, J	1
Ayme, Y; Carton, M; Daban, A; Delozier, T; Fargeot, P; Fumoleau, P; Garcia-Giralt, E; Gorins, A; Guerin, D; Guerin, R	1
Kosaka, A; Sakaguchi, T; Watahiki, Y	1
Gomi, K; Horiuchi, R; Ishida, H; Okabe, M	1
Adachi, I; Fukutomi, T; Nanasawa, T; Watanabe, T; Yamamoto, H	2
Classen, S; Pelka-Fleischer, R; Possinger, K; Wilmanns, W	1
Bron, H; de Jong, J; Fickers, M; Hupperets, PS; Jager, J; Schouten, HC; Schouten, L; Smeets, J; Volovics, L; Wils, J	1
Abe, O; Aoki, N; Asaishi, K; Enomoto, K; Izuo, M; Koyama, H; Nomura, Y; Ohshima, A; Tominaga, T; Tsukada, T	1
Skegg, DC	1
Joosten, JW; Kloosterboer, HJ; Schoonen, WG	2
Hackenberg, R; Schulz, KD	1
Fraser, I; Hickey, M	1
Nomura, Y; Shirouzu, M; Takayama, T; Tashiro, H	1
Morimoto, T; Nishiki, M; Senoo, T; Sonoo, H; Takashima, S	1
Ansai, Y; Fujimaki, M; Hino, K; Karaki, Y; Shimada, K; Yamashita, Y	1
Iacopino, F; Recchia, F; Sica, G	1
Bianco, AR; Carlomagno, C; De Placido, S; Lauria, R; Morabito, A; Perrone, F	1
Egami, T; Ikeda, S; Kuroda, Y; Mitsuyama, S; Mori, A; Murakami, F; Nakamura, Y; Nishikata, F; Ohe, H; Ohsato, K	1
Kimura, M; Koida, T; Sekihara, M	1
Daxenbichler, G; Hofstädter, F; Marth, C; Müller-Holzner, E; Zeimet, AG	1
Baker, P; Blackledge, GR; Clinton, OP; Dunn, J; Earl, H; Latief, TN; Murphy, A; Priestman, TJ	1
Paul, C; Skegg, DC; Spears, GF; Williams, SM	1
Chilvers, CE	1
Hideshima, T; Ogawa, M; Shirakusa, T; Yamashita, J	1
Claudio, JA; Emerman, JT	1
Kuroda, Y; Murakami, M; Yamada, K	1
Aichberger, A; Krebs, D; Werner, A	1
Aikawa, T; Furukawa, J; Kobayashi, T; Kotsuma, Y; Maeura, Y; Miyauchi, K; Takatsuka, Y; Yayoi, E	1
Abbadessa, G; Berta, GN; Conti, G; D'Avolio, A; Di Carlo, F; Gambino, G; Ghezzo, F; Racca, S	1
Iacopino, F; Robustelli della Cuna, G; Sica, G	1
Kuribayashi, H; Nishibe, M; Nishihara, H; Sato, T; Watanabe, I	1
Byrne, MJ; Coates, AS; Dewar, J; Flower, C; Forbes, J; Gebski, V; Gill, PG; Lunn, M; Simes, RJ; Stewart, J; Tattersall, MH	1
Nussey, SS; Shotliff, K	1
Baba, K; Fukuda, M; Higuchi, A; Ikeda, K; Matsuda, M; Matsuoka, Y; Nagao, K; Nishimura, R; Yamashita, H	1
Arima, Y; Furukawa, K; Hasegawa, H; Higuchi, K; Minobe, K; Onda, M; Tanaka, N	1
Hyder, SM; Murthy, L; Stancel, GM	1
Shin, E; Takatsuka, Y	1
Hitosugi, M; Kan, S; Kitamura, O; Takatsu, A; Watanabe, K	1
Fujii, T; Kanno, K; Ogata, T; Roppongi, T; Yokota, T	1
Fujii, H; Igarashi, T; Imoto, S; Itoh, K; Kohagura, M; Ohtsu, T; Sasaki, Y; Wakita, H	1
Akinaga, S; Akiyama, T; Ishida, H; Okabe, M; Shimizu, M; Sugiyama, K; Tamaoki, T	1
Higashi, Y; Iino, Y; Ishiguro, S; Kurihara, T; Morishita, Y; Suemasu, K; Tabei, T; Takeda, F	1
Confalonieri, C; Fossati, R; Ghislandi, E; Liberati, A; Penna, A; Pistotti, V; Tinazzi, A; Torri, V	1
Kihara, M; Maeda, M; Matsusaka, K; Miyauchi, A	1
Lunn, M	1
Kurebayashi, J; Otsuki, T; Sonoo, H; Yamamoto, S	1
Barrett-Connor, E; Bassett, LW; Bush, T; Gatewood, O; Greendale, GA; Olson, LK; Reboussin, BA; Sie, A; Singh, HR; Wasilauskas, C	1
Jones, KP	1
Abe, O; Abe, R; Asaishi, K; Enomoto, K; Iino, Y; Koyama, H; Miura, S; Nakazato, H; Nomura, Y; Tominaga, T	1
Blijham, GH; de Jong, JM; Hupperets, PS; Jager, JJ; Schouten, LJ; Schutte, B; Volovics, L; von Meyenfeldt, MF	1
Hoshino, K; Ikeda, H; Koyama, T; Morishita, Y; Nakamura, M	1
Fujitake, S; Kataoka, S; Maeda, Y; Nozaki, H; Shimizu, M; Tohyama, M	1
Becher, R; Bechtel, C; Berke, A; Borquez, D; Donsbach, GM; Hartwich, G; Hawig, I; Heckmann, M; Hirche, H; Huhn, R; Klaassen, U; Kloke, O; Oberhoff, C; Rudolph, R; Schindler, AE; Schnepper, U; Seeber, S; Stephan, L; Szanto, J; Wolf, E	1
Hino, N; Isozaki, H; Matsukawa, H; Naomoto, Y; Sadamori, H; Saito, S; Shirakawa, Y; Takakura, N; Tanaka, N; Yamatsuji, T	1
Bentel, JM; Birrell, SN; Holds, DJ; Horsfall, DJ; Pickering, MA; Tilley, WD	1
Shiba, E; Sugimoto, T; Takai, S; Watanabe, T	1
Koga, T; Mitsuyama, S; Nomura, Y; Ogawa, M; Ogawa, N; Ohno, S; Shirouzu, K; Sugimachi, K; Takayama, T; Yamashita, J	1
Goto, T; Ishimaru, K; Kano, Y; Kiyono, T; Koga, T; Nishiwaki, M; Okuda, K; Sumiyama, M; Tsujitsuka, K	1
Haslam, SZ; Hofseth, LJ; Osuch, JR; Pathak, DR; Raafat, AM; Slomski, CA	1
Baillie, R; Cooper, D; Dent, D; Gudgeon, A; Hoffman, M; Katzenellenbogen, J; Rao, S; Rosenberg, L; Shapiro, S; Truter, H; van Zyl, J	1
Fujitomi, Y; Fujiyoshi, K; Yasue, K	1
Kokawa, Y; Naito, Y; Oura, S; Sakurai, T; Tamaki, T; Umemura, T; Yoshimura, G	1
Arcuri, F; Carducci, A; Cintorino, M; Paulesu, L; Ricci, C; Runci, Y; Sestini, S	1
Kunisue, H; Kurebayashi, J; Shimozuma, K; Sonoo, H; Tanaka, K; Udagawa, K; Yamamoto, S; Yamamoto, Y	1
Katagata, N; Matsuoka, T; Nomizu, T; Takenoshita, S; Tsuchiya, A; Watanabe, F; Yabuta, T; Yamaki, Y	1
Fukuda, K; Kim, YH; Kitano, H; Kokufu, I; Taniguchi, H; Yamada, K; Yamamoto, M; Yano, T	1
Kunisue, H; Kurebayashi, J; Kurosumi, M; Otsuki, T; Sonoo, H; Yamamoto, S	1
Baba, K; Fukuda, M; Hamamoto, R; Matsuda, M; Matsuoka, Y; Miyayama, H; Mizumoto, T; Nagao, K; Nishimura, R; Yamashita, H	1
Anan, K; Mitsuyama, S	1
Fujii, M; Kaiga, T; Ueda, T; Watanabe, Y	1
Bamberger, AM; Schulte, HM; Thuneke, I	1
Ino, H; Kanaya, Y; Kawasaki, K; Maruyama, S; Okumoto, T; Otani, J; Soda, M; Yokoyama, N	1
Aoki, T; Kaise, H; Koyanagi, Y; Kusama, M; Nakayama, S; Oota, D; Shimizu, H	1
Akao, S; Hiraide, H; Ishikawa, H; Maruyama, M; Matsumoto, F; Mochizuki, H; Okamura, H; Sato , K; Tabei, T; Tamakuma, S; Touma, M; Yagi, Y	1
Chiappetta, C; Hyder, SM; Stancel, GM	1
Beauduin, M; de Greve, J; de Wasch, G; Focan, C; Lobelle, JP; Majois, F; Salamon, E; Tagnon, A; Tytgat, J; van Belle, S; Vandervellen, R; Vindevoghel , A	1
Aihara, N; Fukunaga, M; Iba, T; Kidokoro, A; Suda, M; Sugiyama, K	1
Akaike, H; Ashizawa, I; Chiba, S; Imamura, K; Mitui, T; Miyauchi, Y; Muto, S; Nakagomi, H; Nakazawa, M; Okuda, J; Takahashi, M	1
Gram, IT; Pike, MC; Spicer, DV; Ursin, G	1
Allemand, I; Bishay, K; Chevillard, S; Fouchet, P; Lebeau, J; Levalois, C; Ory, K; Therwath, A	1
Lippert, C; Mueck, AO; Seeger, H; Wallwiener, D	2
Hara, Y; Hikosaka, Y; Iwase, H; Kobayashi, S; Toyama, T; Yamashita, H	1
Imatomi, M; Miyamoto, H; Nakata, A; Saitoh, T; Yoshida, S	1
Franceschi, S; La Vecchia, C	1
Ahola, TM; Pennanen, P; Purmonen, S; Tuohimaa, P; Ylikomi, T; Zhuang, YH	1
Aoki, T; Kaise, H; Koyanagi, Y; Kusama, M; Matunaga, T; Misaka, T; Nakayama, S; Ota, D	1
Nachtigall, LE; Nachtigall, MJ; Nachtigall, RD; Nachtigall, RH; Smilen, SW	1
Christodoulides, A; Ghilchik, MW; Koistinen, R; Reed, MJ; Seppälä, M; Teale, JD	1
Asaishi, K; Hirata, K; Narimatsu, E; Okazaki, A; Okazaki, M; Okazaki, Y; Sato, H; Toda, K; Watanabe, Y; Yamada, T	1
Horikawa, K; Okada, Y	1
Horobin, JM; Newman, EL; Preece, PE; Reid, AD	1
Furusawa, A; Momono, S; Nakagawa, K; Sasaki, Y; Sato, T; Toshima, T	1
Alkhalaf, M; Murphy, LC	1
Denisov, LE; Odintsov, SV; Vinogradova, NN	1
Katoh, T; Kawahara, T; Kobayakawa, K; Takatsuka, Y; Tsumura, I	1
Sapire, KE	1
Aikawa, T; Hirai, T; Kotsuma, Y; Maeura, Y; Miyauchi, K; Takatsuka, Y; Yayoi, E	1
Gundersen, S; Hannisdal, E; Høst, H; Klepp, O; Kvinnsland, S; Lund, E	1
Iacopino, F; Marini, L; Robustelli della Cuna, G; Sica, G	1
Etienne, MC; Francois, E; Frenay, M; Milano, G; Namer, M; Renee, N; Schneider, M; Thyss, A	1
Stone, R	1
Abe, K	1
Fujiwara, Y; Furukawa, J; Hasuike, Y; Maruyama, H; Miyoshi, H; Naoi, M; Nishihara, M; Okahara, K; Takata, N; Yayoi, E	1
Pike, MC; Shoupe, D; Spicer, DV	1
Allen, MY; Bonhomme, MG; Fortney, JA; Potts, DM	1
Guillebaud, J; Szareswki, A	1
Larsen, M; Pors, H; Sørensen, OS; von Eyben, FE	1
Clavel, M	1
Canova, N; Longhi, A; Martoni, A; Pannuti, F	1
Ohtagaki, S; Toge, T; Toi, M; Yagi, M; Yoshinaka, K	1
Hortobagyi, GN; Hug, V; Jones, L; Kau, S	1
Farquhar, C; Liddell, H; McClure, F; McCowan, L; Roberts, H; Roke, C; Say, PJ; Thakurdas, N; Wilson, J	1
Houjou, T; Kadota, K; Mori, N; Wada, T; Watatani, M; Yasutomi, M	1
Aikawa, T; Maeura, Y; Miyauchi, K; Takatsuka, Y; Yayoi, E	1
Imaoka, S; Inaji, H; Iwanaga, T; Koyama, H; Miyauchi, K; Noguchi, S; Yamamoto, H	1
Murphy, LC; Wong, MS	1
Focan, C	1
Alonso, MC; Anglada, L; Batiste-Alentorn, E; Beltrán, M; Catalán, G; Ferrer, J; Izquierdo, A; Ojeda, MB; Picó, C; Tusquets, I	1
Jeng, MH; Jordan, VC	1
Brockerhoff, P; Grill, HJ; Holzer, A; Kreienberg, R; Pollow, K; Rathgen, GH; Schicketanz, KH; Schwarz, V	1
Benedetti, MS; Efthymiopoulos, C; Etienne, MC; Frenay, M; Hurteloup, P; Milano, G; Montcuquet, P; Namer, M; René, N; Vo Van, ML	1
Namer, M	1
Dotzlaw, H; Miller, T; Murphy, LC; Murphy, LJ; Wong, MS	1
Ashikari, A; Kumaki, T; Miyazaki, I; Noguchi, M; Tajiri, K; Taniya, T	1
Imaoka, S; Inaji, H; Koyama, H; Noguchi, S; Yamamoto, H	2
Braunsberg, H; Coldham, NG; Patel, K	1
De Lena, M; Lorusso, V; Paradiso, A; Schittulli, F; Tommasi, S	1
Lynch, M; Martin, J; van den Berg, HW	1
McCowan, L	1
Imaoka, S; Inaji, H; Iwanaga, T; Koyama, H; Miyauchi, K; Nishizawa, Y; Noguchi, S; Yamamoto, H	1
Sleijfer, DT; Tjabbes, T; van der Ploeg, E; van Veelen, H; Willemse, PH	1
Dikkeschei, LD; Sleijfer, DT; Tjabbes, T; van Veelen, H; Willemse, PH	1
Bocchini, R; Cavallotti, GP; Genovese, MG; Godano, A; Grassi, G; Massara, D	1
Lundgren, S; Lønning, PE	1
Day, BJ; McCallum, AB; Tong, DD; Zambrano, D	1
Dauvois, S; Dumont, M; Hatton, AC; Labrie, C; Labrie, F; Mérand, Y; Poirier, D; Poulin, R; Simard, J; Zhao, HF	1
Coldham, NG; Ghilchik, MW; James, VH; Lai, LC; Reed, MJ; Shaikh, NA	1
Kawahara, T; Kobayakawa, K; Okamura, Y; Takatsuka, Y; Tsumura, I	1
Biakhov, MIu; Meshcheriakova, NG; Vasiuta, NIu; Voznyĭ, EK	1
Doihara, H; Kurita, A; Moriwaki, S; Saeki, H; Soga, H; Takashima, S; Takiyama, W; Tanada, M; Yokoyama, N	1
Abrams, JS; Aisner, J; Parnes, H	1
Bates, T; Bozzino, JM; Brock, JE; Clarke, DG; Durrant, KR; Evans, RG; Roberts, JT; Tobias, JS	1
Bye, A; Cranny, A; Daly, PA; Feely, J; Halpenny, O	1
Børmer, O; Gundersen, S; Høst, H; Klepp, O; Kvinnsland, S; Lund, E; Lundgren, S	1
Dietrich, K; Krebs, D; Mallmann, P	1
Ando, K; Funahashi, H; Imai, T; Kato, M; Kato, N; Narita, T; Odaka, K; Oike, E; Ono, M; Sato, Y	1
Berger, U; Coombes, RC; McClelland, RA; Miller, LS; Powles, TJ	1
Aoki, T; Ishikawa, M; Kakuta, T; Kimura, K; Kusama, M; Suzuki, K; Yoshimatsu, A	1
Braunsberg, H; Ghilchik, MW; Owen, AM; Shaikh, N	1
Becher, R; Gerhold, U; Hirche, H; Höffken, K; Miller, AA; Schmidt, CG	1
Braunsberg, H; Ghilchik, MW; Owen, AM; Shaikh, NA	1
Rostom, AY; Stockdale, AD	1
Dotzlaw, H; Murphy, LC	1
Aizawa, M; Houjou, T; Kadota, K; Kurooka, K; Matunami, N; Mori, N; Morikawa, E; Nakano, K; Wada, T; Yamato, M	1
Baker, D; Labrie, F; Poirier, D; Poulin, R	1
Baudoux, A; Beauduin, M; Bunescu, U; Dehasque, N; Dewasch, L; Focan, C; Lobelle, JP; Longeval, E; Majois, F; Mazy, V	1
Banno, T; Kimura, T; Kutsuna, T; Matsumoto, S; Mizuno, Y; Shinohara, M; Tann, M; Yoshizaki, S	1
Dao, TL; Halvorson, H; Nemoto, T; Patel, JK; Rosner, D	1
Buzdar, AU; Fritsche, HA; Holmes, FA; Hortobagyi, GN; Hug, V; Kau, SW	1
Dryzhak, VI	1
Kumaki, T; Miyazaki, I; Noguchi, M; Tajiri, K; Taniya, T	1
Paul, C; Skegg, DC; Spears, GF	1
Inaii, H; Koyama, H; Noguchi, S; Yamamoto, H	1
Collins, JP; Green, MD; Russell, IS; Smith, JA	1
Gray, RH	1
Kvinnsland, S; Lundgren, S; Utaaker, E	1
Mouridsen, HT	1
Beranek, PA; Braunsberg, H; Ghilchik, M; Reed, MJ; Shaikh, NA	1
Coldham, NG; Ghilchik, MW; James, VH; Lai, LC; Purohit, A; Reed, MJ; Singh, A	1
Bush, TL; Ernster, VL; Huggins, GR; Hulka, BS; Kelsey, JL; Schottenfeld, D	1
Carpenter, JT	1
Noonan, L; Thomas, DB; Whitehead, A	1
Chi, IC; Hatcher, RA; Higgins, JE; Wilkens, LR	1
Abe, O; Enomoto, K; Izuo, M; Kubo, K; Nomura, Y; Takatani, O; Tominaga, T; Yoshida, M	2
Koyama, H; Shiba, E	1
Di Lauro, L; Lazzaro, B; Lopez, M; Papaldo, P	1
Izuo, M; Yokoe, T	1
De Sanctis, R; Fruet, F; Martoni, A; Murari, G; Pannuti, F; Strocchi, E	1
Dikkeschei, LD; Nagel, GT; van Veelen, H; Willemse, PH; Wolthers, BG	1
Mullins, K; Osborne, CK; Von Hoff, DD	1
Hirai, T; Iino, Y; Ishida, T; Izuo, M; Kawai, T; Ogawa, T; Suzuki, H; Yokoe, T	1
Samonigg, H	1
Braunsberg, HA; Coldham, NG; Wong, W	1
Abe, O; Enomoto, K; Fujiwara, K; Fukutomi, T; Ikeda, T; Ishii, S; Jinnaka, H; Koh, J; Nakamura, A; Tsuru, S	1
Bonte, J; Ide, P; Janssens, JP	1
Böck, G; Dapunt, O; Daxenbichler, G; Dürken, M; Marth, C	1
Schweitzer, MJ; Sleijfer, DT; Tjabbes, T; van Veelen, H; Willemse, PH	1
Agustin, BM; Jimenez, MV; Ngelangel, CA; Villalon, AH	1
Camaggi, CM; Martoni, A; Pannuti, F; Strocchi, E	1
Bonichon, F; Chauvergne, J; Durand, M; Mauriac, L	1
Ashley, S; Coombes, RC; Goss, PE; Powles, TJ	1
Blossey, HC; Kleeberg, U; Nagel, GA; Wander, HE	1
Horikoshi, N; Imajo, K; Inoue, K; Ito, Y; Mukaiyama, T; Nakamura, T; Ogawa, M; Ozeki, H; Ueno, K	1
Andersen, AP; Brincker, H; Dombernowsky, P; Frederiksen, PL; Hansen, PV; Hesselius, I; Jakobsen, A; Kjaer, M; Møller, KA	1
Blackledge, GR; Latief, T; Morrison, M; Mould, JJ; Spooner, D	1
Bakke, O; Kvinnsland, S; Lundgren, S; Ueland, PM; Utaaker, E	1
Frenay, M; Khater, R; Milano, G; Namer, M; Renée, N; Thyss, A	1
Manni, A	1
Abel, U; Edler, L; Fritze, D; Kaufmann, M; Massner, B; Queisser, W; Schmid, H; Schmidt, R; Westerhausen, M	1
Dowsett, M; Jeffcoate, SL; Lal, A; Smith, IE	1
Emrich, D; Luig, H; Nagel, GA; Wander, HE	1
Bönisch, E; Gärtner, E; Hartlapp, J; Kleeberg, UR; Nagel, GA; Scherpe, A; Wander, HE	1
Jonat, W; Maass, H	1
Izuo, M	2
Cremer, P; Kuhn, W; Nagel, GA; Seidel, D; Teichmann, AT; Wander, HE; Wieland, H	1
Chapman, D; Mould, GP; Rostom, AY; Stockdale, AD	1
Carlson, RW; Hannigan, JF; Hendrickson, C; Kohler, M; McWhirter, K; Tan, YO	1
Belnome, NA; Calbo, E; Gorgone, S; Lazzara, S; Melita, P; Palmeri, R; Papalia, E	1
Braunsberg, H; Coldham, NG; Leake, RE	1
Braunsberg, H; Coldham, NG; Cowan, SK; Leake, RE; Wong, W	1
Langecker, P; Possinger, K; Schmid, L; Wagner, H; Willich, S; Wilmanns, W	1
Matsumoto, K; Noguchi, S	1
Brema, F; Canobbio, L; Crivellari, D; Di Fronzo, G; Fassio, T; Galligioni, E; Gasparini, G; Monfardini, S; Talamini, R; Villalta, D	1
Blossey, HC; Essers, U; Kleeberg, UR; Nagel, GA; Wander, HE	1
Grimaldo, C; Lee, NC; Oberle, MW; Rosero-Bixby, L; Rovira, EZ; Whatley, AS	1
Murphy, LC; Murphy, LJ; Shiu, RP	1
Petru, E; Schmähl, D	1
Becher, R	1
Baroni, M; Longhi, A; Martoni, A; Pannuti, F; Piana, E	1
Cairnduff, F; Gallagher, CJ; Smith, IE	1
Koyama, H; Miyauchi, K; Nishizawa, Y; Noguchi, S	1
Hisamatsu, K; Nomura, Y; Tashiro, H; Toi, M	1
Horiuchi, R; Iino, Y; Ishida, T; Izuo, M; Kurebayashi, J; Nakamura, T; Takigawa, H	1
Becher, R; Miller, AA; Schmidt, CG	1
Kawahara, T; Nakayama, H; Takatsuka, Y	1
Cairns, V; Davila, E; East, D; Hilsenbeck, S; Vogel, CL	1
Castelli, P; Del Giacco, S; Iacobelli, S; Maccio, A; Mancuso, S; Mantovani, G; Massidda, B; Panici, PB; Scambia, G; Serri, F	1
Wils, JA	1
Camaggi, CM; Cilenti, G; Fruet, F; Martoni, A; Pannuti, F	1
Falkson, CI; Falkson, G; Falkson, HC	1
Clarke, CL; Hall, RE; Musgrove, EA; Pang, GY; Sutherland, RL	1
Kvinnsland, S; Lönning, PE; Lundgren, S; Wiedemann, G	1
Canney, PA; Griffiths, T; Latief, TN; Mould, JJ; Priestman, TJ; Spooner, D	1
Blomqvist, C; Elomaa, I; Mäntylä, M; Rissanen, P	1
Canney, PA; Dowsett, M; Priestman, TJ	1
Aakvaag, A; Kvinnsland, S; Lundgren, S; Utaaker, E	1
Nomura, Y	1
Glińska, H; Krawczyk, J; Zulichowska, J	1
Aitokallio-Tallberg, A; Kärkkäinen, J; Pantzar, P; Wahlström, T; Ylikorkala, O	1
Lazarus, L; Murphy, LJ; Sutherland, RL	1
Lazarus, L; Murphy, LC; Murphy, LJ; Stead, B; Sutherland, RL	1
Glick, JH; Haller, DG	1
Blijham, GH; Mellink, WA; Meulenberg, PM; Van Deijk, WA	1
Caterson, ID; Christie, M; Hedley, DW; Weatherby, RP	1
Lorenz, I; Mechl, Z	1
Nomura, Y; Takaeko, F; Tashiro, H	1
Camaggi, CM; Canova, N; Costanti, B; Pannuti, F; Strocchi, E	1
Cremer, P; Kruse, B; Kuhn, W; Nagel, GA; Seidel, D; Teichmann, AT; Wander, HE; Wieland, H	1
Miura, S; Murai, H; Yoshida, M	1
Farabegoli, G; Martoni, A; Pannuti, F; Piana, E	1
Doorenbos, H; Sleijfer, DT; Sluiter, WJ; van der Ploeg, E; van Veelen, H; Willemse, PH	1
Blumenschein, GR; Buzdar, AU; Fraschini, G; Frye, D; Halvorson, HC; Hortobagyi, GN; Hug, V; Pinnamaneni, K; Yap, HY	1

Reviews

61 review(s) available for medroxyprogesterone acetate and Breast Neoplasms

Article	Year
'Tis but a scratch: a critical review of the Women's Health Initiative evidence associating menopausal hormone therapy with the risk of breast cancer. Menopause (New York, N.Y.), 2023, Dec-01, Volume: 30, Issue:12 Topics: Breast Neoplasms; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Menopause; Quality of Life; United States; Women's Health	2023
Menopausal hormone therapy and breast cancer: what is the evidence from randomized trials? Climacteric : the journal of the International Menopause Society, 2018, Volume: 21, Issue:6 Topics: Breast Neoplasms; Drug Therapy, Combination; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Postmenopause; Randomized Controlled Trials as Topic	2018
Genomic and non-genomic actions of progestogens in the breast. The Journal of steroid biochemistry and molecular biology, 2014, Volume: 142 Topics: Breast; Breast Neoplasms; Cell Proliferation; Epithelial Cells; Female; Humans; Medroxyprogesterone Acetate; Membrane Proteins; Postmenopause; Progestins; Receptors, Progesterone; Risk; Women's Health	2014
The Women's Health Initiative trial and related studies: 10 years later: a clinician's view. The Journal of steroid biochemistry and molecular biology, 2014, Volume: 142 Topics: Aged; Atherosclerosis; Breast Neoplasms; Calcium; Cognition; Coronary Disease; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Fractures, Bone; Humans; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Progestins; Randomized Controlled Trials as Topic; Risk Assessment; Stroke; Testosterone; Venous Thromboembolism; Vitamin D; Women's Health	2014
Use of medroxyprogesterone acetate for hormone therapy in postmenopausal women: is it safe? The Journal of steroid biochemistry and molecular biology, 2014, Volume: 142 Topics: Animals; Blood Coagulation; Brain; Breast Neoplasms; Cardiovascular Diseases; Cognition; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone Acetate; Postmenopause	2014
Hormone therapy and venous thromboembolism among postmenopausal women. Frontiers of hormone research, 2014, Volume: 43 Topics: Administration, Cutaneous; Breast Neoplasms; Clinical Trials as Topic; Estrogen Replacement Therapy; Estrogens; Female; Humans; Medroxyprogesterone Acetate; Postmenopause; Progestins; Risk; Venous Thromboembolism	2014
Postmenopausal hormone therapy and the risks of coronary heart disease, breast cancer, and stroke. Seminars in reproductive medicine, 2014, Volume: 32, Issue:6 Topics: Aged; Aged, 80 and over; Brain Ischemia; Breast Neoplasms; Coronary Disease; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Evidence-Based Medicine; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Progestins; Risk Factors; Stroke; United States	2014
Treatment strategy for metastatic breast cancer with estrogen receptor-positive tumor. International journal of clinical oncology, 2015, Volume: 20, Issue:2 Topics: Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Medroxyprogesterone Acetate; Neoplasm Metastasis; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Signal Transduction	2015
Clinical benefit of sequential use of endocrine therapies for metastatic breast cancer. International journal of clinical oncology, 2015, Volume: 20, Issue:2 Topics: Androgens; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Estradiol; Estrogens; Female; Fulvestrant; Gonadotropin-Releasing Hormone; Humans; Medroxyprogesterone Acetate; Neoplasm Metastasis; Ovariectomy; Postmenopause; Premenopause; Progesterone; Selective Estrogen Receptor Modulators; Tamoxifen	2015
The molecular, cellular and clinical consequences of targeting the estrogen receptor following estrogen deprivation therapy. Molecular and cellular endocrinology, 2015, Dec-15, Volume: 418 Pt 3 Topics: Apoptosis; Breast Neoplasms; Drug Resistance, Neoplasm; Estrogens; Female; Humans; Medroxyprogesterone Acetate; Mutation; Nandrolone; Receptors, Estrogen	2015
Progestogen safety and tolerance in hormonal replacement therapy. Expert opinion on drug safety, 2016, Volume: 15, Issue:11 Topics: Animals; Breast Neoplasms; Cardiovascular Diseases; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Menopause; Progestins; Risk	2016
Use of maintenance endocrine therapy after chemotherapy in metastatic breast cancer. European journal of cancer (Oxford, England : 1990), 2016, Volume: 69 Topics: Antineoplastic Agents; Antineoplastic Agents, Hormonal; Breast Neoplasms; Female; Humans; Maintenance Chemotherapy; Medroxyprogesterone Acetate; Neoplasm Metastasis; Receptor, ErbB-2; Receptors, Estrogen; Tamoxifen; Trastuzumab	2016
Update on medications with adverse skeletal effects. Mayo Clinic proceedings, 2011, Volume: 86, Issue:4 Topics: Animals; Aromatase Inhibitors; Bone and Bones; Bone Density; Breast Neoplasms; Contraceptive Agents, Female; Diphosphonates; Fractures, Bone; Glucocorticoids; Gonadotropin-Releasing Hormone; Humans; Medroxyprogesterone Acetate; Osteoporosis; Peroxisome Proliferator-Activated Receptors; Proton Pump Inhibitors; Selective Serotonin Reuptake Inhibitors; Thiazolidinediones	2011
Hormone replacement therapy and risk of breast cancer: the role of progestins. Acta obstetricia et gynecologica Scandinavica, 2003, Volume: 82, Issue:7 Topics: Breast Neoplasms; Drug Administration Schedule; Epidemiologic Studies; Estrogen Replacement Therapy; Europe; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Meta-Analysis as Topic; Middle Aged; Norethindrone; Norethindrone Acetate; Progestins; Risk Factors; United States	2003
Hormone replacement therapy in postmenopausal women. The journal of medical investigation : JMI, 2003, Volume: 50, Issue:3-4 Topics: Administration, Cutaneous; Atrophy; Breast Neoplasms; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Medroxyprogesterone Acetate; Osteoporosis, Postmenopausal; Postmenopause; Randomized Controlled Trials as Topic; Risk; Vagina	2003
Hormone replacement therapy update: who should we be prescribing this to now? Current opinion in obstetrics & gynecology, 2003, Volume: 15, Issue:6 Topics: Breast Neoplasms; Cardiovascular Diseases; Clinical Trials as Topic; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Hot Flashes; Humans; Medroxyprogesterone Acetate; Practice Guidelines as Topic; Practice Patterns, Physicians'; Time Factors; Women's Health	2003
MPA and postmenopausal coronary artery atherosclerosis revisited. Steroids, 2003, Volume: 68, Issue:10-13 Topics: Animals; Antineoplastic Agents, Hormonal; Arteriosclerosis; Breast Neoplasms; Cholesterol, HDL; Contraceptive Agents, Female; Contraceptives, Oral; Coronary Vessels; Estrogens; Female; Haplorhini; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Menopause; Models, Biological; Postmenopause; Risk	2003
[Depot medroxyprogesterone acetate (DMPA) injectable contraception--safe, effective but neglected method of family planning in Poland]. Wiadomosci lekarskie (Warsaw, Poland : 1960), 2003, Volume: 56, Issue:7-8 Topics: Adult; Bone Density; Breast Neoplasms; Cardiovascular Diseases; Contraceptive Agents, Female; Family Planning Services; Female; Humans; Injections; Medroxyprogesterone Acetate; Poland; Pregnancy; Weight Gain; Women's Health	2003
Menopausal hormone therapy after breast cancer: the Stockholm randomized trial. Journal of the National Cancer Institute, 2005, Apr-06, Volume: 97, Issue:7 Topics: Aged; Breast Neoplasms; Confidence Intervals; Drug Administration Schedule; Estradiol; Estrogen Replacement Therapy; Female; Follow-Up Studies; Hot Flashes; Humans; Incidence; Medroxyprogesterone Acetate; Menopause; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Odds Ratio; Research Design; Survivors; Sweden	2005
Recent epidemiological evidence relevant to the clinical management of the menopause. Climacteric : the journal of the International Menopause Society, 2007, Volume: 10 Suppl 2 Topics: Breast Neoplasms; Coronary Disease; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Evidence-Based Medicine; Female; Hot Flashes; Humans; Medroxyprogesterone Acetate; Menopause; Ovarian Neoplasms; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Stroke; United States; Venous Thromboembolism; Women's Health	2007
[Bone-related events in breast cancer]. Clinical calcium, 2008, Volume: 18, Issue:4 Topics: Antineoplastic Agents; Antineoplastic Agents, Hormonal; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Chemotherapy, Adjuvant; Diphosphonates; Female; Humans; Medroxyprogesterone Acetate; Osteolysis; Parathyroid Hormone-Related Protein; RANK Ligand; Transforming Growth Factor beta	2008
Current status of high dose progestin treatment in advanced breast cancer. Breast cancer research and treatment, 1983, Volume: 3, Issue:2 Topics: Administration, Oral; Antineoplastic Agents; Breast Neoplasms; Dose-Response Relationship, Drug; Female; Humans; Immunosuppressive Agents; Injections, Intramuscular; Medroxyprogesterone; Medroxyprogesterone Acetate; Receptors, Progesterone	1983
Long acting injectable hormonal contraceptives. Clinical reproduction and fertility, 1982, Volume: 1, Issue:1 Topics: Animals; Breast Neoplasms; Contraceptive Agents; Delayed-Action Preparations; Dogs; Drug Administration Schedule; Female; Fetus; Humans; Infertility, Female; Infusions, Parenteral; Lactation; Macaca mulatta; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation; Norethindrone; Norethindrone Acetate; Pregnancy; Time Factors; Uterine Neoplasms	1982
Progestin therapy of endometrial, breast and ovarian carcinoma. A review of clinical observations. Acta obstetricia et gynecologica Scandinavica, 1984, Volume: 63, Issue:5 Topics: Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bromocriptine; Dose-Response Relationship, Drug; Estrogen Antagonists; Female; Forecasting; Humans; Hydroxyprogesterones; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Neoplasm Recurrence, Local; Ovarian Neoplasms; Progestins; Receptors, Steroid; Uterine Neoplasms	1984
A comprehensive review of injectable contraception with special emphasis on depot medroxyprogesterone acetate. The Medical journal of Australia, 1981, 01-24, Volume: 1, Issue:SP1 Topics: Australia; Blood Pressure; Breast Neoplasms; Contraceptives, Oral; Drug Implants; Female; Fertility; Fetus; Humans; Injections; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation Disturbances; Neoplasms; Norethindrone; Thrombophlebitis; Uterine Cervical Neoplasms	1981
Depo provera in perspective. Papua and New Guinea medical journal, 1981, Volume: 24, Issue:4 Topics: Adenocarcinoma; Animals; Breast Neoplasms; Contraceptive Agents, Female; Dogs; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation Disturbances; Pregnancy; Uterine Cervical Dysplasia; Uterine Neoplasms	1981
[Hormonal therapy of breast cancer]. Bulletin du cancer, 1994, Volume: 81, Issue:10 Suppl Topics: Aminoglutethimide; Breast Neoplasms; Female; Gonadotropin-Releasing Hormone; Humans; Medroxyprogesterone Acetate; Ovariectomy; Tamoxifen	1994
[Systemic therapy, pain relief and quality of life of breast cancer patients with bone metastasis]. Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22 Suppl 1 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Female; Fluorouracil; Humans; Medroxyprogesterone Acetate; Middle Aged; Morphine; Pain, Intractable; Quality of Life; Tamoxifen	1995
Depot medroxyprogesterone acetate and breast cancer. A pooled analysis of the World Health Organization and New Zealand studies. JAMA, 1995, Mar-08, Volume: 273, Issue:10 Topics: Adolescent; Adult; Breast Neoplasms; Delayed-Action Preparations; Female; Humans; Kenya; Logistic Models; Medroxyprogesterone Acetate; Mexico; Middle Aged; New Zealand; Risk Factors; Thailand; Time Factors; World Health Organization	1995
Regulation of gene expression in T-47D human breast cancer cells by progestins and antiprogestins. Human reproduction (Oxford, England), 1994, Volume: 9 Suppl 1 Topics: Breast Neoplasms; Cell Division; Epidermal Growth Factor; ErbB Receptors; Gene Expression Regulation, Neoplastic; Genes, fos; Genes, jun; Genes, myc; Gonanes; Humans; Medroxyprogesterone Acetate; Mifepristone; Neoplasm Proteins; Progestins; Transforming Growth Factors; Tumor Cells, Cultured	1994
[Recent advance of hormonal treatment for breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:16 Topics: Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Medroxyprogesterone Acetate; Receptors, LHRH; Tamoxifen	1994
Breast cancer and depot-medroxyprogesterone acetate: a review. Contraception, 1994, Volume: 49, Issue:3 Topics: Breast Neoplasms; Female; Humans; Medroxyprogesterone Acetate; New Zealand; Risk Factors; World Health Organization	1994
Risk assessment issues in breast cancer. Mutation research, 1995, Volume: 333, Issue:1-2 Topics: Animals; Breast Neoplasms; Case-Control Studies; Cohort Studies; Dogs; Female; Humans; Medroxyprogesterone Acetate; Risk Assessment; Risk Factors	1995
Androgen receptor mediated growth control of breast cancer and endometrial cancer modulated by antiandrogen- and androgen-like steroids. The Journal of steroid biochemistry and molecular biology, 1996, Volume: 56, Issue:1-6 Spec N Topics: Androgen Antagonists; Androgens; Androstane-3,17-diol; Androstenediol; Antineoplastic Agents, Hormonal; Apolipoproteins; Apolipoproteins D; Breast Neoplasms; Carcinoma; Carrier Proteins; Endometrial Neoplasms; Estrogen Antagonists; Female; Fibrocystic Breast Disease; Gene Expression Regulation, Neoplastic; Glycoproteins; Humans; Medroxyprogesterone Acetate; Membrane Transport Proteins; Neoplasm Proteins; Pleural Effusion; Receptors, Androgen; Tumor Cells, Cultured	1996
The contraceptive use of depot medroxyprogesterone acetate. Clinical obstetrics and gynecology, 1995, Volume: 38, Issue:4 Topics: Animals; Bone and Bones; Breast Neoplasms; Clinical Trials as Topic; Contraceptive Agents, Female; Contraindications; Dose-Response Relationship, Drug; Female; Fertility; Genital Neoplasms, Female; Humans; Medroxyprogesterone Acetate; Menstrual Cycle; United States; United States Food and Drug Administration	1995
[New developments in hormonal therapy for breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:6 Topics: Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Estrogen Antagonists; Female; Gonadotropin-Releasing Hormone; Humans; Medroxyprogesterone Acetate; Ovariectomy; Receptors, Estrogen; Tamoxifen	1996
[Chemo-endocrine therapy including mitomycin C and medroxyprogesterone acetate in doxorubicin-refractory advanced breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:4 Topics: Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Doxorubicin; Drug Resistance, Neoplasm; Female; Humans; Medroxyprogesterone Acetate; Methotrexate; Middle Aged; Mitomycin; Prednisolone; Vincristine	1996
Depot medroxyprogesterone acetate contraception and the risk of breast and gynecologic cancer. The Journal of reproductive medicine, 1996, Volume: 41, Issue:5 Suppl Topics: Breast Neoplasms; Case-Control Studies; Contraceptive Agents, Female; Delayed-Action Preparations; Endometrial Neoplasms; Female; Genital Neoplasms, Female; Humans; Medroxyprogesterone Acetate; Risk Factors	1996
Interferon and hormone sensitivity of endocrine-related tumors. Anti-cancer drugs, 1996, Volume: 7, Issue:2 Topics: Androgens; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Division; Drug Resistance, Neoplasm; Endometrial Neoplasms; Female; Hormones; Humans; Interferons; Male; Medroxyprogesterone Acetate; Prostatic Neoplasms; Tamoxifen; Tumor Cells, Cultured	1996
First-line systemic therapy for metastatic breast cancer and management of pleural effusion. Annals of oncology : official journal of the European Society for Medical Oncology, 1995, Volume: 6, Issue:10 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Medroxyprogesterone Acetate; Megestrol; Neoplasm Metastasis; Pleural Effusion, Malignant	1995
Depot medroxyprogesterone acetate and breast cancer. A review of current knowledge. Drug safety, 1996, Volume: 15, Issue:3 Topics: Breast Neoplasms; Clinical Trials as Topic; Contraceptive Agents, Female; Female; Humans; Medroxyprogesterone Acetate; Risk Factors	1996
[Treatment strategy for recurrent breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Epirubicin; Female; Floxuridine; Fluorouracil; Gonadotropin-Releasing Hormone; Humans; Infusions, Intravenous; Medroxyprogesterone Acetate; Neoplasm Recurrence, Local; Palliative Care; Survival Rate; Tamoxifen	1998
[A case of dural sinus thrombosis during the medication of medroxyprogesterone acetate]. Nihon hoigaku zasshi = The Japanese journal of legal medicine, 1997, Volume: 51, Issue:6 Topics: Antineoplastic Agents, Hormonal; Autopsy; Breast Neoplasms; Death, Sudden; Female; Forensic Medicine; Humans; Lung Neoplasms; Medroxyprogesterone Acetate; Middle Aged; Sinus Thrombosis, Intracranial	1997
Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomized trials involving 31,510 women. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:10 Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Female; Fluorouracil; Humans; Medroxyprogesterone Acetate; Megestrol; Prednisone; Randomized Controlled Trials as Topic; Survival Analysis; Tamoxifen	1998
[Recent development of oral anti-cancer drugs for breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:3 Topics: Administration, Oral; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Breast Neoplasms; Clinical Trials, Phase II as Topic; Cyclophosphamide; Drug Administration Schedule; Fadrozole; Female; Floxuridine; Fluorouracil; Gonadotropin-Releasing Hormone; Humans; Medroxyprogesterone Acetate; Survival Rate; Tamoxifen; Toremifene	1999
Oral contraception: current use and attitudes. Contraception, 1999, Volume: 59, Issue:1 Suppl Topics: Breast Neoplasms; Cardiovascular Diseases; Condoms; Contraception; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Female; Health Knowledge, Attitudes, Practice; Health Personnel; Humans; Intrauterine Devices; Levonorgestrel; Male; Mass Media; Medroxyprogesterone Acetate	1999
[Medroxyprogesterone acetate for treatment of advanced breast cancers]. Nihon rinsho. Japanese journal of clinical medicine, 2000, Volume: 58 Suppl Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Medroxyprogesterone Acetate; Quality of Life; Thrombosis	2000
Injectable contraception. New and existing options. Obstetrics and gynecology clinics of North America, 2000, Volume: 27, Issue:4 Topics: Affect; Bone Density; Breast Neoplasms; Cardiovascular Diseases; Contraceptive Agents, Female; Estradiol; Female; History, 20th Century; Humans; Injections; Medroxyprogesterone Acetate; Pregnancy; Risk Factors; Weight Gain	2000
[A comparative study with 5'-DFUR alone or in combination with tamoxifen (TAM) or medroxyprogesterone acetate (MPA) for advanced or recurrent breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:5 Topics: Adult; Aged; Breast Neoplasms; Drug Administration Schedule; Drug Therapy, Combination; Female; Floxuridine; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local; Tamoxifen	1992
[Hormone therapy of neoplasms]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1991, Mar-10, Volume: 80, Issue:3 Topics: Adenoma, Islet Cell; Aminoglutethimide; Breast Neoplasms; Female; Fluoxymesterone; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Pancreatic Neoplasms; Prostatic Neoplasms; Tamoxifen	1991
GnRH agonists as contraceptive agents: predicted significantly reduced risk of breast cancer. Contraception, 1991, Volume: 44, Issue:3 Topics: Bone and Bones; Breast Neoplasms; Contraceptive Agents, Female; Endometrial Neoplasms; Estrogens, Conjugated (USP); Female; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Lipid Metabolism; Liver; Medroxyprogesterone; Medroxyprogesterone Acetate; Ovarian Neoplasms; Ovary; Risk Factors	1991
Management of breast cancer with bone metastases. Bone, 1991, Volume: 12 Suppl 1 Topics: Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Combined Modality Therapy; Estrogens; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Palliative Care; Survival Rate	1991
[Adjuvant hormone therapy of primary breast cancer. Review of the literature]. Revue medicale de Liege, 1991, Volume: 46, Issue:5 Topics: Amenorrhea; Aminoglutethimide; Antineoplastic Agents; Breast Neoplasms; Delayed-Action Preparations; Female; Gonadotropin-Releasing Hormone; Hormones; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Tamoxifen	1991
Current status of high-dose progestins in breast cancer. Seminars in oncology, 1990, Volume: 17, Issue:6 Suppl 9 Topics: Antineoplastic Agents; Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Progesterone Congeners	1990
Clinical significance of differences in bioavailability of medroxyprogesterone acetate preparations. Clinical pharmacokinetics, 1989, Volume: 16, Issue:3 Topics: Antineoplastic Agents; Biological Availability; Breast Neoplasms; Drug Compounding; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate	1989
[Estrogen antagonists and inhibitors in hormone therapy of breast cancer]. Voprosy onkologii, 1989, Volume: 35, Issue:7 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Estrogen Antagonists; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Progestins; Tamoxifen	1989
Benefits and risks of menopausal estrogen and/or progestin hormone use. Preventive medicine, 1988, Volume: 17, Issue:2 Topics: Breast Neoplasms; Coronary Disease; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Osteoporosis; Progesterone Congeners; Risk Factors; Uterine Neoplasms	1988
Progestational agents in the treatment of breast cancer. Cancer treatment and research, 1988, Volume: 39 Topics: Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Norethindrone; Norethindrone Acetate; Progestins	1988
Tamoxifen therapy of metastatic breast cancer. The Journal of laboratory and clinical medicine, 1987, Volume: 109, Issue:3 Topics: Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Clinical Trials as Topic; Female; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Neoplasm Metastasis; Random Allocation; Tamoxifen	1987
[Medroxyprogesterone acetate (MPA) in the treatment of advanced breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1987, Volume: 14, Issue:8 Topics: Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate	1987
[Breast cancer and hormone therapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 1987, Volume: 14, Issue:10 Topics: Breast Neoplasms; Combined Modality Therapy; Female; Humans; Mastectomy; Medroxyprogesterone; Medroxyprogesterone Acetate; Ovariectomy; Tamoxifen	1987

Trials

111 trial(s) available for medroxyprogesterone acetate and Breast Neoplasms

Article	Year
Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women's Health Initiative Randomized Clinical Trials. JAMA, 2020, 07-28, Volume: 324, Issue:4 Topics: Aged; Breast Neoplasms; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Hormone Replacement Therapy; Humans; Hysterectomy; Incidence; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Risk	2020
Progestogen addition with low-dose levonorgestrel intrauterine system in menopausal hormone treatment gives less normal breast tissue proliferation than oral norethisterone acetate or medroxyprogesterone acetate. Hormone molecular biology and clinical investigation, 2020, Jul-31, Volume: 41, Issue:3 Topics: Administration, Oral; Aged; Breast Neoplasms; Cell Proliferation; Estrogen Replacement Therapy; Female; Humans; Levonorgestrel; Mammary Glands, Human; Medroxyprogesterone Acetate; Middle Aged; Norethindrone Acetate; Progestins; Uterus	2020
Mammographic Density Change With Estrogen and Progestin Therapy and Breast Cancer Risk. Journal of the National Cancer Institute, 2017, 09-01, Volume: 109, Issue:9 Topics: Aged; Breast Density; Breast Neoplasms; Case-Control Studies; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Logistic Models; Medroxyprogesterone Acetate; Middle Aged; Postmenopause	2017
Prevention of postmenopausal osteoporosis in Chinese women: a 5-year, double-blind, randomized, parallel placebo-controlled study. Climacteric : the journal of the International Menopause Society, 2017, Volume: 20, Issue:4 Topics: Adult; Asian People; Bone Density; Breast Neoplasms; China; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Female; Femur Neck; Glycolipids; Humans; Lumbar Vertebrae; Medroxyprogesterone Acetate; Middle Aged; Osteoporosis, Postmenopausal; Pelvic Bones; Placebos; Postmenopause; Treatment Outcome	2017
Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials. JAMA, 2013, Oct-02, Volume: 310, Issue:13 Topics: Aged; Breast Neoplasms; Colorectal Neoplasms; Coronary Disease; Drug Therapy, Combination; Endometrial Neoplasms; Estrogens; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Hip Fractures; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Pulmonary Embolism; Quality of Life; Risk; Stroke; Treatment Outcome; United States	2013
Sex hormone associations with breast cancer risk and the mediation of randomized trial postmenopausal hormone therapy effects. Breast cancer research : BCR, 2014, Mar-26, Volume: 16, Issue:2 Topics: Aged; Breast Neoplasms; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Gonadal Steroid Hormones; Humans; Logistic Models; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Risk Factors; Treatment Outcome	2014
A phase II study of medroxyprogesterone acetate in patients with hormone receptor negative metastatic breast cancer: translational breast cancer research consortium trial 007. Breast cancer research and treatment, 2014, Volume: 148, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Breast Neoplasms; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Receptors, Estrogen; Receptors, Progesterone	2014
Breast Cancer After Use of Estrogen Plus Progestin and Estrogen Alone: Analyses of Data From 2 Women's Health Initiative Randomized Clinical Trials. JAMA oncology, 2015, Volume: 1, Issue:3 Topics: Aged; Breast Neoplasms; Drug Combinations; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Incidence; Linear Models; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Proportional Hazards Models; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; United States	2015
Breast cancer after use of estrogen plus progestin in postmenopausal women. The New England journal of medicine, 2009, Feb-05, Volume: 360, Issue:6 Topics: Aged; Breast Neoplasms; Causality; Drug Combinations; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Humans; Incidence; Mammography; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Risk Factors; United States	2009
Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause. American journal of epidemiology, 2009, Jul-01, Volume: 170, Issue:1 Topics: Aged; Breast Neoplasms; Colorectal Neoplasms; Contraceptive Agents, Female; Coronary Disease; Endometrial Neoplasms; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Fractures, Bone; Humans; Incidence; Medroxyprogesterone Acetate; Menopause; Middle Aged; Postmenopause; Progestins; Pulmonary Embolism; Retrospective Studies; Risk Factors; Stroke; Survival Rate; Thrombosis; Time Factors; Washington	2009
New-onset breast tenderness after initiation of estrogen plus progestin therapy and breast cancer risk. Archives of internal medicine, 2009, Oct-12, Volume: 169, Issue:18 Topics: Aged; Breast; Breast Neoplasms; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Pain; Postmenopause; Proportional Hazards Models; Sensitivity and Specificity	2009
Estimating absolute risks in the presence of nonadherence: an application to a follow-up study with baseline randomization. Epidemiology (Cambridge, Mass.), 2010, Volume: 21, Issue:4 Topics: Aged; Breast Neoplasms; Confidence Intervals; Double-Blind Method; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens; Female; Humans; Kaplan-Meier Estimate; Medication Adherence; Medroxyprogesterone Acetate; Middle Aged; Monte Carlo Method; Odds Ratio; Proportional Hazards Models; Risk Factors; Selection Bias	2010
Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women. JAMA, 2010, Oct-20, Volume: 304, Issue:15 Topics: Aged; Breast Neoplasms; Drug Combinations; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Hormone Replacement Therapy; Humans; Incidence; Lymphatic Metastasis; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Postmenopause; Prognosis; United States	2010
Effects of percutaneous estradiol-oral progesterone versus oral conjugated equine estrogens-medroxyprogesterone acetate on breast cell proliferation and bcl-2 protein in healthy women. Fertility and sterility, 2011, Mar-01, Volume: 95, Issue:3 Topics: Administration, Oral; Biopsy; Breast; Breast Neoplasms; Cell Division; Contraceptive Agents, Female; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Prospective Studies; Proto-Oncogene Proteins c-bcl-2; Risk Factors	2011
Percutaneous estradiol/oral micronized progesterone has less-adverse effects and different gene regulations than oral conjugated equine estrogens/medroxyprogesterone acetate in the breasts of healthy women in vivo. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2012, Volume: 28 Suppl 2 Topics: Administration, Cutaneous; Administration, Oral; Adult; Breast Density; Breast Neoplasms; Cell Proliferation; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Gels; Gene Expression Profiling; Gene Expression Regulation; Humans; Ki-67 Antigen; Mammary Glands, Human; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Risk Factors; RNA, Messenger; Sweden	2012
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA, 2002, Jul-17, Volume: 288, Issue:3 Topics: Aged; Breast Neoplasms; Clinical Trials Data Monitoring Committees; Colorectal Neoplasms; Coronary Disease; Endometrial Neoplasms; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Fractures, Bone; Humans; Medroxyprogesterone Acetate; Middle Aged; Myocardial Infarction; Postmenopause; Progesterone Congeners; Proportional Hazards Models; Pulmonary Embolism; Risk; Stroke; Survival Analysis; Thrombosis; Treatment Outcome	2002
Intramuscular depot medroxyprogesterone versus oral megestrol for the control of postmenopausal hot flashes in breast cancer patients: a randomized study. Annals of oncology : official journal of the European Society for Medical Oncology, 2002, Volume: 13, Issue:6 Topics: Administration, Oral; Aged; Breast Neoplasms; Chi-Square Distribution; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Hot Flashes; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Megestrol Acetate; Middle Aged; Patient Satisfaction; Postmenopause; Probability; Reference Values; Severity of Illness Index; Treatment Outcome	2002
Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. JAMA, 2003, Jun-25, Volume: 289, Issue:24 Topics: Aged; Breast Neoplasms; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Humans; Mammography; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Staging; Postmenopause; Progesterone Congeners; Proportional Hazards Models; Risk	2003
[Risk and benefits of hormone replacement therapy by postmenopausal women. WHI-Study]. Der Internist, 2003, Volume: 44, Issue:7 Topics: Aged; Breast Neoplasms; Colorectal Neoplasms; Coronary Disease; Endometrial Neoplasms; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Fractures, Bone; Hormone Replacement Therapy; Humans; Incidence; Medroxyprogesterone Acetate; Middle Aged; Myocardial Infarction; Postmenopause; Progesterone Congeners; Proportional Hazards Models; Pulmonary Embolism; Risk Assessment; Stroke; Survival Analysis; Thrombosis; Treatment Outcome; United States; Women's Health	2003
High-dose oral medroxyprogesterone acetate or tamoxifen as adjuvant hormone therapy for node-negative early-stage breast cancer: randomized trial with 7-year update. Clinical breast cancer, 2004, Volume: 5, Issue:2 Topics: Age Factors; Aged; Analysis of Variance; Antineoplastic Agents, Hormonal; Belgium; Biopsy, Needle; Breast Neoplasms; Chemotherapy, Adjuvant; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Immunohistochemistry; Lymph Nodes; Mastectomy; Medroxyprogesterone Acetate; Middle Aged; Multivariate Analysis; Neoplasm Staging; Probability; Reference Values; Risk Assessment; Survival Analysis; Tamoxifen; Time Factors; Treatment Outcome	2004
Menopausal hormone therapy after breast cancer: the Stockholm randomized trial. Journal of the National Cancer Institute, 2005, Apr-06, Volume: 97, Issue:7 Topics: Aged; Breast Neoplasms; Confidence Intervals; Drug Administration Schedule; Estradiol; Estrogen Replacement Therapy; Female; Follow-Up Studies; Hot Flashes; Humans; Incidence; Medroxyprogesterone Acetate; Menopause; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Odds Ratio; Research Design; Survivors; Sweden	2005
Postmenopausal hormone therapy and mammographic breast density. Maturitas, 2006, Jan-10, Volume: 53, Issue:1 Topics: Breast; Breast Neoplasms; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Humans; Mammography; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Postmenopause; Prospective Studies; Single-Blind Method; Treatment Outcome	2006
Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial. Journal of the National Cancer Institute, 2005, Sep-21, Volume: 97, Issue:18 Topics: Age Factors; Aged; Breast; Breast Neoplasms; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Mammography; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Research Design; Risk Factors; United States; Women's Health	2005
Endocrine response after prior treatment with fulvestrant in postmenopausal women with advanced breast cancer: experience from a single centre. Endocrine-related cancer, 2006, Volume: 13, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Double-Blind Method; Drug Resistance, Neoplasm; Estradiol; Estrogen Receptor Modulators; Female; Fulvestrant; Humans; Medroxyprogesterone Acetate; Megestrol Acetate; Middle Aged; Postmenopause; Prognosis; Retrospective Studies; Salvage Therapy; Survival Rate; Tamoxifen; Treatment Outcome	2006
Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin. Maturitas, 2006, Sep-20, Volume: 55, Issue:2 Topics: Aged; Breast Neoplasms; Chi-Square Distribution; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Humans; Medroxyprogesterone Acetate; Middle Aged; Risk Factors; Women's Health	2006
A 10-year follow-up of postmenopausal women on long-term continuous combined hormone replacement therapy: Update of safety and quality-of-life findings. The journal of the British Menopause Society, 2006, Volume: 12, Issue:3 Topics: Breast Neoplasms; Dose-Response Relationship, Drug; Endometrial Neoplasms; Estradiol; Estrogens, Conjugated (USP); Female; Finland; Follow-Up Studies; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Quality of Life; Stroke; Treatment Outcome	2006
Continuous versus intermittent tamoxifen versus intermittent/alternated tamoxifen and medroxyprogesterone acetate as first line endocrine treatment in advanced breast cancer: an EORTC phase III study (10863). European journal of cancer (Oxford, England : 1990), 2006, Volume: 42, Issue:18 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Tamoxifen	2006
Estrogen plus progestin and breast cancer detection by means of mammography and breast biopsy. Archives of internal medicine, 2008, Feb-25, Volume: 168, Issue:4 Topics: Aged; Biopsy; Breast Neoplasms; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Mammography; Medroxyprogesterone Acetate; Middle Aged; Progestins	2008
Breast cancer, cervical cancer, and depot medroxyprogesterone acetate. WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Lancet (London, England), 1984, Nov-24, Volume: 2, Issue:8413 Topics: Adult; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Risk; Uterine Cervical Neoplasms	1984
[Calcitonin in bone-metastasizing breast carcinoma. Results of a pilot study]. Onkologie, 1984, Volume: 7, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Calcitonin; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Methotrexate; Middle Aged; Pain, Intractable; Palliative Care; Pilot Projects	1984
[High dose medroxyprogesteroneacetate in metastasizing breast cancer: correlations between course of the disease and hormone profiles]. Klinische Wochenschrift, 1983, Jun-01, Volume: 61, Issue:11 Topics: Administration, Oral; Breast Neoplasms; Dose-Response Relationship, Drug; Female; Humans; Hydrocortisone; Medroxyprogesterone; Medroxyprogesterone Acetate; Prolactin	1983
Additive hormonal therapy in women with advanced breast cancer. Cancer, 1984, Feb-01, Volume: 53, Issue:3 Suppl Topics: Aminoglutethimide; Androgens; Breast Neoplasms; Clinical Trials as Topic; Danazol; Drug Therapy, Combination; Estrogens; Female; Gonadal Steroid Hormones; Gonadotropin-Releasing Hormone; Humans; Hypophysectomy; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Random Allocation; Tamoxifen	1984
5-Fluorouracil, adriamycin and cyclophosphamide combined with high-dose medroxyprogesterone acetate in advanced breast cancer. Tumori, 1983, Dec-31, Volume: 69, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Evaluation; Female; Fluorouracil; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis	1983
Randomized trial of low- versus high-dose medroxyprogesterone acetate in the induction treatment of postmenopausal patients with advanced breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1984, Volume: 2, Issue:5 Topics: Age Factors; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Drug Administration Schedule; Female; Humans; Injections, Intramuscular; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Random Allocation; Time Factors	1984
Clinical trial of combined hormone therapy (MAP + TAM) for metastatic breast cancer. Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1984, Volume: 3, Issue:4 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Tamoxifen	1984
[Metastatic breast cancer: a comparative study of the efficacy of tamoxifen and the sequential administration of tamoxifen and medroxyprogesterone acetate]. Bulletin du cancer, 1984, Volume: 71, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Drug Tolerance; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Random Allocation; Receptors, Cell Surface; Tamoxifen; Time Factors	1984
Hormone therapy in advanced breast cancer: high dose medroxyprogesterone acetate (MAP) vs tamoxifen (TMX). Preliminary results. European journal of cancer, 1980, Volume: Suppl 1 Topics: Administration, Oral; Aged; Body Weight; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Random Allocation; Tamoxifen	1980
Assessment of five serum marker assays in patients with advanced breast cancer treated with medroxyprogesterone acetate. European journal of cancer (Oxford, England : 1990), 1995, Volume: 31A, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Breast Neoplasms; Carcinoembryonic Antigen; Disease Progression; Dose-Response Relationship, Drug; Female; Humans; Keratins; Medroxyprogesterone Acetate; Middle Aged; Mucin-1; Neoplasm Proteins; Prospective Studies; Sensitivity and Specificity	1995
[A comparison of intra-arterial chemoembolization and infusion chemotherapy for liver metastases of breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22, Issue:11 Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemoembolization, Therapeutic; Epirubicin; Female; Hepatic Artery; Humans; Infant, Newborn; Infusion Pumps, Implantable; Iodized Oil; Liver Neoplasms; Medroxyprogesterone Acetate; Middle Aged; Prognosis	1995
Effect of postmenopausal hormonal replacement therapy on mammographic density and parenchymal pattern. Radiology, 1995, Volume: 196, Issue:2 Topics: Breast; Breast Neoplasms; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Mammography; Medroxyprogesterone Acetate; Middle Aged; Multivariate Analysis; Risk Factors	1995
Adjuvant chemo-hormonal therapy with cyclophosphamide, doxorubicin and 5-fluorouracil (CAF) with or without medroxyprogesterone acetate for node-positive cancer patients. Update at 7-year follow-up. Annals of oncology : official journal of the European Society for Medical Oncology, 1995, Volume: 6, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Fluorouracil; Follow-Up Studies; Humans; Medroxyprogesterone Acetate; Middle Aged; Prospective Studies; Survival Rate	1995
[Intra-arterial infusion chemotherapy for advanced or recurrent breast cancers]. Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22 Suppl 1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Humans; Infusions, Intra-Arterial; Lymphatic Metastasis; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local; Remission Induction	1995
[The effect of combination treatment consisted of 5'-deoxy-5-fluorouridine and medroxyprogesterone acetate for recurrent breast cancer patient]. Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22, Issue:6 Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Drug Administration Schedule; Female; Floxuridine; Humans; Liver Neoplasms; Lung Neoplasms; Mastectomy, Radical; Medroxyprogesterone Acetate; Middle Aged; Soft Tissue Neoplasms	1995
Weekly doxorubicin with or without high-dose medroxyprogesterone acetate in hormone-resistant advanced breast cancer. A randomised study. The Norwegian Breast Cancer Group. European journal of cancer (Oxford, England : 1990), 1994, Volume: 30A, Issue:12 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Doxorubicin; Drug Administration Schedule; Drug Resistance; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis	1994
Comparison of chemotherapy with or without medroxyprogesterone acetate for advanced or recurrent breast cancer. European journal of cancer (Oxford, England : 1990), 1994, Volume: 30A, Issue:7 Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorouracil; Humans; Infusions, Intravenous; Leukocyte Count; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local; Platelet Count	1994
[2d and 3d line hormonal therapy in postmenopausal metastatic breast tumor. Comparison of medroxyprogesterone acetate and aminoglutethimide in tamoxifen-resistant patients]. La Clinica terapeutica, 1994, Volume: 145, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Aminoglutethimide; Breast Neoplasms; Drug Resistance; Female; Humans; Lymphatic Metastasis; Medroxyprogesterone Acetate; Menopause; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Tamoxifen; Time Factors	1994
Tamoxifen versus high-dose oral medroxyprogesterone acetate as initial endocrine therapy for patients with metastatic breast cancer: a Piedmont Oncology Association study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Volume: 12, Issue:8 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Drug Administration Schedule; Female; Humans; Liver Neoplasms; Medroxyprogesterone Acetate; Middle Aged; Prospective Studies; Regression Analysis; Soft Tissue Neoplasms; Survival Analysis; Tamoxifen	1994
[Chemo-endocrine therapy with high dose medroxyprogesterone acetate for recurrent or advanced breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:14 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Survival Rate	1993
Primary endocrine therapy for advanced breast cancer: to start with tamoxifen or with medroxyprogesterone acetate? Annals of oncology : official journal of the European Society for Medical Oncology, 1993, Volume: 4, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Survival Rate; Tamoxifen	1993
Pilot trial of a gonadotropin hormone agonist with replacement hormones as a prototype contraceptive to prevent breast cancer. Contraception, 1993, Volume: 47, Issue:5 Topics: Adult; Bone Density; Breast; Breast Neoplasms; Contraceptives, Oral, Combined; Delayed-Action Preparations; Drug Tolerance; Endometrium; Estrogens, Conjugated (USP); Female; Humans; Leuprolide; Lipids; Medroxyprogesterone Acetate; Menstruation; Pilot Projects	1993
A randomized trial of mitomycin-C (M) versus mitomycin-C plus high-dose medroxyprogesterone acetate (MMPA) in the treatment of patients with advanced breast cancer. American journal of clinical oncology, 1993, Volume: 16, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Mitomycin; Neoplasm Metastasis; Survival Analysis	1993
Second and third line hormonotherapy in advanced post-menopausal breast cancer: a multicenter randomized trial comparing medroxyprogesterone acetate with aminoglutethimide in patients who have become resistant to tamoxifen. Breast cancer research and treatment, 1992, Volume: 24, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Aminoglutethimide; Breast Neoplasms; Drug Resistance; Female; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Prospective Studies; Tamoxifen; Time Factors; Treatment Outcome	1992
Effects of chemoendocrine therapy on the coagulation-fibrinolytic systems in patients with advanced breast cancer. Japan Advanced Breast Cancer Study Group and Japan Clinical Oncology Group. Japanese journal of cancer research : Gann, 1993, Volume: 84, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Coagulation; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fibrinolysis; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Prospective Studies; Tamoxifen	1993
Adjuvant chemohormonal therapy with cyclophosphamide, doxorubicin and 5-fluorouracil (CAF) with or without medroxyprogesterone acetate for node-positive breast cancer patients. Annals of oncology : official journal of the European Society for Medical Oncology, 1993, Volume: 4, Issue:4 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Medroxyprogesterone Acetate; Middle Aged; Prospective Studies; Survival Rate	1993
Effects of medroxyprogesterone acetate therapy on advanced or recurrent breast cancer and its influences on blood coagulation and the fibrinolytic system. Surgery today, 1995, Volume: 25, Issue:8 Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Antithrombin III; Blood Coagulation; Breast Neoplasms; Chi-Square Distribution; Cyclophosphamide; Doxorubicin; Factor X; Female; Fibrinogen; Fibrinolysis; Fluorouracil; Humans; Japan; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local; Protein C; Remission Induction	1995
[Chemo-endocrine therapy including mitomycin C and medroxyprogesterone acetate in doxorubicin-refractory advanced breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:4 Topics: Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Doxorubicin; Drug Resistance, Neoplasm; Female; Humans; Medroxyprogesterone Acetate; Methotrexate; Middle Aged; Mitomycin; Prednisolone; Vincristine	1996
[Effectiveness of combination hormonal therapies in advanced or recurrent breast cancer--a randomized trial of tamoxifen (TAM), medroxyprogesterone acetate (MPA), their simultaneous combination, and an alternating sequential combination of TAM plus MPA]. Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:4 Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local; Tamoxifen	1996
[Administration method and recurrence-preventing effect of medroxyprogesterone acetate (MPA) as a postoperative adjuvant endocrine therapy for stage III breast cancer. Kitakyushu Collaborative Study Group for Breast Cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:9 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Drug Administration Schedule; Female; Fluorouracil; Humans; Hydrocortisone; Lymphatic Metastasis; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Staging; Postoperative Care; Tamoxifen	1996
A prospective randomized trial to evaluate different oral dose regimens of medroxyprogesterone acetate in women with advanced breast cancer. Clinical oncology (Royal College of Radiologists (Great Britain)), 1995, Volume: 7, Issue:4 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma; Carcinoma, Ductal, Breast; Drug Administration Schedule; Estrogen Antagonists; Female; Follow-Up Studies; Humans; Incidence; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local; Progesterone Congeners; Prospective Studies; Remission Induction; Survival Rate; Tamoxifen; Time Factors	1995
[A comparative study between low-dose and high-dose medroxyprogesterone acetate (MPA) in the treatment of advanced and recurrent breast cancer--in relation to dose, serum concentration and response. Osaka Breast Cancer Research Group]. Gan to kagaku ryoho. Cancer & chemotherapy, 1997, Volume: 24, Issue:7 Topics: Adult; Aged; Breast Neoplasms; Chromatography, High Pressure Liquid; Drug Administration Schedule; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies	1997
Medroxyprogesterone acetate addition or substitution for tamoxifen in advanced tamoxifen-resistant breast cancer: a phase III randomized trial. Australian-New Zealand Breast Cancer Trials Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:9 Topics: Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease Progression; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Proportional Hazards Models; Receptors, Progesterone; Risk; Tamoxifen; Treatment Failure; Treatment Outcome	1997
Predictive value of serum medroxyprogesterone acetate concentration for response in advanced or recurrent breast cancer. European journal of cancer (Oxford, England : 1990), 1997, Volume: 33, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Bone Neoplasms; Breast Neoplasms; Dose-Response Relationship, Drug; Female; Forecasting; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Neoplasm Metastasis; Prognosis; Receptors, Estrogen; Soft Tissue Neoplasms; Treatment Outcome	1997
[Effects of neoadjuvant intra-arterial infusion chemotherapy in patients with stage III breast carcinoma]. Gan to kagaku ryoho. Cancer & chemotherapy, 1997, Volume: 24, Issue:12 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Staging; Tamoxifen	1997
Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Postmenopausal Estrogen/Progestin Interventions (PEPI) Investigators. Annals of internal medicine, 1999, Feb-16, Volume: 130, Issue:4 Pt 1 Topics: Breast; Breast Neoplasms; Confounding Factors, Epidemiologic; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Longitudinal Studies; Mammography; Medroxyprogesterone Acetate; Middle Aged; Progesterone; Risk Factors; Surveys and Questionnaires	1999
A randomized controlled comparative study of oral medroxyprogesterone acetate 1,200 and 600 mg in patients with advanced or recurrent breast cancer. Oncology, 1999, Volume: 56, Issue:4 Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Drug Administration Schedule; Female; Humans; Hydrocortisone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local; Survival Analysis; Treatment Outcome	1999
Loco-regional recurrences after mastectomy in breast cancer: prognostic factors and implications for postoperative irradiation. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 1999, Volume: 50, Issue:3 Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; DNA, Neoplasm; Female; Flow Cytometry; Follow-Up Studies; Forecasting; Humans; Lymph Nodes; Lymphatic Metastasis; Mastectomy, Modified Radical; Medroxyprogesterone Acetate; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Neoplasm Staging; Ploidies; Prognosis; Proportional Hazards Models; Prospective Studies; Radiotherapy, Adjuvant; Risk Factors; S Phase; Thorax	1999
Maintenance treatment with medroxyprogesterone acetate in patients with advanced breast cancer responding to chemotherapy: results of a randomized trial. Essen Breast Cancer Study Group. Breast cancer research and treatment, 1999, Volume: 55, Issue:1 Topics: Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease-Free Survival; Epirubicin; Female; Germany; Humans; Ifosfamide; Medroxyprogesterone Acetate; Middle Aged; Prospective Studies; Quality of Life; Survival Analysis	1999
[Study on CAF + medroxyprogesterone acetate (MPA) therapy for advanced or recurrent breast cancer--comparison between MPA 600 mg and 1,200 mg. Kyushu CAFT Therapy Study Group (Third Study)]. Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:13 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Humans; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local; Survival Rate	1999
5'-deoxy-5-fluorouridine, medroxyprogestrone acetate and mitoxantrone hydrochloride for advanced or recurrent breast cancer. Breast cancer (Tokyo, Japan), 2001, Volume: 8, Issue:1 Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Evaluation; Drug Resistance, Neoplasm; Female; Floxuridine; Humans; Medroxyprogesterone Acetate; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Salvage Therapy; Time Factors	2001
Adjuvant high-dose medroxyprogesterone acetate for early breast cancer: 13 years update in a multicentre randomized trial. British journal of cancer, 2001, Jul-06, Volume: 85, Issue:1 Topics: Age Factors; Analysis of Variance; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Fluorouracil; Follow-Up Studies; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Methotrexate; Middle Aged; Neoplasm Staging; Survival Rate; Treatment Outcome	2001
[The efficacy of combination chemotherapy of 5'-deoxy-5-fluorouridine (5'-DFUR), cyclophosphamide (CPA) and medroxyprogesterone acetate (MPA) for bone metastasis in breast cancer patients]. Gan to kagaku ryoho. Cancer & chemotherapy, 2001, Volume: 28, Issue:7 Topics: Adult; Antineoplastic Agents, Hormonal; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Drug Administration Schedule; Female; Floxuridine; Humans; Medroxyprogesterone Acetate; Middle Aged; Pain, Intractable; Palliative Care; Quality of Life	2001
Reversal of gonadotropin-releasing hormone agonist induced reductions in mammographic densities on stopping treatment. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2001, Volume: 10, Issue:11 Topics: Adult; Antineoplastic Agents, Hormonal; Breast Neoplasms; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Mammography; Medroxyprogesterone Acetate; Premenopause	2001
Incidence of breast cancer in a 22-year study of women receiving estrogen-progestin replacement therapy. Obstetrics and gynecology, 1992, Volume: 80, Issue:5 Topics: Adult; Aged; Breast Neoplasms; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Humans; Incidence; Life Tables; Matched-Pair Analysis; Medroxyprogesterone Acetate; Middle Aged; Prospective Studies; Time Factors	1992
Tamoxifen metabolism is altered by simultaneous administration of medroxyprogesterone acetate in breast cancer patients. Breast cancer research and treatment, 1992, Volume: 22, Issue:2 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Interactions; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Tamoxifen	1992
Mitomycin C + high-dose medroxyprogesterone versus cyclophosphamide+doxorubicin plus fluorouracil as first-line treatment for metastatic breast cancer. Oncology, 1992, Volume: 49, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Medroxyprogesterone Acetate; Middle Aged; Mitomycin; Neoplasm Metastasis; Pilot Projects	1992
Chemotherapy with or without high-dose medroxyprogesterone acetate in oestrogen-receptor-negative advanced breast cancer. Norwegian Breast Cancer Group. European journal of cancer (Oxford, England : 1990), 1992, Volume: 28, Issue:2-3 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Mitomycins; Neoplasm Metastasis; Neoplasm Proteins; Receptors, Estrogen; Vincristine	1992
Breast cancer and depot-medroxyprogesterone acetate: a multinational study. WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Lancet (London, England), 1991, Oct-05, Volume: 338, Issue:8771 Topics: Abortion, Induced; Abortion, Spontaneous; Adult; Age Factors; Breast Neoplasms; Contraceptive Agents, Female; Female; Humans; International Cooperation; Maternal Age; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Parity; Pregnancy; Pregnancy, High-Risk; Risk Factors; Single Parent; Socioeconomic Factors; World Health Organization	1991
High-dose medroxyprogesterone acetate versus oophorectomy as first-line therapy of advanced breast cancer in premenopausal patients. Oncology, 1991, Volume: 48, Issue:1 Topics: Adult; Antineoplastic Agents; Breast Neoplasms; Combined Modality Therapy; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Ovariectomy; Prospective Studies; Random Allocation; Survival Rate	1991
[A controlled study with medroxyprogesterone acetate (MPA) alone or in combination with cyclophosphamide (CPA) in the treatment of advanced or recurrent breast cancer unresponsive to other therapies. Osaka Study Group for the Treatment of Breast Cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1991, Volume: 18, Issue:6 Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies	1991
Alternating sequential endocrine therapy: tamoxifen and medroxyprogesterone acetate versus tamoxifen in postmenopausal advanced breast cancer patients. Annals of oncology : official journal of the European Society for Medical Oncology, 1991, Volume: 2, Issue:7 Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Remission Induction; Tamoxifen	1991
Improved bioavailability of a new oral preparation of medroxyprogesterone acetate. Journal of pharmaceutical sciences, 1991, Volume: 80, Issue:12 Topics: Administration, Oral; Adult; Aged; Analysis of Variance; Antineoplastic Agents; Biological Availability; Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Uterine Neoplasms	1991
Sequential alternate administration of tamoxifen and medroxyprogesterone acetate in advanced breast cancer: clinical-biological randomized study. Tumori, 1990, Apr-30, Volume: 76, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chromatography, High Pressure Liquid; Drug Administration Schedule; Estrogens; Female; Fluorometry; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasms, Hormone-Dependent; Progesterone; Randomized Controlled Trials as Topic; Tamoxifen	1990
A randomized comparison of megestrol acetate (MA) and medroxyprogesterone acetate (MPA) in patients with advanced breast cancer. European journal of cancer (Oxford, England : 1990), 1990, Volume: 26, Issue:3 Topics: Aged; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Middle Aged; Randomized Controlled Trials as Topic	1990
Adrenal steroids as parameters of the bioavailability of MA and MPA. European journal of cancer (Oxford, England : 1990), 1990, Volume: 26, Issue:3 Topics: Adrenal Cortex Hormones; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Biological Availability; Breast Neoplasms; Dehydroepiandrosterone; Estradiol; Estrone; Female; Humans; Hydrocortisone; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate	1990
Influence of progestins on serum hormone levels in postmenopausal women with advanced breast cancer--II. A differential effect of megestrol acetate and medroxyprogesterone acetate on serum estrone sulfate and sex hormone binding globulin. Journal of steroid biochemistry, 1990, Volume: 36, Issue:1-2 Topics: Aged; Aged, 80 and over; Breast Neoplasms; Estradiol; Estrone; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Middle Aged; Sex Hormone-Binding Globulin	1990
Treatment of carcinoma of the breast with high dose oral medroxyprogesterone acetate: does increased bioavailability improve the therapeutic ratio? Clinical oncology (Royal College of Radiologists (Great Britain)), 1990, Volume: 2, Issue:6 Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Biological Availability; Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Pilot Projects	1990
The induction of a hypercoagulable state by medroxyprogesterone acetate in breast cancer patients. The Japanese journal of surgery, 1990, Volume: 20, Issue:6 Topics: Antineoplastic Agents; Blood Coagulation Disorders; Breast Neoplasms; Combined Modality Therapy; Female; Humans; Mastectomy, Radical; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Retrospective Studies; Tamoxifen	1990
Cyclical use of tamoxifen and high-dose medroxyprogesterone acetate in advanced estrogen receptor positive breast cancer. Breast cancer research and treatment, 1990, Volume: 17, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Norway; Prospective Studies; Receptors, Estrogen; Receptors, Progesterone; Survival Rate; Tamoxifen; Up-Regulation	1990
Adjuvant treatment with high dose medroxyprogesterone acetate in node-negative early breast cancer. A 3-year interim report on a randomized trial (I). Acta oncologica (Stockholm, Sweden), 1989, Volume: 28, Issue:2 Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Multicenter Studies as Topic; Random Allocation	1989
Cyclic and sequential therapy with tamoxifen and medroxyprogesterone acetate in metastatic breast cancer. Journal of surgical oncology, 1989, Volume: 41, Issue:4 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Drug Administration Schedule; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Receptors, Progesterone; Tamoxifen	1989
How to improve adjuvant treatment results in postmenopausal patients. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1989, Volume: 115 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Diphosphonates; Drug Therapy, Combination; Female; Fluorouracil; Follow-Up Studies; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Meta-Analysis as Topic; Methotrexate; Middle Aged; Prednisone; Randomized Controlled Trials as Topic; Retrospective Studies; Survival Rate; Tamoxifen; Vincristine	1989
Protective effect of high-dose medroxyprogesterone acetate (HD-MPA) on hematological toxicity induced by chemotherapy for advanced solid tumors: a multicentric controlled clinical trial. MPA-Hematology Italian Cooperative Group. Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1986, Volume: 5, Issue:2 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood Coagulation Tests; Bone Marrow; Breast Neoplasms; Clinical Trials as Topic; Colonic Neoplasms; Female; Humans; Leukopenia; Lung Neoplasms; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasms; Random Allocation; Rectal Neoplasms; Thrombocytopenia; Time Factors	1986
A phase III trial of oral high-dose medroxyprogesterone acetate (MPA) versus mepitiostane in advanced postmenopausal breast cancer. Cancer, 1985, Dec-01, Volume: 56, Issue:11 Topics: Adult; Androstanols; Breast Neoplasms; Clinical Trials as Topic; Double-Blind Method; Estrogen Antagonists; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Ovariectomy; Random Allocation	1985
Oral high-dose medroxyprogesterone acetate versus tamoxifen. A randomized crossover trial in postmenopausal patients with advanced breast cancer. Cancer, 1986, Jul-01, Volume: 58, Issue:1 Topics: Aged; Breast Neoplasms; Clinical Trials as Topic; Drug Administration Schedule; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Random Allocation; Tamoxifen	1986
MPA at high doses in advanced breast cancer: a statistical evaluation. Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1986, Volume: 5, Issue:3 Topics: Administration, Oral; Biological Availability; Breast Neoplasms; Clinical Trials as Topic; Computers; Female; Humans; Injections, Intramuscular; Kinetics; Medroxyprogesterone; Medroxyprogesterone Acetate; Retrospective Studies; Statistics as Topic	1986
[Hormonotherapy of metastatic breast cancer with tamoxifen and medroxyprogesterone acetate. Randomized trial comparing alternating sequences with successive applications]. Bulletin du cancer, 1986, Volume: 73, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Random Allocation; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen	1986
Medroxyprogesterone acetate and prednisone in advanced breast cancer. A randomized trial. European journal of cancer & clinical oncology, 1986, Volume: 22, Issue:9 Topics: Administration, Oral; Adult; Aged; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Injections, Intramuscular; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Prednisone; Random Allocation	1986
Tamoxifen therapy of metastatic breast cancer. The Journal of laboratory and clinical medicine, 1987, Volume: 109, Issue:3 Topics: Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Clinical Trials as Topic; Female; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Neoplasm Metastasis; Random Allocation; Tamoxifen	1987
Prospective randomized trial concerning hyper- and normoprolactinemia and the use of bromoergocryptine in patients with metastatic breast cancer. Onkologie, 1986, Volume: 9, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bromocriptine; Cyclophosphamide; Dactinomycin; Female; Fluorouracil; Humans; Hyperprolactinemia; Medroxyprogesterone; Medroxyprogesterone Acetate; Methotrexate; Middle Aged; Neoplasm Metastasis; Prognosis; Prolactin; Vincristine	1986
[Megestrol acetate versus medroxyprogesterone acetate in the treatment of metastasizing breast cancers. Intermediate report of a multicenter phase III study]. Onkologie, 1987, Volume: 10, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Female; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Random Allocation	1987
Medroxyprogesterone acetate and lipid metabolic changes. Arzneimittel-Forschung, 1987, Volume: 37, Issue:5 Topics: Adult; Aged; Apolipoprotein A-I; Apolipoproteins A; Apolipoproteins B; Breast Neoplasms; Cholesterol; Endometriosis; Female; Humans; Lipid Metabolism; Lipids; Lipoproteins; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Triglycerides; Uterine Neoplasms	1987
Medroxyprogesterone acetate: variation in serum concentrations achieved with three commercially available preparations. Cancer treatment reports, 1987, Volume: 71, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Kinetics; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Random Allocation	1987
[Aminoglutethimide plus high-dose medroxyprogesterone acetate versus aminoglutethimide plus cortisone in therapy of metastasizing breast cancer. An AIO phase III study]. Onkologie, 1987, Volume: 10, Issue:5 Topics: Aminoglutethimide; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cortisone; Drug Therapy, Combination; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasm Metastasis; Random Allocation	1987
High dose versus low dose medroxyprogesterone acetate: a randomized trial in advanced breast cancer. European journal of cancer & clinical oncology, 1987, Volume: 23, Issue:12 Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Random Allocation	1987
Myeloprotective effect of high dose medroxyprogesterone acetate (MPA). Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1988, Volume: 7, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; In Vitro Techniques; Medroxyprogesterone; Medroxyprogesterone Acetate; Random Allocation; Stem Cells	1988
Adjuvant therapy for operable breast cancer with medroxyprogesterone acetate alone in postmenopausal patients or in combination with CMF in premenopausal patients. European journal of cancer & clinical oncology, 1988, Volume: 24, Issue:3 Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Methotrexate; Middle Aged; Prospective Studies; Recurrence	1988
High-dose medroxyprogesterone acetate plus mitomycin-C or vindesine in the treatment of advanced breast cancer. American journal of clinical oncology, 1988, Volume: 11, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Mitomycin; Mitomycins; Random Allocation; Vindesine	1988
Randomized trial comparing aminoglutethimide with high-dose medroxyprogesterone acetate in therapy for advanced breast carcinoma. Journal of the National Cancer Institute, 1988, Sep-21, Volume: 80, Issue:14 Topics: Aminoglutethimide; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Random Allocation; Tamoxifen; Time Factors	1988
Weekly low-dose doxorubicin with or without high-dose medroxyprogesterone acetate as secondary treatment in metastatic breast cancer--a randomized trial. Acta oncologica (Stockholm, Sweden), 1988, Volume: 27, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Doxorubicin; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Random Allocation	1988
[Results of the treatment of patients with advanced breast with large doses of medroxyprogesterone acetate]. Polski tygodnik lekarski (Warsaw, Poland : 1960), 1988, May-30, Volume: 43, Issue:22 Topics: Aged; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Injections, Intramuscular; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Staging; Remission Induction	1988
[Clinical investigation of oral high-dose medroxyprogesterone acetate (MPA) in advanced breast cancer--double-blind controlled study: Japanese Group for MPA Treatment of Breast Cancer]. Gan no rinsho. Japan journal of cancer clinics, 1985, Volume: 31, Issue:5 Topics: Administration, Oral; Adult; Androstanols; Antineoplastic Agents; Breast Neoplasms; Capsules; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged	1985

Other Studies

413 other study(ies) available for medroxyprogesterone acetate and Breast Neoplasms

Article	Year
5-Aryl-1,2,3,4-tetrahydrochromeno[3,4-f]quinolin-3-ones as a novel class of nonsteroidal progesterone receptor agonists: effect of A-ring modification. Journal of medicinal chemistry, 1999, Apr-22, Volume: 42, Issue:8 Topics: Animals; Binding, Competitive; Breast Neoplasms; Cell Line; Chlorocebus aethiops; Humans; Ligands; Quinolones; Receptors, Progesterone; Structure-Activity Relationship; Tumor Cells, Cultured	1999
Novel 6-aryl-1,4-dihydrobenzo[d]oxazine-2-thiones as potent, selective, and orally active nonsteroidal progesterone receptor agonists. Bioorganic & medicinal chemistry letters, 2003, Apr-07, Volume: 13, Issue:7 Topics: Alkaline Phosphatase; Animals; Breast Neoplasms; Cross Reactions; Decidua; Female; Humans; Medroxyprogesterone Acetate; Ovariectomy; Oxazines; Rats; Receptors, Androgen; Receptors, Glucocorticoid; Receptors, Progesterone; Structure-Activity Relationship; Thiones	2003
Novel 5-aryl-1,3-dihydro-indole-2-thiones. potent, orally active progesterone receptor agonists. Bioorganic & medicinal chemistry letters, 2003, Apr-07, Volume: 13, Issue:7 Topics: Alkaline Phosphatase; Animals; Binding, Competitive; Breast Neoplasms; Decidua; Drug Design; Female; Humans; Indicators and Reagents; Indoles; Medroxyprogesterone Acetate; Ovariectomy; Rats; Receptors, Progesterone; Structure-Activity Relationship; Thiones; Tumor Cells, Cultured	2003
5-benzylidene-1,2-dihydrochromeno[3,4-f]quinolines as selective progesterone receptor modulators. Journal of medicinal chemistry, 2003, Sep-11, Volume: 46, Issue:19 Topics: Androgen Receptor Antagonists; Animals; Benzylidene Compounds; Binding, Competitive; Breast Neoplasms; Cell Division; Cells, Cultured; Chlorocebus aethiops; Epithelial Cells; Estrone; Female; Humans; Mammary Glands, Animal; Medroxyprogesterone Acetate; Progesterone; Progesterone Congeners; Quinolines; Rats; Receptors, Androgen; Receptors, Glucocorticoid; Receptors, Progesterone; Structure-Activity Relationship; Uterus; Vagina	2003
Upregulation of an estrogen receptor-regulated gene by first generation progestins requires both the progesterone receptor and estrogen receptor alpha. Frontiers in endocrinology, 2022, Volume: 13 Topics: Breast Neoplasms; Cathepsin D; Estradiol; Estrogen Receptor alpha; Female; Humans; Medroxyprogesterone Acetate; Norethindrone; Progesterone; Progesterone Congeners; Progestins; Receptors, Estrogen; Receptors, Progesterone; Up-Regulation	2022
Identification of Candidate Genes in Breast Cancer Induced by Estrogen Plus Progestogens Using Bioinformatic Analysis. International journal of molecular sciences, 2022, Oct-06, Volume: 23, Issue:19 Topics: Breast Neoplasms; Computational Biology; Estradiol; Estrogen Receptor Antagonists; Estrogen Replacement Therapy; Estrogens; Female; Humans; Medroxyprogesterone Acetate; Menopause; Molecular Docking Simulation; Progesterone; Progestins; Proto-Oncogene Proteins p21(ras); Receptors, Estrogen; Transcription Factors	2022
Retrospective study on the effectiveness of medroxyprogesterone acetate in the treatment of ER-positive/HER2-negative post-menopausal advanced breast cancer: an additional analysis of the JBCRG-C06 Safari study. Japanese journal of clinical oncology, 2023, Mar-07, Volume: 53, Issue:3 Topics: Breast Neoplasms; Cohort Studies; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Postmenopause; Retrospective Studies	2023
Progesterone receptor isoform ratios influence the transcriptional activity of progestins via the progesterone receptor. The Journal of steroid biochemistry and molecular biology, 2023, Volume: 232 Topics: Breast Neoplasms; Female; Humans; Medroxyprogesterone Acetate; Progesterone; Progestins; Receptors, Progesterone	2023
Depomedroxyprogesterone acetate therapy for hot flashes in survivors of breast cancer: no unfavorable impact on recurrence and survival. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2020, Volume: 28, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Cancer Survivors; Case-Control Studies; Cohort Studies; Contraceptive Agents, Hormonal; Disease-Free Survival; Female; Hot Flashes; Humans; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local; Progression-Free Survival; Retrospective Studies	2020
Anti-proliferative transcriptional effects of medroxyprogesterone acetate in estrogen receptor positive breast cancer cells are predominantly mediated by the progesterone receptor. The Journal of steroid biochemistry and molecular biology, 2020, Volume: 199 Topics: Androgens; Breast Neoplasms; Cell Proliferation; Dexamethasone; Dihydrotestosterone; Estrogen Receptor alpha; Female; Gene Expression Regulation, Neoplastic; Humans; Medroxyprogesterone Acetate; Progesterone; Receptors, Androgen; Receptors, Progesterone; Transcriptome; Tumor Cells, Cultured	2020
Forty-year trends in menopausal hormone therapy use and breast cancer incidence among postmenopausal black and white women. Cancer, 2020, 07-01, Volume: 126, Issue:13 Topics: Aged; Black or African American; Breast Neoplasms; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Incidence; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; SEER Program; Time Factors; United States; White People; Women's Health	2020
Highlights of the San Antonio Breast Cancer Symposium 2019 Part 1: the challenges of tumor heterogeneity. Future oncology (London, England), 2020, Volume: 16, Issue:21 Topics: Breast Neoplasms; Early Detection of Cancer; Estrogens, Conjugated (USP); Female; Humans; Image-Guided Biopsy; Magnetic Resonance Imaging; Mammography; Medroxyprogesterone Acetate; Neoplasm, Residual; Postmenopause; Radiotherapy; Tumor Microenvironment	2020
Hormone-Independent Mouse Mammary Adenocarcinomas with Different Metastatic Potential Exhibit Different Metabolic Signatures. Biomolecules, 2020, 08-27, Volume: 10, Issue:9 Topics: Adenocarcinoma; Animals; Biomarkers, Tumor; Breast Neoplasms; Cell Line, Tumor; Citric Acid Cycle; Female; Glucose; Glycolysis; Humans; Lipid Metabolism; Magnetic Resonance Spectroscopy; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Metabolome; Mice; Mice, Inbred BALB C; Neoplasm Metastasis; Neoplasms, Hormone-Dependent	2020
COX-2 promotes mammary adipose tissue inflammation, local estrogen biosynthesis, and carcinogenesis in high-sugar/fat diet treated mice. Cancer letters, 2021, 04-01, Volume: 502 Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Aromatase; Breast Neoplasms; Cell Line, Tumor; Chemokine CCL2; Cyclooxygenase 2; Diet, High-Fat; Dinoprostone; Disease Models, Animal; Etoricoxib; Female; Gene Expression Regulation, Neoplastic; Humans; Interleukin-6; MCF-7 Cells; Medroxyprogesterone Acetate; Mice; Sugars; Up-Regulation	2021
MPA/DMBA-driven mammary carcinomas. Methods in cell biology, 2021, Volume: 163 Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Breast Neoplasms; Carcinoma; Female; Humans; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Mice; Mice, Inbred C57BL	2021
The angiotensin receptor blocker, Losartan, inhibits mammary tumor development and progression to invasive carcinoma. Oncotarget, 2017, Mar-21, Volume: 8, Issue:12 Topics: 9,10-Dimethyl-1,2-benzanthracene; Angiotensin II Type 1 Receptor Blockers; Animals; Biopsy; Breast Neoplasms; Carcinogenesis; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Cell Proliferation; Disease Progression; Female; Humans; Immunohistochemistry; Interleukin-6; Losartan; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Mice; Neoplasm Invasiveness; Phosphorylation; Real-Time Polymerase Chain Reaction; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Signal Transduction; STAT3 Transcription Factor; Tumor Burden; Tumor Necrosis Factor-alpha; Up-Regulation	2017
Menopausal hormone therapy for primary prevention: why the USPSTF is wrong. Climacteric : the journal of the International Menopause Society, 2017, Volume: 20, Issue:5 Topics: Breast Neoplasms; Cardiovascular Diseases; Chronic Disease; Coronary Disease; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Postmenopause; Primary Prevention; Risk Factors; Time Factors; United States; Women's Health	2017
Estrogen metabolism in menopausal hormone users in the women's health initiative observational study: Does it differ between estrogen plus progestin and estrogen alone? International journal of cancer, 2019, 02-15, Volume: 144, Issue:4 Topics: Aged; Breast Neoplasms; Case-Control Studies; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Progestins; Risk Factors; Treatment Outcome	2019
Overexpression of progesterone receptor membrane component 1: possible mechanism for increased breast cancer risk with norethisterone in hormone therapy. Menopause (New York, N.Y.), 2013, Volume: 20, Issue:5 Topics: Animals; Breast Neoplasms; Cell Proliferation; Contraceptives, Oral, Synthetic; Drug Therapy, Combination; Estradiol; Estrogens; Female; Gene Expression; Humans; MCF-7 Cells; Medroxyprogesterone Acetate; Membrane Proteins; Mice; Mice, Nude; Norethindrone; Receptors, Progesterone; Transfection; Tumor Burden	2013
Progestin as an alternative treatment option for multi-treated recurrent triple-negative breast cancer. Swiss medical weekly, 2013, Volume: 143 Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease-Free Survival; Female; Humans; Kaplan-Meier Estimate; Medroxyprogesterone Acetate; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Retrospective Studies; Salvage Therapy; Treatment Outcome	2013
Medroxyprogesterone acetate-driven increase in breast cancer risk might be mediated via cross-talk with growth factors in the presence of progesterone receptor membrane component-1. Maturitas, 2013, Volume: 76, Issue:2 Topics: Breast Neoplasms; Cell Proliferation; Female; Formazans; Humans; Intercellular Signaling Peptides and Proteins; MCF-7 Cells; Medroxyprogesterone Acetate; Membrane Proteins; Norethindrone; Progesterone; Receptor Cross-Talk; Receptors, Progesterone; Tetrazolium Salts	2013
Assessment of mammographic density in postmenopausal women during long term hormone replacement therapy. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2013, Volume: 29, Issue:12 Topics: Adult; Body Mass Index; Breast Density; Breast Neoplasms; Estradiol; Estrogen Replacement Therapy; Female; Humans; Mammary Glands, Human; Mammography; Medroxyprogesterone Acetate; Middle Aged; Parity; Postmenopause; Time Factors	2013
Effects of estradiol and progestogens on human breast cells: regulation of sex steroid receptors. Taiwanese journal of obstetrics & gynecology, 2013, Volume: 52, Issue:3 Topics: Apoptosis; Breast Neoplasms; Caspase 3; Cell Proliferation; Cell Transformation, Neoplastic; Cyproterone Acetate; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Female; Humans; MCF-7 Cells; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Progesterone; Progestins; Receptors, Progesterone	2013
The Women's Health Initiative--a victory for women and their health. JAMA, 2013, Oct-02, Volume: 310, Issue:13 Topics: Breast Neoplasms; Coronary Disease; Estrogens; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate	2013
Expansion of CD11b(+)Ly6G (+)Ly6C (int) cells driven by medroxyprogesterone acetate in mice bearing breast tumors restrains NK cell effector functions. Cancer immunology, immunotherapy : CII, 2013, Volume: 62, Issue:12 Topics: Animals; Antigens, Ly; Antineoplastic Agents, Hormonal; Blotting, Western; Breast Neoplasms; CD11b Antigen; Cell Differentiation; Cell Proliferation; Cytotoxicity, Immunologic; Female; Flow Cytometry; Fluorescent Antibody Technique; Humans; Killer Cells, Natural; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Myeloid Cells; Receptors, Glucocorticoid; STAT3 Transcription Factor; Tumor Cells, Cultured	2013
Effects of dietary apigenin on tumor latency, incidence and multiplicity in a medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced breast cancer model. Nutrition and cancer, 2013, Volume: 65, Issue:8 Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Apigenin; Breast Neoplasms; Dietary Supplements; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Hormone Replacement Therapy; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Postmenopause; Rats; Rats, Sprague-Dawley	2013
Reproductive endocrinology: Hormone therapy to treat menopause--breaking a taboo. Nature reviews. Endocrinology, 2014, Volume: 10, Issue:1 Topics: Breast Neoplasms; Coronary Disease; Estrogens; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate	2014
Progesterone receptor assembly of a transcriptional complex along with activator protein 1, signal transducer and activator of transcription 3 and ErbB-2 governs breast cancer growth and predicts response to endocrine therapy. Breast cancer research : BCR, 2013, Dec-17, Volume: 15, Issue:6 Topics: Animals; Breast Neoplasms; Cell Nucleus; Cyclin D1; Female; Follow-Up Studies; Humans; Medroxyprogesterone Acetate; Mice, Inbred BALB C; Phosphorylation; Promoter Regions, Genetic; Receptor, ErbB-2; Receptors, Progesterone; Retrospective Studies; Selective Estrogen Receptor Modulators; STAT3 Transcription Factor; Tamoxifen; Transcription Factor AP-1; Treatment Outcome	2013
What if the Women's Health Initiative had used transdermal estradiol and oral progesterone instead? Menopause (New York, N.Y.), 2014, Volume: 21, Issue:7 Topics: Administration, Cutaneous; Administration, Oral; Adult; Breast Neoplasms; Cardiovascular Diseases; Dose-Response Relationship, Drug; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Progesterone; Randomized Controlled Trials as Topic; Risk Assessment; Venous Thromboembolism; Women's Health	2014
Menopausal hormone therapy has risks and benefits during the intervention and poststopping phase. Evidence-based medicine, 2014, Volume: 19, Issue:3 Topics: Breast Neoplasms; Coronary Disease; Estrogens; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate	2014
Selective AKR1C3 inhibitors do not recapitulate the anti-leukaemic activities of the pan-AKR1C inhibitor medroxyprogesterone acetate. British journal of cancer, 2014, Mar-18, Volume: 110, Issue:6 Topics: 3-Hydroxysteroid Dehydrogenases; Aldo-Keto Reductase Family 1 Member C3; Breast Neoplasms; Drug Interactions; Enzyme Inhibitors; Female; Humans; Hydroxyprostaglandin Dehydrogenases; Leukemia; Male; Mass Spectrometry; Medroxyprogesterone Acetate; Prostatic Neoplasms; Substrate Specificity	2014
Menopausal hormone therapy and prevention of chronic diseases: IMS members react to the recent JAMA paper. Climacteric : the journal of the International Menopause Society, 2014, Volume: 17, Issue:1 Topics: Breast Neoplasms; Coronary Disease; Estrogens; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate	2014
Fatal breast cancer risk in relation to use of unopposed estrogen and combined hormone therapy. Breast cancer research and treatment, 2014, Volume: 145, Issue:2 Topics: Adult; Aged; Breast Neoplasms; Case-Control Studies; Confidence Intervals; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Odds Ratio; Risk Factors; Saskatchewan	2014
Raman and coherent anti-Stokes Raman scattering microscopy studies of changes in lipid content and composition in hormone-treated breast and prostate cancer cells. Journal of biomedical optics, 2014, Volume: 19, Issue:11 Topics: Breast Neoplasms; Cell Line, Tumor; Female; Humans; Lipid Droplets; Lipids; Male; Medroxyprogesterone Acetate; Metribolone; Microscopy; Molecular Imaging; Prostatic Neoplasms; Spectrum Analysis, Raman	2014
MTDH-SND1 interaction is crucial for expansion and activity of tumor-initiating cells in diverse oncogene- and carcinogen-induced mammary tumors. Cancer cell, 2014, Jul-14, Volume: 26, Issue:1 Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Breast Neoplasms; Cell Adhesion Molecules; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Cell Transformation, Viral; Endonucleases; Female; Gene Expression Regulation, Neoplastic; Genetic Predisposition to Disease; HEK293 Cells; Humans; Mammary Glands, Animal; Mammary Tumor Virus, Mouse; Medroxyprogesterone Acetate; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Neoplasm Invasiveness; Neoplastic Stem Cells; Nuclear Proteins; Phenotype; Protein Binding; RNA Interference; RNA-Binding Proteins; Time Factors; Transfection; Tumor Cells, Cultured	2014
Molecular modulation of estrogen-induced apoptosis by synthetic progestins in hormone replacement therapy: an insight into the women's health initiative study. Cancer research, 2014, Dec-01, Volume: 74, Issue:23 Topics: Apoptosis; Breast Neoplasms; Dexamethasone; Estrogens; Female; Glucocorticoids; Hormone Replacement Therapy; Humans; MCF-7 Cells; Medroxyprogesterone Acetate; Mifepristone; Norethindrone; Norethindrone Acetate; Postmenopause; Progesterone Congeners; Receptors, Estrogen; Receptors, Glucocorticoid; Risk; Women's Health	2014
Commentary on "menopausal hormone treatment in postmenopausal women: risks and benefits". Southern medical journal, 2014, Volume: 107, Issue:11 Topics: Breast Neoplasms; Coronary Disease; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Progesterone Congeners	2014
Women's Health Initiative estrogen plus progestin clinical trial: a study that does not allow establishing relevant clinical risks. Menopause (New York, N.Y.), 2015, Volume: 22, Issue:12 Topics: Breast Neoplasms; Colorectal Neoplasms; Coronary Disease; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Hip Fractures; Humans; Medroxyprogesterone Acetate; Monte Carlo Method; Placebos; Proportional Hazards Models; Pulmonary Embolism; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Survival Rate; Women's Health	2015
Progesterone Exposure and Breast Cancer Risk: Understanding the Biological Roots. JAMA oncology, 2015, Volume: 1, Issue:3 Topics: Breast Neoplasms; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate	2015
Progesterone and Synthetic Progestin Controversies. JAMA oncology, 2015, Volume: 1, Issue:7 Topics: Breast Neoplasms; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate	2015
Progesterone and Synthetic Progestin Controversies. JAMA oncology, 2015, Volume: 1, Issue:7 Topics: Breast Neoplasms; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate	2015
Progesterone and Synthetic Progestin Controversies--Reply. JAMA oncology, 2015, Volume: 1, Issue:7 Topics: Breast Neoplasms; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate	2015
[Medroxyprogesterone Acetate as Part of Palliative Care for Terminal-Stage Breast Cancer Patients--A Report of Two Cases]. Gan to kagaku ryoho. Cancer & chemotherapy, 2016, Volume: 43, Issue:3 Topics: Aged; Antineoplastic Agents, Hormonal; Breast Neoplasms; Fatal Outcome; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Palliative Care; Terminally Ill	2016
Antiproliferative actions of the synthetic androgen, mibolerone, in breast cancer cells are mediated by both androgen and progesterone receptors. The Journal of steroid biochemistry and molecular biology, 2008, Volume: 110, Issue:3-5 Topics: Androgens; Breast Neoplasms; Cell Proliferation; Dihydrotestosterone; Drug Evaluation, Preclinical; Estradiol; Humans; Medroxyprogesterone Acetate; Nandrolone; Progestins; Receptors, Androgen; Receptors, Progesterone; Testosterone Congeners; Tumor Cells, Cultured	2008
Comparative actions of progesterone, medroxyprogesterone acetate, drospirenone and nestorone on breast cancer cell migration and invasion. BMC cancer, 2008, Jun-09, Volume: 8 Topics: Actins; Androstenes; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cytoskeleton; Estradiol; Humans; Medroxyprogesterone Acetate; Microfilament Proteins; Neoplasm Invasiveness; Norprogesterones; Progesterone; Signal Transduction	2008
Extra-nuclear signaling of progesterone receptor to breast cancer cell movement and invasion through the actin cytoskeleton. PloS one, 2008, Jul-30, Volume: 3, Issue:7 Topics: Actins; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cytoskeleton; Disease Progression; Humans; Medroxyprogesterone Acetate; Microfilament Proteins; Neoplasm Invasiveness; Progesterone; Receptors, Progesterone; rho-Associated Kinases; rhoA GTP-Binding Protein; Signal Transduction	2008
Temporal trends in the use of adjuvant systemic therapy in breast cancer: a population based study in Sweden 1976-2005. Acta oncologica (Stockholm, Sweden), 2009, Volume: 48, Issue:1 Topics: Adult; Age Factors; Aged; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Goserelin; Humans; Medroxyprogesterone Acetate; Megestrol Acetate; Middle Aged; Ovariectomy; Sweden; Tamoxifen	2009
Re: "Conjugated equine estrogens and breast cancer risk in the Women's Health Initiative clinical trial and observational study". American journal of epidemiology, 2008, Nov-15, Volume: 168, Issue:10 Topics: Breast Neoplasms; Contraceptive Agents, Female; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Risk Assessment	2008
Effects of estradiol and progestogens on tumor-necrosis factor-alpha-induced changes of biochemical markers for breast cancer growth and metastasis. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2008, Volume: 24, Issue:10 Topics: Biomarkers; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Chemokine CCL2; Dose-Response Relationship, Drug; Estradiol; Female; Humans; Matrix Metalloproteinase 9; Medroxyprogesterone Acetate; Neoplasm Metastasis; Progestins; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A	2008
[Doxifluridine, medroxyprogesterone acetate and cyclophosphamide (DMpC) combination therapy is effective against recurrent triple negative breast cancer--a case report]. Gan to kagaku ryoho. Cancer & chemotherapy, 2008, Volume: 35, Issue:13 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Female; Floxuridine; Humans; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Tomography, X-Ray Computed	2008
Re: Estrogen plus progestin therapy and breast cancer in recently postmenopausal women. American journal of epidemiology, 2009, Mar-15, Volume: 169, Issue:6 Topics: Aged; Breast Neoplasms; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Invasiveness; Postmenopause; Randomized Controlled Trials as Topic; Risk; Time Factors	2009
Clinical-translational strategies for the elevation of Nm23-H1 metastasis suppressor gene expression. Molecular and cellular biochemistry, 2009, Volume: 329, Issue:1-2 Topics: Animals; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Line, Tumor; Clinical Trials as Topic; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Humans; Medroxyprogesterone Acetate; Mice; NM23 Nucleoside Diphosphate Kinases; Receptors, Glucocorticoid; Time Factors; Treatment Outcome	2009
[A case of stage IV breast cancer with large cancer ulcer responding to combination therapy of capecitabine and medroxyprogesterone acetate and cyclophosphamide]. Gan to kagaku ryoho. Cancer & chemotherapy, 2009, Volume: 36, Issue:9 Topics: Adenocarcinoma, Scirrhous; Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Cyclophosphamide; Deoxycytidine; Female; Fluorouracil; Humans; Medroxyprogesterone Acetate; Middle Aged; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Skin Ulcer	2009
Pfizer ordered to pay $103m over hormone drugs and breast cancer. BMJ (Clinical research ed.), 2009, Nov-27, Volume: 339 Topics: Breast Neoplasms; Compensation and Redress; Drug Combinations; Drug Industry; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Legislation, Drug; Medroxyprogesterone Acetate; Philadelphia	2009
Progesterone receptor induces ErbB-2 nuclear translocation to promote breast cancer growth via a novel transcriptional effect: ErbB-2 function as a coactivator of Stat3. Molecular and cellular biology, 2010, Volume: 30, Issue:23 Topics: Active Transport, Cell Nucleus; Animals; Base Sequence; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Gene Knockdown Techniques; Genes, bcl-1; Humans; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Progestins; Promoter Regions, Genetic; Receptor, ErbB-2; Receptors, Progesterone; RNA, Small Interfering; Signal Transduction; STAT3 Transcription Factor; Trans-Activators; Transcription, Genetic	2010
RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis. Nature, 2010, Nov-04, Volume: 468, Issue:7320 Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Breast Neoplasms; Cell Proliferation; Cell Transformation, Neoplastic; Disease Models, Animal; Epithelial Cells; Female; Humans; Lung Neoplasms; Mammary Neoplasms, Experimental; Mammary Tumor Virus, Mouse; Medroxyprogesterone Acetate; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neoplasm Invasiveness; Precancerous Conditions; Progesterone; Progestins; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B	2010
Postmenopausal hormone therapy and breast cancer: an uncertain trade-off. JAMA, 2010, Oct-20, Volume: 304, Issue:15 Topics: Aged; Breast Neoplasms; Decision Making; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Postmenopause; Risk	2010
Breast cancer in postmenopausal women after hormone therapy. JAMA, 2011, Feb-02, Volume: 305, Issue:5 Topics: Breast Neoplasms; Cohort Studies; Drug Combinations; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Postmenopause; Progesterone; Reproducibility of Results	2011
Breast cancer in postmenopausal women after hormone therapy. JAMA, 2011, Feb-02, Volume: 305, Issue:5 Topics: Breast Neoplasms; Cohort Studies; Drug Combinations; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Postmenopause; Progestins	2011
Combination hormone therapy tied to slight increase in breast cancer deaths. Mayo Clinic women's healthsource, 2011, Volume: 15, Issue:3 Topics: Breast Neoplasms; Drug Combinations; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Survival Analysis; United States; Women's Health	2011
Glucocorticoid receptor activity discriminates between progesterone and medroxyprogesterone acetate effects in breast cells. Breast cancer research and treatment, 2012, Volume: 131, Issue:1 Topics: Adolescent; Adult; Breast; Breast Neoplasms; Carrier Proteins; Cell Line, Tumor; Cell Proliferation; Estradiol; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; High-Throughput Nucleotide Sequencing; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Norpregnadienes; Progesterone; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Progesterone; RNA Interference; RNA, Small Interfering; Steroids; Transcriptome; Young Adult	2012
Examination of the use of Exemestane in patients with metastatic breast cancer. Breast cancer (Tokyo, Japan), 2011, Volume: 18, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Androstadienes; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Liver Neoplasms; Lung Neoplasms; Medroxyprogesterone Acetate; Middle Aged; Retrospective Studies; Tamoxifen	2011
Interaction between FGFR-2, STAT5, and progesterone receptors in breast cancer. Cancer research, 2011, May-15, Volume: 71, Issue:10 Topics: Animals; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Line, Tumor; Extracellular Signal-Regulated MAP Kinases; Female; Gene Expression Regulation, Neoplastic; Humans; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Mice, Inbred NOD; Mice, SCID; Neoplasm Transplantation; Receptor, Fibroblast Growth Factor, Type 2; Receptors, Progesterone; STAT5 Transcription Factor	2011
The presence of a membrane-bound progesterone receptor sensitizes the estradiol-induced effect on the proliferation of human breast cancer cells. Menopause (New York, N.Y.), 2011, Volume: 18, Issue:8 Topics: Breast Neoplasms; Cell Division; Cell Line, Tumor; Cell Proliferation; Contraceptive Agents, Female; Dose-Response Relationship, Drug; Estradiol; Female; Fulvestrant; Humans; Medroxyprogesterone Acetate; Membrane Proteins; Receptors, Progesterone	2011
Can the increase in breast cancer observed in the estrogen plus progestin arm of the Women's Health Initiative trial be explained by progesterone receptor membrane component 1? Menopause (New York, N.Y.), 2011, Volume: 18, Issue:8 Topics: Breast Neoplasms; Contraceptive Agents, Female; Estradiol; Female; Fulvestrant; Humans; Medroxyprogesterone Acetate; Membrane Proteins; Receptors, Progesterone	2011
Improper analysis of trials randomised using stratified blocks or minimisation. Statistics in medicine, 2012, Feb-20, Volume: 31, Issue:4 Topics: Antineoplastic Agents; Back Injuries; Bias; Breast Neoplasms; Carcinoma; Computer Simulation; Data Interpretation, Statistical; Deoxyribonucleases; Drug Therapy, Combination; Female; Fibrinolytic Agents; Humans; Interferon-alpha; Kidney Neoplasms; Liver Cirrhosis, Biliary; Male; Medroxyprogesterone Acetate; Penicillamine; Pleural Effusion; Randomized Controlled Trials as Topic; Survival Analysis; Tamoxifen; Tissue Plasminogen Activator; Treatment Outcome	2012
Progestogens and membrane-initiated effects on the proliferation of human breast cancer cells. Climacteric : the journal of the International Menopause Society, 2012, Volume: 15, Issue:5 Topics: Breast Neoplasms; Cell Membrane; Cell Proliferation; Female; Gene Expression; Humans; MCF-7 Cells; Medroxyprogesterone Acetate; Membrane Proteins; Norethindrone; Progesterone; Progesterone Congeners; Progestins; Receptors, Progesterone; Transfection	2012
Effect of depo-medroxyprogesterone acetate on breast cancer risk among women 20 to 44 years of age. Cancer research, 2012, Apr-15, Volume: 72, Issue:8 Topics: Adult; Breast Neoplasms; Case-Control Studies; Contraceptive Agents, Female; Female; Humans; Medroxyprogesterone Acetate; Risk Factors; Young Adult	2012
Estrogen receptor alpha mediates progestin-induced mammary tumor growth by interacting with progesterone receptors at the cyclin D1/MYC promoters. Cancer research, 2012, May-01, Volume: 72, Issue:9 Topics: Animals; Breast Neoplasms; Cell Growth Processes; Cell Nucleus; Cyclin D1; Estradiol; Estrogen Receptor alpha; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Genes, myc; Genes, Reporter; Humans; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Neoplasms, Hormone-Dependent; Promoter Regions, Genetic; Receptors, Progesterone	2012
Risks and benefits of menopausal hormone therapy in postmenopausal Chinese women. Menopause (New York, N.Y.), 2012, Volume: 19, Issue:8 Topics: Aged; Asian People; Breast Neoplasms; Cardiovascular Diseases; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Myocardial Infarction; Postmenopause; Risk Assessment; Taiwan	2012
Apigenin induces apoptosis and blocks growth of medroxyprogesterone acetate-dependent BT-474 xenograft tumors. Hormones & cancer, 2012, Volume: 3, Issue:4 Topics: Animals; Apigenin; Apoptosis; Breast Neoplasms; Cell Growth Processes; Cell Line, Tumor; Female; Hormone Replacement Therapy; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Medroxyprogesterone Acetate; Mice; Mice, Nude; Neoplasms, Hormone-Dependent; Postmenopause; Progesterone Congeners; Xenograft Model Antitumor Assays	2012
Beyond politics: new medical concerns for contraceptive users. The American journal of nursing, 2012, Volume: 112, Issue:7 Topics: Administration, Cutaneous; Adult; Androstenes; Breast Neoplasms; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Female; Humans; Medroxyprogesterone Acetate; Mineralocorticoid Receptor Antagonists; Thrombosis; United States	2012
[The role of estrogen receptor alpha in breast cancer cell proliferation mediated by progestins]. Medicina, 2012, Volume: 72, Issue:4 Topics: Animals; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma; Cell Proliferation; Chromatin Immunoprecipitation; Cyclin D1; Estradiol; Estrogen Receptor alpha; Female; Fulvestrant; Genes, myc; Humans; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Murinae; Progestins; Receptors, Progesterone; Transcription, Genetic	2012
[Doxifluridine, medroxyprogesterone acetate and cyclophosphamide(DMpC)combination therapy found effective for case of chest wall recurrent breast cancer with bone and pleural metastases]. Gan to kagaku ryoho. Cancer & chemotherapy, 2012, Volume: 39, Issue:8 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Female; Floxuridine; Humans; Medroxyprogesterone Acetate; Pleural Neoplasms; Quality of Life; Recurrence; Thoracic Wall	2012
Progestin modulates the lipid profile and sensitivity of breast cancer cells to docetaxel. Molecular and cellular endocrinology, 2012, Nov-05, Volume: 363, Issue:1-2 Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Docetaxel; Drug Resistance, Neoplasm; Fatty Acids, Nonesterified; Female; Gene Expression; Glucose; Gonanes; Humans; Lipogenesis; Medroxyprogesterone Acetate; Phospholipids; Progestins; Receptors, Progesterone; Stearoyl-CoA Desaturase; Taxoids; Triglycerides	2012
Membrane-receptor initiated proliferative effects of dienogest in human breast cancer cells. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2013, Volume: 29, Issue:2 Topics: Breast Neoplasms; Cell Proliferation; Clone Cells; Contraceptive Agents, Female; Drug Interactions; Estradiol; Estrogens; Female; Humans; MCF-7 Cells; Medroxyprogesterone Acetate; Membrane Proteins; Nandrolone; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Norethindrone; Osmolar Concentration; Progesterone; Progestins; Receptors, Progesterone; Recombinant Proteins	2013
p42/p44 MAPK-mediated Stat3Ser727 phosphorylation is required for progestin-induced full activation of Stat3 and breast cancer growth. Endocrine-related cancer, 2013, Volume: 20, Issue:2 Topics: Animals; Breast Neoplasms; Cell Proliferation; Cyclin D1; Female; Humans; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; STAT3 Transcription Factor	2013
Failure of estrogen plus progestin therapy for prevention. JAMA, 2002, Jul-17, Volume: 288, Issue:3 Topics: Breast Neoplasms; Coronary Disease; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Postmenopause; Progesterone Congeners; Risk	2002
Women's health. The vanishing promises of hormone replacement. Science (New York, N.Y.), 2002, Jul-19, Volume: 297, Issue:5580 Topics: Breast Neoplasms; Cardiovascular Diseases; Colorectal Neoplasms; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Fractures, Bone; Humans; Medroxyprogesterone Acetate; Menopause; Postmenopause; Pulmonary Embolism; Randomized Controlled Trials as Topic; Risk Factors; Selection Bias; Time Factors	2002
[One case of locally advanced breast cancer in which multidisciplinary treatment, chiefly, therapy with preoperative intraarterial infusion of docetaxel (TXT), was successful]. Gan to kagaku ryoho. Cancer & chemotherapy, 2002, Volume: 29, Issue:7 Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Docetaxel; Female; Floxuridine; Humans; Infusions, Intra-Arterial; Medroxyprogesterone Acetate; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Taxoids	2002
Depo Provera: still controversial. International health news, 1988, Volume: 9, Issue:2 Topics: Americas; Animals, Laboratory; Biology; Breast Neoplasms; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Developed Countries; Developing Countries; Disease; Economics; Endocrine System; Family Planning Services; Government Agencies; Hormones; Medroxyprogesterone Acetate; Neoplasms; North America; Organizations; Physiology; Politics; Reproductive Control Agents; Research; Technology; United States	1988
G protein-coupled receptor 30 is critical for a progestin-induced growth inhibition in MCF-7 breast cancer cells. Endocrinology, 2002, Volume: 143, Issue:9 Topics: Breast Neoplasms; Cell Cycle; Cell Division; Cyclin D1; DNA; Estradiol; Flow Cytometry; G1 Phase; Gene Expression; Humans; Medroxyprogesterone Acetate; Oligodeoxyribonucleotides, Antisense; Progestins; Receptors, Cell Surface; Receptors, Estrogen; Receptors, G-Protein-Coupled; Receptors, Progesterone; RNA, Messenger; Tetracycline; Transfection; Tumor Cells, Cultured	2002
Long-term use of three-monthly injectable contraceptive DMPA not linked to breast cancer. Entre nous (Copenhagen, Denmark), 1996, Issue:32 Topics: Africa; Africa South of the Sahara; Africa, Eastern; Americas; Asia; Asia, Southeastern; Breast Neoplasms; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Developed Countries; Developing Countries; Disease; Family Planning Services; Health; Injections; Kenya; Latin America; Medroxyprogesterone Acetate; Mexico; Neoplasms; New Zealand; North America; Pacific Islands; Public Health; Safety; Thailand	1996
The case for hormone replacement: new studies that should inform the debate. Cleveland Clinic journal of medicine, 2002, Volume: 69, Issue:9 Topics: Aged; Breast Neoplasms; Clinical Trials as Topic; Coronary Artery Disease; Depression; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Risk Assessment; Risk Factors	2002
Contraception and cancer prevention. Advances in contraceptive delivery systems : CDS, 1994, Volume: 10, Issue:3-4 Topics: Americas; Biology; Breast Neoplasms; California; Case-Control Studies; Cell Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Developed Countries; Disease; Endocrine System; Endometrial Neoplasms; Estrogens; Family Planning Services; Hormones; Lipids; Medroxyprogesterone Acetate; Neoplasms; North America; Ovarian Neoplasms; Physiology; Pilot Projects; Pituitary Hormone-Releasing Hormones; United States	1994
Long-term use of hormonal contraceptive DMPA not linked to breast cancer. Progress in human reproduction research, 1995, Issue:33 Topics: Biology; Breast Neoplasms; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Disease; Endometrial Neoplasms; Family Planning Services; Medroxyprogesterone Acetate; Neoplasms; Risk Factors	1995
20 years, 20 articles: studies to know. Contraceptive technology update, 2000, Volume: 21, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Americas; Breast Feeding; Breast Neoplasms; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Developed Countries; Disease; Family Planning Services; Health; HIV Infections; Infant Nutritional Physiological Phenomena; Intrauterine Devices; Lactation; Medroxyprogesterone Acetate; Neoplasms; North America; Nutritional Physiological Phenomena; Research; Sterilization, Reproductive; Sterilization, Tubal; United States; Virus Diseases	2000
Injectable contraception. IPPF medical bulletin, 1980, Volume: 14, Issue:6 Topics: Breast Neoplasms; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Disease; Endometrial Neoplasms; Family Planning Services; Infertility; Injections; International Agencies; Lactation; Medroxyprogesterone Acetate; Neoplasms; Organizations; Pregnancy; Uterine Cervical Neoplasms; Voluntary Health Agencies; Women	1980
Hormone interference in metastatic breast cancer patients treated with medroxyprogesterone acetate at massive doses: preliminary results. IRCS journal of medical science, 1978, Volume: 6, Issue:4 Topics: Biology; Breast Neoplasms; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Disease; Endocrine System; Family Planning Services; Follicle Stimulating Hormone; Hormones; Luteinizing Hormone; Medroxyprogesterone Acetate; Neoplasms; Physiology; Prolactin	1978
A comparison of levonorgestrel implants with depo-medroxyprogesterone acetate injections for contraception. Journal SOGC : journal of the Society of Obstetricians and Gynaecologists of Canada, 1993, Volume: 15, Issue:8 Topics: Americas; Biology; Breast Neoplasms; Canada; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Developed Countries; Disease; Family Planning Services; Injections; Levonorgestrel; Medroxyprogesterone Acetate; Menstruation Disturbances; Metabolism; Neoplasms; North America; Patient Acceptance of Health Care; Physiology; Research	1993
Researcher explains status of Depo Provera. [Answer to question of Marienetta Blackwell]. Contraceptive technology update, 1981, Volume: 2, Issue:3 Topics: Americas; Biology; Breast Neoplasms; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Counseling; Delivery of Health Care; Developed Countries; Disease; Endocrine System; Estrogens; Evaluation Studies as Topic; Family Planning Services; Health Planning; Health Services Accessibility; Hormones; Injections; Medroxyprogesterone Acetate; Neoplasms; North America; Organization and Administration; Physicians; Physiology; Politics; United States	1981
Not FDA-approved, but experts recommend Depo-Provera. Contraceptive technology update, 1992, Volume: 13, Issue:1 Topics: Americas; Breast Neoplasms; Consumer Product Safety; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Delivery of Health Care; Developed Countries; Disease; Drug Prescriptions; Evaluation Studies as Topic; Family Planning Services; Health Planning; Legislation as Topic; Medroxyprogesterone Acetate; Neoplasms; North America; Organization and Administration; Risk Assessment; United States	1992
What is breast cancer risk with Depo-Provera? Contraceptive technology update, 1992, Volume: 13, Issue:1 Topics: Age Factors; Breast Neoplasms; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Demography; Disease; Evaluation Studies as Topic; Family Planning Services; International Agencies; Medroxyprogesterone Acetate; Neoplasms; Organizations; Population; Population Characteristics; Population Dynamics; Research; Research Design; Risk Assessment; Time; Time Factors; United Nations; World Health Organization	1992
FDA gives final approval to Depo amid concerns over safety, cost and coercion. Washington memo, 1992, Nov-12, Issue:17 Topics: Americas; Breast Neoplasms; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Developed Countries; Developing Countries; Disease; Economics; Endometrial Neoplasms; Family Planning Services; Government Agencies; International Agencies; Medroxyprogesterone Acetate; Neoplasms; North America; Organizations; Ovarian Neoplasms; Ovulation; Poverty; Social Class; Socioeconomic Factors; United Nations; United States; United States Public Health Service; Uterine Cervical Neoplasms; World Health Organization	1992
Contraception and the big "C". Malaysian journal of reproductive health : a publication of the Reproductive Research Centre of the National Population and Family Development Board, Malaysia, 1992, Volume: 10, Issue:1 Topics: Biology; Breast Neoplasms; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Demography; Disease; Endocrine System; Endometrial Neoplasms; Estrogens; Family Planning Services; Hormones; Intrauterine Devices; Lactation; Medroxyprogesterone Acetate; Neoplasms; Ovarian Neoplasms; Ovulation; Physiology; Population; Population Dynamics; Time; Time Factors; Uterine Cervical Neoplasms	1992
Injectable contraception: the USA perspective. IPPF medical bulletin, 1992, Volume: 26, Issue:6 Topics: Americas; Breast Neoplasms; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Developed Countries; Disease; Endometrial Neoplasms; Evaluation Studies as Topic; Family Planning Services; Government Agencies; Health Services Accessibility; Injections; Medroxyprogesterone Acetate; Menstruation Disturbances; Neoplasms; Norethindrone; North America; Organizations; United States; United States Food and Drug Administration; United States Public Health Service	1992
HDLG5/KIAA0583, encoding a MAGUK-family protein, is a primary progesterone target gene in breast cancer cells. International journal of cancer, 2002, Nov-01, Volume: 102, Issue:1 Topics: Blotting, Northern; Breast Neoplasms; Estrogens; Female; Gene Expression Profiling; Genes, Tumor Suppressor; Guanylate Kinases; Humans; Medroxyprogesterone Acetate; Membrane Proteins; Mifepristone; Nucleoside-Phosphate Kinase; Progestins; Protein Structure, Tertiary; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; src Homology Domains; Tumor Cells, Cultured; Tumor Suppressor Proteins; Up-Regulation	2002
The relevance of the Women's Health Initiative results on combined hormone replacement therapy in clinical practice. Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2002, Volume: 24, Issue:9 Topics: Age Factors; Aged; Breast Neoplasms; Cardiovascular Diseases; Confounding Factors, Epidemiologic; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Prospective Studies; Randomized Controlled Trials as Topic; Research Design; Risk Assessment; Women's Health	2002
Women's Health Initiative study. Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2002, Volume: 24, Issue:9 Topics: Breast Neoplasms; Confounding Factors, Epidemiologic; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Patient Dropouts; Randomized Controlled Trials as Topic; Women's Health	2002
Translating the latest scientific advances into clinical practice. Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2002, Volume: 24, Issue:10 Topics: Breast Neoplasms; Coronary Disease; Diffusion of Innovation; Drug Combinations; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Evidence-Based Medicine; Female; Gynecology; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Patient Selection; Practice Patterns, Physicians'; Risk Factors; Stroke; Time Factors	2002
The SOGC statement on the WHI report on estrogen and progestin use in postmenopausal women. Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2002, Volume: 24, Issue:10 Topics: Aged; Breast Neoplasms; Cardiovascular Diseases; Drug Combinations; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Evidence-Based Medicine; Female; Humans; Informed Consent; Medroxyprogesterone Acetate; Middle Aged; Osteoporosis, Postmenopausal; Patient Education as Topic; Patient Selection; Postmenopause; Risk; Risk Factors; Women's Health	2002
Discussing breast cancer and hormone replacement therapy with women. Cleveland Clinic journal of medicine, 2002, Volume: 69, Issue:11 Topics: Breast Neoplasms; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Genetic Predisposition to Disease; Humans; Medroxyprogesterone Acetate; Models, Statistical; Patient Education as Topic; Postmenopause; Progesterone Congeners; Prognosis; Randomized Controlled Trials as Topic; Research Design; Risk Assessment	2002
Progestin and G protein-coupled receptor 30 inhibit mitogen-activated protein kinase activity in MCF-7 breast cancer cells. Endocrinology, 2002, Volume: 143, Issue:12 Topics: Breast Neoplasms; Butadienes; Cell Division; DNA, Antisense; Enzyme Inhibitors; Flavonoids; Gene Expression; GTP-Binding Proteins; Humans; Medroxyprogesterone Acetate; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Nitriles; Progestins; Receptors, Cell Surface; Receptors, Estrogen; Receptors, G-Protein-Coupled; Signal Transduction; Tumor Cells, Cultured	2002
Health risks outweigh benefits for combined estrogen plus progestin. Clinical trial stopped early in major study. Ginecologia y obstetricia de Mexico, 2002, Volume: 70 Topics: Aged; Breast Neoplasms; Colorectal Neoplasms; Coronary Disease; Drug Combinations; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Hip Fractures; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Middle Aged; Placebos; Postmenopause; Progesterone Congeners; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Time Factors; Venous Thrombosis	2002
NIH workshop tries to create consensus on HRT use. Journal of the National Cancer Institute, 2003, Jan-01, Volume: 95, Issue:1 Topics: Age Factors; Breast Neoplasms; Cardiovascular Diseases; Consensus Development Conferences, NIH as Topic; Coronary Disease; Drug Combinations; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Randomized Controlled Trials as Topic; Risk; United Kingdom; United States; United States Food and Drug Administration	2003
Postmenopausal hormone therapy and change in mammographic density. Journal of the National Cancer Institute, 2003, Jan-01, Volume: 95, Issue:1 Topics: Breast; Breast Neoplasms; Drug Administration Schedule; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Mammography; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Progesterone Congeners; Randomized Controlled Trials as Topic; Reproducibility of Results	2003
[Hormone replacement therapy in menopause]. Deutsche medizinische Wochenschrift (1946), 2003, Feb-21, Volume: 128, Issue:8 Topics: Aged; Breast Neoplasms; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Myocardial Infarction	2003
[A case of advanced recurrent breast cancer responding to treatment with weekly docetaxel combined with doxorubicin]. Gan to kagaku ryoho. Cancer & chemotherapy, 2003, Volume: 30, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Combined Modality Therapy; Docetaxel; Doxorubicin; Drug Administration Schedule; Female; Floxuridine; Humans; Lung Neoplasms; Lymphatic Metastasis; Mastectomy, Modified Radical; Medroxyprogesterone Acetate; Middle Aged; Paclitaxel; Skin Neoplasms; Taxoids	2003
Norelgestromin as selective estrogen enzyme modulator in human breast cancer cell lines. Effect on sulfatase activity in comparison to medroxyprogesterone acetate. The Journal of steroid biochemistry and molecular biology, 2003, Volume: 84, Issue:2-3 Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Ethisterone; Humans; Inhibitory Concentration 50; Medroxyprogesterone Acetate; Models, Chemical; Norgestrel; Oximes; Selective Estrogen Receptor Modulators; Sulfatases; Tumor Cells, Cultured	2003
The effect of progesterone and synthetic progestins on serum- and estradiol-stimulated proliferation of human breast cancer cells. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2003, Volume: 35, Issue:2 Topics: Analysis of Variance; Breast Neoplasms; Cell Division; Chlormadinone Acetate; Culture Media; Estradiol; Female; Humans; Medroxyprogesterone Acetate; Norethindrone; Progesterone; Progestins; Tumor Cells, Cultured	2003
Differential effects of raloxifene, tamoxifen and fulvestrant on a murine mammary carcinoma. Breast cancer research and treatment, 2003, Volume: 79, Issue:1 Topics: Animals; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Division; Chorionic Gonadotropin, beta Subunit, Human; Estradiol; Estrogen Receptor Modulators; Female; Medroxyprogesterone Acetate; Melitten; Mice; Mice, Inbred BALB C; Raloxifene Hydrochloride; Receptors, Progesterone; Tamoxifen; Tumor Cells, Cultured	2003
[After the early termination of the Women's Health Initiative study. New American recommendations for postmenopausal hormone therapy]. Lakartidningen, 2003, May-15, Volume: 100, Issue:20 Topics: Aged; Breast Neoplasms; Coronary Disease; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Middle Aged; Osteoporosis, Postmenopausal; Postmenopause; Practice Guidelines as Topic; Progesterone Congeners; Randomized Controlled Trials as Topic; Risk Factors; Women's Health	2003
Combined hormone therapy and breast cancer: a single-edged sword. JAMA, 2003, Jun-25, Volume: 289, Issue:24 Topics: Breast Neoplasms; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Mammography; Medroxyprogesterone Acetate; Progesterone Congeners; Risk	2003
[A case of postoperative recurrent breast cancer with multiple lung metastases that completely responded to combination therapy of docetaxel (TXT) and medroxyprogesterone acetate (MPA)]. Gan to kagaku ryoho. Cancer & chemotherapy, 2003, Volume: 30, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Docetaxel; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Mastectomy, Modified Radical; Medroxyprogesterone Acetate; Middle Aged; Paclitaxel; Postoperative Period; Remission Induction; Taxoids	2003
Influence of postmenopausal hormone replacement therapy on an estrogen metabolite biomarker of risk for breast cancer. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2003, Volume: 35, Issue:6 Topics: Biomarkers, Tumor; Breast Neoplasms; Cross-Sectional Studies; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Hydroxyestrones; Medroxyprogesterone Acetate; Postmenopause; Risk Factors	2003
Identification of a 6,21-dihydroxylated metabolite of medroxyprogesterone acetate in human urine. The Journal of clinical endocrinology and metabolism, 1962, Volume: 22 Topics: Breast Neoplasms; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate	1962
Dexamethasone and medroxyprogesterone acetate elevate Nm23-H1 metastasis suppressor gene expression in metastatic human breast carcinoma cells: new uses for old compounds. Clinical cancer research : an official journal of the American Association for Cancer Research, 2003, Sep-01, Volume: 9, Issue:10 Pt 1 Topics: Agar; Antineoplastic Agents, Hormonal; Blotting, Western; Breast Neoplasms; Cell Division; Cell Line, Tumor; Contraceptives, Oral, Synthetic; Dexamethasone; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Glucocorticoids; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Mutagenesis; Neoplasm Metastasis; NM23 Nucleoside Diphosphate Kinases; Nucleoside-Diphosphate Kinase; Promoter Regions, Genetic; Protein Biosynthesis; RNA Processing, Post-Transcriptional; Time Factors; Transcription, Genetic; Transfection	2003
Comparison of the proliferative effects of estradiol and conjugated equine estrogens on human breast cancer cells and impact of continuous combined progestogen addition. Climacteric : the journal of the International Menopause Society, 2003, Volume: 6, Issue:3 Topics: Breast Neoplasms; Cell Division; Dose-Response Relationship, Drug; Equilin; Estradiol; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Norethindrone; Progesterone; Progestins; Tumor Cells, Cultured	2003
Clinical trials report. Risks and benefits of hormone replacement therapy. Current hypertension reports, 2003, Volume: 5, Issue:6 Topics: Breast Neoplasms; Contraceptive Agents, Female; Coronary Disease; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Progesterone; Risk Assessment; Women's Health	2003
Positive response to oral chemoendocrine combination therapy using 5"-deoxy-5-fluorouridine for locally advanced breast cancer with carcinomatous pleurisy: report of a case. Surgery today, 2003, Volume: 33, Issue:12 Topics: Administration, Oral; Antimetabolites, Antineoplastic; Breast Neoplasms; Drug Therapy, Combination; Endocrine System; Female; Floxuridine; Humans; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local; Pleural Effusion, Malignant; Quality of Life; Tamoxifen	2003
[Estrogen plus gestagen especially risky. Breast cancer risk doubled]. MMW Fortschritte der Medizin, 2003, Nov-13, Volume: 145, Issue:46 Topics: Breast Neoplasms; Controlled Clinical Trials as Topic; Estrogen Replacement Therapy; Estrogens; Female; Humans; Medroxyprogesterone Acetate; Ovarian Neoplasms; Placebos; Risk; Time Factors; Uterine Neoplasms	2003
Risks of estrogen plus progestin therapy: a sensitivity analysis of findings in the Women's Health Initiative randomized controlled trial. Climacteric : the journal of the International Menopause Society, 2003, Volume: 6, Issue:4 Topics: Bias; Breast Neoplasms; Contraceptive Agents, Female; Coronary Disease; Data Interpretation, Statistical; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Incidence; Medroxyprogesterone Acetate; Pulmonary Embolism; Randomized Controlled Trials as Topic; Research Design; Risk; Stroke	2003
Report on the 4th European Breast Cancer Conference, Hamburg, Germany, 16-20 March 2004. Breast cancer research : BCR, 2004, Volume: 6, Issue:4 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aromatase Inhibitors; Biotransformation; Breast Neoplasms; Cardiovascular Diseases; Chemotherapy, Adjuvant; Clinical Trials as Topic; Disease-Free Survival; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Enzyme Inhibitors; Gene Expression Profiling; Genes, p53; Humans; Medroxyprogesterone Acetate; Neoplasm Recurrence, Local; Paclitaxel; Pharmacogenetics; Tamoxifen; Trastuzumab	2004
Post-menopausal hormone replacement therapy (cont'd): risk-benefit balance in the hot seat. Prescrire international, 2004, Volume: 13, Issue:71 Topics: Breast Neoplasms; Coronary Disease; Dementia; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Europe; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Randomized Controlled Trials as Topic; Risk Assessment; Stroke; Thromboembolism; Time Factors; United States; Women's Health	2004
HT and WHI: the baby and the bathwater. Climacteric : the journal of the International Menopause Society, 2004, Volume: 7, Issue:1 Topics: Blood Coagulation Factors; Breast Neoplasms; Contraceptive Agents, Female; Estradiol; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Genetic Predisposition to Disease; Humans; Medroxyprogesterone Acetate; Mutation; Progesterone; Thrombosis	2004
Effects of estrogen-only treatment in postmenopausal women. JAMA, 2004, Aug-11, Volume: 292, Issue:6 Topics: Breast Neoplasms; Coronary Disease; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Hysterectomy; Medroxyprogesterone Acetate; Middle Aged; Neoplasms, Hormone-Dependent; Postmenopause	2004
Effects of estrogen-only treatment in postmenopausal women. JAMA, 2004, Aug-11, Volume: 292, Issue:6 Topics: Breast Neoplasms; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Hysterectomy; Medroxyprogesterone Acetate; Middle Aged; Neoplasms, Hormone-Dependent; Ovariectomy; Postmenopause	2004
Effects of estrogen-only treatment in postmenopausal women. JAMA, 2004, Aug-11, Volume: 292, Issue:6 Topics: Breast Neoplasms; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Insulin Resistance; Insulin-Like Growth Factor I; Medroxyprogesterone Acetate; Middle Aged; Neoplasms, Hormone-Dependent; Postmenopause	2004
Effects of estrogen-only treatment in postmenopausal women. JAMA, 2004, Aug-11, Volume: 292, Issue:6 Topics: Breast Neoplasms; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Mammography; Medroxyprogesterone Acetate; Middle Aged; Neoplasms, Hormone-Dependent; Postmenopause	2004
Effects of estrogen-only treatment in postmenopausal women. JAMA, 2004, Aug-11, Volume: 292, Issue:6 Topics: Breast Neoplasms; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Neoplasms, Hormone-Dependent; Postmenopause	2004
Effects of estrogen-only treatment in postmenopausal women. JAMA, 2004, Aug-11, Volume: 292, Issue:6 Topics: Breast Neoplasms; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Hip Fractures; Humans; Medroxyprogesterone Acetate; Middle Aged; Neoplasms, Hormone-Dependent; Postmenopause; Spinal Fractures	2004
Long-term survival of a patient with primarily chemo-resistant metastatic breast cancer treated with medroxyprogesterone acetate. Breast (Edinburgh, Scotland), 2004, Volume: 13, Issue:4 Topics: Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Disease Progression; Drug Resistance, Neoplasm; Epirubicin; Female; Fluorouracil; Humans; Liver Neoplasms; Mastectomy, Modified Radical; Medroxyprogesterone Acetate; Prognosis; Treatment Outcome	2004
[Hormone replacement therapy and the risk of developing breast cancer]. MMW Fortschritte der Medizin, 2004, Feb-26, Volume: 146, Issue:9 Topics: Breast Neoplasms; Cardiovascular Diseases; Climacteric; Endometrial Neoplasms; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Risk Assessment	2004
Isolation of a stromal cell line from an early passage of a mouse mammary tumor line: a model for stromal parenchymal interactions. Journal of cellular physiology, 2005, Volume: 202, Issue:3 Topics: Animals; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Shape; Coculture Techniques; Epidermal Growth Factor; Estradiol; Female; Fibroblasts; Genetic Markers; Hormone Antagonists; Humans; Keratins; Mammary Glands, Animal; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Mifepristone; Mutation; Neoplasm Transplantation; Receptors, Estrogen; Receptors, Progesterone; Stromal Cells; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tumor Suppressor Protein p53	2005
[A long-surviving patient with Stage IV breast cancer with no recurrence after combined therapy of medroxy progesterone acetate (MPA) and intra-arterial infusion chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2004, Volume: 31, Issue:9 Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Epirubicin; Female; Floxuridine; Humans; Infusions, Intra-Arterial; Lymphatic Metastasis; Mastectomy, Segmental; Medroxyprogesterone Acetate; Neoplasm Staging; Survivors; Tamoxifen	2004
Clinical background of women prescribed tibolone or combined estrogen + progestogen therapies: a UK MediPlus study. Climacteric : the journal of the International Menopause Society, 2004, Volume: 7, Issue:2 Topics: Breast Neoplasms; Drug Administration Schedule; Drug Therapy, Combination; Drug Utilization; Endometrial Neoplasms; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norgestrel; Norpregnenes; Practice Patterns, Physicians'; Registries; Retrospective Studies; Risk Factors; United Kingdom	2004
Ligand- and cell-specific effects of signal transduction pathway inhibitors on progestin-induced vascular endothelial growth factor levels in human breast cancer cells. Molecular endocrinology (Baltimore, Md.), 2005, Volume: 19, Issue:2 Topics: Antineoplastic Agents, Hormonal; Base Sequence; Breast Neoplasms; Cell Line, Tumor; Disease Progression; Dose-Response Relationship, Drug; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Humans; Immunoblotting; Ligands; Luciferases; Medroxyprogesterone Acetate; Molecular Sequence Data; Phosphatidylinositol 3-Kinases; Phosphorylation; Plasmids; Progesterone; Progestins; Promoter Regions, Genetic; Protein Isoforms; Protein Structure, Tertiary; Reverse Transcriptase Polymerase Chain Reaction; RNA Processing, Post-Transcriptional; RNA, Messenger; Signal Transduction; Time Factors; Transcription, Genetic; Transfection; Vascular Endothelial Growth Factor A	2005
[Successful combination therapy with 5'-DFUR and MPA for breast cancer with spinal and vertebral metastases]. Gan to kagaku ryoho. Cancer & chemotherapy, 2004, Volume: 31, Issue:13 Topics: Adenocarcinoma, Scirrhous; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Floxuridine; Fluorouracil; Humans; Magnetic Resonance Imaging; Mastectomy; Medroxyprogesterone Acetate; Middle Aged; Remission Induction; Spinal Cord Neoplasms; Spinal Neoplasms	2004
[Effective reduction of elevated tumor markers by exemestane--a 12-year follow-up of a case of bone metastatic breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:3 Topics: Aged; Androstadienes; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Neoplasms; Breast Neoplasms; Carcinoembryonic Antigen; Drug Administration Schedule; Female; Floxuridine; Humans; Medroxyprogesterone Acetate; Mucin-1; Radionuclide Imaging	2005
Proliferation of endothelial and tumor epithelial cells by progestin-induced vascular endothelial growth factor from human breast cancer cells: paracrine and autocrine effects. Endocrinology, 2005, Volume: 146, Issue:8 Topics: Breast Neoplasms; Cell Division; Cell Line, Tumor; Cell Survival; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Female; Gene Expression Regulation, Neoplastic; Humans; Medroxyprogesterone Acetate; Progestins; Reverse Transcriptase Polymerase Chain Reaction; Umbilical Veins; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2	2005
[A case of recurrent breast cancer with bone metastasis causing pancytopenia--efficacy of low-dose CPT-11+ MPA]. Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Camptothecin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Irinotecan; Mastectomy, Segmental; Medroxyprogesterone Acetate; Middle Aged; Pancytopenia; Quality of Life	2005
Estradiol and medroxyprogesterone acetate regulated genes in T47D breast cancer cells. Molecular and cellular endocrinology, 2005, May-12, Volume: 235, Issue:1-2 Topics: Breast Neoplasms; Cell Line, Tumor; Estradiol; Estrogen Receptor alpha; Female; Gene Expression Regulation, Neoplastic; Humans; Medroxyprogesterone Acetate; Microarray Analysis; Platelet-Derived Growth Factor; Receptors, Progesterone; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Necrosis Factor-alpha	2005
Medroxyprogesterone acetate and metastases: of mice and (wo)men. Journal of the National Cancer Institute, 2005, May-04, Volume: 97, Issue:9 Topics: Animals; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Breast Neoplasms; Disease Models, Animal; Female; Genes, Tumor Suppressor; Humans; Medroxyprogesterone Acetate; Mice; NM23 Nucleoside Diphosphate Kinases; Nucleoside-Diphosphate Kinase	2005
Medroxyprogesterone acetate elevation of Nm23-H1 metastasis suppressor expression in hormone receptor-negative breast cancer. Journal of the National Cancer Institute, 2005, May-04, Volume: 97, Issue:9 Topics: Animals; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; DNA, Antisense; Female; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Humans; Immunohistochemistry; Medroxyprogesterone Acetate; Mice; NM23 Nucleoside Diphosphate Kinases; Nucleoside-Diphosphate Kinase; Transfection	2005
The Women's Health Initiative conundrum. Archives of women's mental health, 2005, Volume: 8, Issue:1 Topics: Adult; Age Factors; Aged; Bias; Breast Neoplasms; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Patient Selection; Progesterone Congeners; Research Design; Stroke; United States; Women's Health	2005
[Two cases of advanced breast cancer responding to oral chemoendocrine therapy with 5'-deoxy-5-fluorouridine, medroxyprogesterone acetate and cyclophosphamide (DMpC)]. Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:5 Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Drug Administration Schedule; Female; Floxuridine; Humans; Leukopenia; Lymph Nodes; Lymphatic Metastasis; Medroxyprogesterone Acetate; Middle Aged	2005
[A case of anthracycline and taxane-resistant breast cancer with life-thereatening multiple liver metastases responding to oral combination chemotherapy by UFT, cyclophosphamide and medroxyprogesterone acetate]. Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:5 Topics: Adenocarcinoma, Scirrhous; Administration, Oral; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bridged-Ring Compounds; Cyclophosphamide; Drug Administration Schedule; Drug Combinations; Drug Resistance, Neoplasm; Female; Humans; Liver Neoplasms; Medroxyprogesterone Acetate; Middle Aged; Taxoids; Tegafur; Uracil	2005
Progestins induce transcriptional activation of signal transducer and activator of transcription 3 (Stat3) via a Jak- and Src-dependent mechanism in breast cancer cells. Molecular and cellular biology, 2005, Volume: 25, Issue:12 Topics: Active Transport, Cell Nucleus; Animals; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Line, Tumor; DNA; DNA-Binding Proteins; Epithelial Cells; Female; Humans; Janus Kinase 1; Janus Kinase 2; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Progestins; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Receptors, Progesterone; src-Family Kinases; STAT3 Transcription Factor; Trans-Activators; Transcriptional Activation	2005
Sensitivity to further endocrine therapy is retained following progression on first-line fulvestrant. Breast cancer research and treatment, 2005, Volume: 92, Issue:2 Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Drug Resistance, Neoplasm; Estradiol; Female; Fulvestrant; Humans; Medroxyprogesterone Acetate; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Postmenopause; Retrospective Studies; Salvage Therapy; Tamoxifen; Treatment Outcome	2005
Re: Medroxyprogesterone acetate and metastases: of mice and (wo)men. Journal of the National Cancer Institute, 2005, Aug-17, Volume: 97, Issue:16 Topics: Animals; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Breast Neoplasms; Female; Medroxyprogesterone Acetate; Mice; NM23 Nucleoside Diphosphate Kinases; Nucleoside-Diphosphate Kinase	2005
Medroxyprogesterone acetate induces cell proliferation through up-regulation of cyclin D1 expression via phosphatidylinositol 3-kinase/Akt/nuclear factor-kappaB cascade in human breast cancer cells. Endocrinology, 2005, Volume: 146, Issue:11 Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Female; Humans; Medroxyprogesterone Acetate; NF-kappa B; Phosphatidylinositol 3-Kinases; Phosphorylation; Up-Regulation	2005
Dose-dependent changes of the ratio of apoptosis to proliferation by norethisterone and medroxyprogesterone acetate in human breast epithelial cells. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2005, Volume: 37, Issue:8 Topics: Apoptosis; Breast; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Dose-Response Relationship, Drug; Epithelial Cells; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone Acetate; Norethindrone	2005
Steroid hormone receptors and coregulators in endocrine-resistant and estrogen-independent breast cancer cells. International journal of cancer, 2006, Feb-15, Volume: 118, Issue:4 Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Proliferation; DNA-Binding Proteins; Drug Resistance, Neoplasm; Estradiol; Estrogen Receptor beta; Female; Gene Expression Profiling; Gene Silencing; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Nuclear Receptor Co-Repressor 2; Progestins; Receptors, Progesterone; Repressor Proteins; Toremifene; Transcription, Genetic; Tumor Cells, Cultured; Up-Regulation	2006
Quantitative analysis of gene regulation by seven clinically relevant progestins suggests a highly similar mechanism of action through progesterone receptors in T47D breast cancer cells. The Journal of steroid biochemistry and molecular biology, 2005, Volume: 97, Issue:4 Topics: Alkaline Phosphatase; Androstenes; Breast Neoplasms; Cell Line, Tumor; Cluster Analysis; Desogestrel; Dose-Response Relationship, Drug; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Humans; Levonorgestrel; Ligands; Medroxyprogesterone Acetate; Oligonucleotide Array Sequence Analysis; Progesterone; Progestins; Promegestone; Receptors, Estrogen; Receptors, Progesterone; Reverse Transcriptase Polymerase Chain Reaction; RNA; Transcription, Genetic	2005
Decreased androgen receptor levels and receptor function in breast cancer contribute to the failure of response to medroxyprogesterone acetate. Cancer research, 2005, Sep-15, Volume: 65, Issue:18 Topics: Animals; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Line, Tumor; Chlorocebus aethiops; COS Cells; Drug Resistance, Neoplasm; Female; Humans; Immunohistochemistry; Medroxyprogesterone Acetate; Mutation; Postmenopause; Protein Conformation; Protein Isoforms; Radioligand Assay; Receptors, Androgen; Receptors, Estrogen; Signal Transduction	2005
Progestins initiate a luminal to myoepithelial switch in estrogen-dependent human breast tumors without altering growth. Cancer research, 2005, Nov-01, Volume: 65, Issue:21 Topics: Animals; Breast Neoplasms; Cell Differentiation; Cell Growth Processes; Female; Humans; Keratins; Medroxyprogesterone Acetate; Mice; Mice, Nude; Neoplasm Transplantation; Progesterone; Receptors, Estrogen; Receptors, Progesterone; Transplantation, Heterologous	2005
Apoptosis and proliferation in breast cancer cells, cultured in vitro: effects of SERMs. Climacteric : the journal of the International Menopause Society, 2005, Volume: 8, Issue:3 Topics: Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Contraceptive Agents, Female; Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Humans; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Norpregnenes; Progesterone; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen; Tumor Cells, Cultured	2005
The progestational and androgenic properties of medroxyprogesterone acetate: gene regulatory overlap with dihydrotestosterone in breast cancer cells. Breast cancer research : BCR, 2005, Volume: 7, Issue:6 Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Line, Tumor; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Medroxyprogesterone Acetate; Progesterone; Receptors, Androgen; Receptors, Progesterone; Testosterone	2005
High survivin predicts a poor response to endocrine therapy, but a good response to chemotherapy in advanced breast cancer. Breast cancer research and treatment, 2006, Volume: 98, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Enzyme-Linked Immunosorbent Assay; Female; Humans; Inhibitor of Apoptosis Proteins; Medroxyprogesterone Acetate; Microtubule-Associated Proteins; Middle Aged; Neoplasm Proteins; Survivin; Tamoxifen	2006
Women's Health Initiative: not over yet. The largest study of women's health has raised at least as many questions as it has answered. Stay tuned. Harvard women's health watch, 2006, Volume: 13, Issue:9 Topics: Aged; Breast Neoplasms; Calcium, Dietary; Cardiovascular Diseases; Colonic Neoplasms; Diet, Fat-Restricted; Drug Combinations; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Osteoporosis; Women's Health	2006
Effects of estradiol with micronized progesterone or medroxyprogesterone acetate on risk markers for breast cancer in postmenopausal monkeys. Breast cancer research and treatment, 2007, Volume: 101, Issue:2 Topics: Animals; Apoptosis; Biomarkers, Tumor; Breast; Breast Neoplasms; Cell Proliferation; Contraceptive Agents, Female; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Gene Expression; Macaca fascicularis; Medroxyprogesterone Acetate; Postmenopause; Progesterone; Progestins; Receptors, Estrogen; Receptors, Progesterone; Reverse Transcriptase Polymerase Chain Reaction; Risk Factors	2007
Differential effects of progestogens, by type and regimen, on estrogen-metabolizing enzymes in human breast cancer cells. Maturitas, 2007, Feb-20, Volume: 56, Issue:2 Topics: 17-Hydroxysteroid Dehydrogenases; Aromatase; Breast Neoplasms; Cell Proliferation; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Humans; Medroxyprogesterone Acetate; Progestins; Steryl-Sulfatase; Structure-Activity Relationship; Tumor Cells, Cultured	2007
Effects of estradiol and medroxyprogesterone acetate on morphology, proliferation and apoptosis of human breast tissue in organ cultures. BMC cancer, 2006, Oct-18, Volume: 6 Topics: Apoptosis; Breast; Breast Neoplasms; Cell Differentiation; Cell Division; DNA Fragmentation; Drug Synergism; Epithelial Cells; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Humans; Image Processing, Computer-Assisted; Immediate-Early Proteins; Ki-67 Antigen; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Proteins; Organ Culture Techniques; Proliferating Cell Nuclear Antigen; Receptors, Progesterone; Stromal Cells	2006
Estrogen and the skin. Journal of the American Academy of Dermatology, 2006, Volume: 55, Issue:6 Topics: Autoimmune Diseases; Breast Neoplasms; Estradiol; Estriol; Estrogens; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Middle Aged; Multicenter Studies as Topic; Pregnancy; Pregnancy Complications; Progesterone; Psoriasis; Randomized Controlled Trials as Topic; Risk; Th1 Cells; Th2 Cells	2006
Effects of the components of hormone therapy on matrix metalloproteinases in breast-cancer cells: an in vitro study. Fertility and sterility, 2007, Volume: 87, Issue:4 Topics: Breast Neoplasms; Cell Line, Tumor; Equilin; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Progesterone	2007
Incidences of breast cancer throughout long-term hormone replacement therapy. The Journal of steroid biochemistry and molecular biology, 2007, Volume: 104, Issue:3-5 Topics: Adult; Age Distribution; Aged; Breast Neoplasms; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Gangliosides; Humans; Incidence; Medroxyprogesterone Acetate; Middle Aged; Time Factors	2007
Roles of hormone replacement therapy and iron in proliferation of breast epithelial cells with different estrogen and progesterone receptor status. Breast (Edinburgh, Scotland), 2008, Volume: 17, Issue:2 Topics: Animals; Breast Neoplasms; Cell Proliferation; Drug Combinations; Epithelial Cells; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; In Vitro Techniques; Iron; Medroxyprogesterone Acetate; Postmenopause; Receptors, Estrogen; Receptors, Progesterone	2008
[A case of recurrent breast cancer with multiple liver metastases responding to combination therapy of capecitabine and MPA]. Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:10 Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Combined Modality Therapy; Deoxycytidine; Female; Fluorouracil; Humans; Liver Neoplasms; Medroxyprogesterone Acetate; Neoplasm Recurrence, Local; Treatment Outcome	2007
Progestin-dependent progression of human breast tumor xenografts: a novel model for evaluating antitumor therapeutics. Cancer research, 2007, Oct-15, Volume: 67, Issue:20 Topics: Angiogenesis Inhibitors; Animals; Aza Compounds; Breast Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Cell Growth Processes; Disease Progression; Female; Humans; Medroxyprogesterone Acetate; Mice; Mifepristone; Neoplasms, Hormone-Dependent; Neovascularization, Pathologic; Progesterone; Progesterone Congeners; Progestins; Receptors, Estrogen; Receptors, Progesterone; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays	2007
So far, victories are few as breast cancer patients sue Wyeth over hormone therapy. Journal of the National Cancer Institute, 2007, Dec-19, Volume: 99, Issue:24 Topics: Aged; Breast Neoplasms; Drug Combinations; Drug Industry; Drug Labeling; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Liability, Legal; Medroxyprogesterone Acetate; Middle Aged; Progestins; United States	2007
Effects of estradiol and medroxyprogesterone acetate on expression of the cell cycle proteins cyclin D1, p21 and p27 in cultured human breast tissues. Cell cycle (Georgetown, Tex.), 2008, Jan-01, Volume: 7, Issue:1 Topics: Adult; Aged; Breast; Breast Neoplasms; Cell Cycle Proteins; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Estradiol; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Organ Culture Techniques; Postmenopause; Premenopause	2008
Estrogen plus progestin therapy and breast cancer in recently postmenopausal women. American journal of epidemiology, 2008, May-15, Volume: 167, Issue:10 Topics: Aged; Breast Neoplasms; Cohort Studies; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Invasiveness; Observation; Postmenopause; Proportional Hazards Models; Randomized Controlled Trials as Topic; Risk; Time Factors	2008
Progestins regulate genes that can elicit both proliferative and antiproliferative effects in breast cancer cells. Oncology reports, 2008, Volume: 19, Issue:6 Topics: Biomarkers, Tumor; Breast Neoplasms; Cell Proliferation; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Medroxyprogesterone Acetate; Oligonucleotide Array Sequence Analysis; Progesterone; Progestins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured	2008
Pharmacokinetic and pharmacodynamic basis for the treatment of metastatic breast cancer with high-dose medroxyprogesterone acetate. Cancer, 1984, Sep-15, Volume: 54, Issue:6 Suppl Topics: Adrenocorticotropic Hormone; Antineoplastic Agents; Breast Neoplasms; Female; Gonadotropins; Humans; Hydrocortisone; Kinetics; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Receptors, Progesterone; Thyrotropin-Releasing Hormone	1984
ACTH and cortisol plasma levels in cancer patients treated with medroxyprogesterone acetate at high dosages. Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1984, Volume: 3, Issue:4 Topics: Adrenocorticotropic Hormone; Adult; Antineoplastic Agents; Breast Neoplasms; Colonic Neoplasms; Female; Humans; Hydrocortisone; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasms; Uterine Neoplasms	1984
Treatment of advanced male breast cancer. Cancer, 1981, May-01, Volume: 47, Issue:9 Topics: Breast Neoplasms; Castration; Diethylstilbestrol; Follow-Up Studies; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasm Metastasis; Palliative Care; Prognosis; Receptors, Estrogen	1981
Therapeutic activity of medroxyprogesterone acetate in metastatic breast cancer: a correlation between estrogen receptors and various dosages. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1984, Volume: 91 Topics: Adult; Age Factors; Aged; Antineoplastic Agents; Breast Neoplasms; Dose-Response Relationship, Drug; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Palliative Care; Receptors, Estrogen	1984
The pharmacokinetics of high-dose medroxyprogesterone acetate (MPA) in the therapy of advanced breast cancer. Cancer chemotherapy and pharmacology, 1982, Volume: 8, Issue:1 Topics: Antineoplastic Agents; Breast Neoplasms; Female; Humans; Kinetics; Medroxyprogesterone; Medroxyprogesterone Acetate	1982
Pharmacokinetic approach to the selection of dose schedules for medroxyprogesterone acetate in clinical oncology. Cancer chemotherapy and pharmacology, 1982, Volume: 8, Issue:2 Topics: Biological Availability; Breast Neoplasms; Female; Humans; Kinetics; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms; Time Factors	1982
[High dose medroxyprogesterone acetate in metastatic breast cancer. Comparative clinical, pharmacokinetic and pharmacodynamic data of different forms of administration]. Onkologie, 1982, Volume: 5 Suppl Topics: Administration, Oral; Antineoplastic Agents; Breast Neoplasms; Delayed-Action Preparations; Female; Humans; Hydrocortisone; Injections, Intramuscular; Kinetics; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasm Metastasis; Tablets	1982
[Medroxyprogesterone acetate (MAP) and aminoglutethimide (AG) in metastatic breast carcinoma. Preliminary report on a phase II study of the German Cancer Society's Internal Medicine Oncology Task Force]. Onkologie, 1982, Volume: 5 Suppl Topics: Adult; Aged; Aminoglutethimide; Antineoplastic Agents; Breast Neoplasms; Delayed-Action Preparations; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis	1982
Oral high-dose medroxyprogesterone acetate (MAP) in treatment of advanced breast cancer. A preliminary report of clinical and experimental studies. Breast cancer research and treatment, 1981, Volume: 1, Issue:2 Topics: Administration, Oral; Breast Neoplasms; Dose-Response Relationship, Drug; Drug Administration Schedule; Estradiol; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Receptors, Estrogen	1981
Combination therapy with progestins and tamoxifen in advanced breast cancer: A preliminary report. American journal of clinical oncology, 1982, Volume: 5, Issue:5 Topics: Adult; Aged; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Drug Therapy, Combination; Female; Humans; Lung Neoplasms; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Skin Neoplasms; Tamoxifen	1982
[Mitomycin C and high-dosage medroxyprogesterone acetate in the therapy of metastasizing breast cancer. Results of a phase II study of the Workshop for Internal Oncology of the German Cancer Association]. Onkologie, 1982, Volume: 5, Issue:5 Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Drug Therapy, Combination; Female; Germany, West; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Mitomycins; Neoplasm Metastasis	1982
[High-dose gestagen therapy with medroxyprogesterone acetate in metastasizing breast carcinoma]. Die Medizinische Welt, 1983, Mar-25, Volume: 34, Issue:12 Topics: Administration, Oral; Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Neoplasm Metastasis; Tablets	1983
Long-acting progestins--promise and prospects. Population reports. Series K, Injectables and implants, 1983, Volume: 11, Issue:2 Topics: Animals; Bibliographies as Topic; Breast Neoplasms; Contraceptives, Oral, Combined; Delayed-Action Preparations; Dogs; Female; Haplorhini; Humans; Injections, Intramuscular; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Norgestrel; Progesterone Congeners; Rats; Reproduction; Uterine Neoplasms	1983
[Successful treatment of brain metastases in breast cancer with blood-brain barrier-impervious cytostatics and hormones]. Onkologie, 1983, Volume: 6, Issue:2 Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain Neoplasms; Breast Neoplasms; Castration; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Prognosis; Tamoxifen	1983
[High-dose gestagen therapy in breast cancer]. Wiener medizinische Wochenschrift (1946), 1983, Apr-15, Volume: 133, Issue:7 Topics: Adult; Bone Neoplasms; Breast Neoplasms; Castration; Dose-Response Relationship, Drug; Estrogen Antagonists; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Risk; Soft Tissue Neoplasms	1983
[Oral high-dose medroxyprogesterone acetate (MPA) in the treatment of advanced and recurrent breast cancer: a dose-response evaluation]. Gan to kagaku ryoho. Cancer & chemotherapy, 1982, Volume: 9, Issue:11 Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Neoplasm Recurrence, Local	1982
Ultrastructure of feline mammary hypertrophy. Veterinary pathology, 1983, Volume: 20, Issue:3 Topics: Abortion, Veterinary; Animals; Breast; Breast Neoplasms; Cat Diseases; Cats; Epithelium; Female; Fibrocystic Breast Disease; Humans; Hypertrophy; Immunosuppressive Agents; Male; Mammary Glands, Animal; Medroxyprogesterone; Medroxyprogesterone Acetate; Pregnancy	1983
A phase II study of high-dose medroxyprogesterone acetate in advanced breast cancer. Cancer chemotherapy and pharmacology, 1983, Volume: 11, Issue:1 Topics: Adult; Antineoplastic Agents; Breast Neoplasms; Drug Evaluation; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged	1983
[Gestagen therapy of breast cancer. Effect of high doses on the blood coagulation system]. MMW, Munchener medizinische Wochenschrift, 1983, Oct-07, Volume: 125, Issue:40 Topics: Aged; Antineoplastic Agents; Blood Coagulation Tests; Breast Neoplasms; Combined Modality Therapy; Dose-Response Relationship, Drug; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Thrombophlebitis	1983
Dual effects of the progestin R5020 on proteins released by the T47D human breast cancer cells. The Journal of biological chemistry, 1984, Jan-25, Volume: 259, Issue:2 Topics: Breast Neoplasms; Cell Line; Dihydrotestosterone; Estradiol; Female; Humans; Mannose; Medroxyprogesterone; Medroxyprogesterone Acetate; Methionine; Norpregnadienes; Progesterone; Promegestone; Proteins; Receptors, Progesterone	1984
The role of progestins in the treatment of breast cancer. Seminars in oncology, 1983, Volume: 10, Issue:4 Suppl 4 Topics: Breast Neoplasms; Cell Line; Cytoplasm; Dose-Response Relationship, Drug; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen	1983
[Medical treatment of the breast]. Minerva medica, 1984, Feb-18, Volume: 75, Issue:6 Topics: Adrenal Cortex Hormones; Aged; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Castration; Estrogen Antagonists; Female; Gonadal Steroid Hormones; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Time Factors	1984
Quality of life after cytotoxic chemotherapy: discussion paper. Journal of the Royal Society of Medicine, 1984, Volume: 77, Issue:6 Topics: Antineoplastic Agents; Breast Neoplasms; Female; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms; Quality of Life; Self-Assessment; Surveys and Questionnaires	1984
An evaluation of high-dose medroxyprogesterone acetate (MPA) therapy in women with advanced breast cancer. British journal of cancer, 1984, Volume: 50, Issue:3 Topics: Adult; Aged; Breast Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Humans; Injections, Intramuscular; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local	1984
Inhibition of steroid sulfatase activity by danazol. Acta obstetricia et gynecologica Scandinavica. Supplement, 1984, Volume: 123 Topics: Aminoglutethimide; Breast Neoplasms; Carcinoma; Culture Techniques; Danazol; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Estrogen Antagonists; Estrone; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Pregnadienes; Tamoxifen	1984
Advanced breast cancer: response to high dose oral medroxyprogesterone acetate. Australian and New Zealand journal of medicine, 1984, Volume: 14, Issue:3 Topics: Antineoplastic Agents; Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasm Metastasis	1984
[Changes of hormone receptor status in various treatment for human breast cancer and DMBA tumor of the rat]. Gan no rinsho. Japan journal of cancer clinics, 1984, Volume: 30, Issue:13 Topics: 9,10-Dimethyl-1,2-benzanthracene; Adult; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Ascorbic Acid; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Rats; Receptors, Estrogen; Receptors, Progesterone	1984
[Prognostic value of serum CEA and therapy-induced nonspecific CEA levels in metastasizing breast carcinoma]. Onkologie, 1984, Volume: 7, Issue:6 Topics: Adult; Aged; Alkaline Phosphatase; Aminoglutethimide; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoembryonic Antigen; Female; Hormones; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Prognosis	1984
Oral route administration of medroxyprogesterone acetate (MAP) at high doses in the treatment of advanced breast cancer: clinical results. Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1984, Volume: 3, Issue:5 Topics: Administration, Oral; Aged; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged	1984
[Medroxyprogesterone acetate as glucocorticoid in combination with aminoglutethimide in the treatment of metastatic breast cancer]. Onkologie, 1982, Volume: 5 Suppl Topics: Adrenocorticotropic Hormone; Aminoglutethimide; Antineoplastic Agents; Breast Neoplasms; Delayed-Action Preparations; Drug Therapy, Combination; Female; Humans; Hydrocortisone; Medroxyprogesterone; Medroxyprogesterone Acetate	1982
Oral high-dose medroxyprogesterone acetate causes adrenal suppression in patients with breast cancer. European journal of cancer & clinical oncology, 1982, Volume: 18, Issue:10 Topics: Administration, Oral; Adrenal Cortex; Adrenocorticotropic Hormone; Breast Neoplasms; Depression, Chemical; Drug Administration Schedule; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Secretory Rate	1982
Hormones and risk of breast cancer. European journal of gynaecological oncology, 1983, Volume: 4, Issue:1 Topics: Adult; Breast Diseases; Breast Neoplasms; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Pain; Risk; Thermography	1983
[Histochemical and biochemical assays of estrogen receptors in breast cancer and significance of endocrine therapy]. Gan no rinsho. Japan journal of cancer clinics, 1983, Volume: 29, Issue:6 Topics: Antineoplastic Agents; Breast Neoplasms; Female; Hexestrol; Histocytochemistry; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local; Receptors, Estrogen; Tamoxifen	1983
[The importance of hormone receptor analysis for diagnosis and therapy of gynecologic malignancies]. Wiener klinische Wochenschrift, 1983, May-27, Volume: 95, Issue:11 Topics: Breast Neoplasms; Estrogen Antagonists; Female; Genital Neoplasms, Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Ovarian Neoplasms; Progesterone; Receptors, Androgen; Receptors, Cell Surface; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Uterine Neoplasms	1983
Adrenal suppression by oral high-dose medroxyprogesterone acetate in breast cancer patients. Cancer chemotherapy and pharmacology, 1984, Volume: 12, Issue:2 Topics: Adrenocorticotropic Hormone; Aged; Androstenedione; Breast Neoplasms; Dehydroepiandrosterone; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Pituitary Hormones	1984
[Hormone treatment of metastasizing breast carcinoma]. Minerva chirurgica, 1981, Jun-30, Volume: 36, Issue:12 Topics: Bone Neoplasms; Breast Neoplasms; Castration; Estradiol Congeners; Humans; Lung Neoplasms; Lymphatic Metastasis; Medroxyprogesterone; Medroxyprogesterone Acetate; Methyltestosterone; Progesterone Congeners; Tamoxifen; Testosterone Congeners	1981
Expression of insulin-like growth factor binding proteins by T-47D human breast cancer cells: regulation by progestins and antiestrogens. Breast cancer research and treatment, 1994, Volume: 32, Issue:2 Topics: Breast Neoplasms; Carrier Proteins; Culture Media, Conditioned; Dexamethasone; Estradiol; Estrogen Antagonists; Gene Expression Regulation, Neoplastic; Humans; Insulin-Like Growth Factor Binding Protein 2; Insulin-Like Growth Factor Binding Protein 4; Insulin-Like Growth Factor Binding Protein 5; Medroxyprogesterone Acetate; Mifepristone; Neoplasm Proteins; Polyunsaturated Alkamides; Pregnenediones; Progesterone; Progestins; Tumor Cells, Cultured	1994
Medroxyprogesterone acetate therapy in advanced breast cancer: the predictive value of androgen receptor expression. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Prognosis; Prospective Studies; Receptors, Androgen; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Treatment Failure	1995
[Clinical trial of high-dose medroxyprogesterone acetate in advanced breast cancer]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 1995, Volume: 17, Issue:1 Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local	1995
Hormonal contraception. ACOG Technical bulletin. Number 198-October 1994 (replaces No. 106, July 1987) American College of Obstetricians and Gynecologists. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 1995, Volume: 48, Issue:1 Topics: Breast Neoplasms; Cardiovascular Diseases; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Contraceptives, Postcoital; Female; Humans; Levonorgestrel; Liver Neoplasms; Medroxyprogesterone Acetate; Risk Factors; Uterine Cervical Neoplasms	1995
[The diverse effects of hormonal therapeutic agents on the proliferations of human breast cancer cell lines, MCF-7 and its variants]. Nihon Naibunpi Gakkai zasshi, 1995, Jan-20, Volume: 71, Issue:1 Topics: Breast Neoplasms; Cell Division; Female; Humans; Medroxyprogesterone Acetate; Mutation; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Toremifene; Tumor Cells, Cultured	1995
Estrogen replacement therapy in women with previously treated breast cancer. ACOG Committee Opinion: Committee on Gynecologic Practice Number 135-April 1994. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 1994, Volume: 45, Issue:2 Topics: Adult; Breast Neoplasms; Case-Control Studies; Delayed-Action Preparations; DNA, Neoplasm; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Norgestrel; Postmenopause; Risk Factors; RNA, Neoplasm; Tamoxifen	1994
Combined effects of estradiol, leuprorelin, tamoxifen and medroxyprogesterone acetate on cell growth and steroid hormone receptors in breast cancer cells. Journal of cancer research and clinical oncology, 1994, Volume: 120, Issue:10 Topics: Breast Neoplasms; Cell Division; Cell Line; Dose-Response Relationship, Drug; Drug Interactions; Estradiol; Humans; Leuprolide; Medroxyprogesterone Acetate; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Tumor Cells, Cultured	1994
[Two cases of advanced breast cancer effectively treated with chemoendocrine therapy and radiotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:14 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Humans; Infusions, Intravenous; Medroxyprogesterone Acetate; Middle Aged; Radiotherapy Dosage; Remission Induction	1994
[A case of recurrent breast cancer responding to combination therapy with mitoxantrone (MIT), 5'-deoxy-5-fluorouridine (5'-DFUR) and medroxyprogesterone acetate (MPA)]. Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:14 Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Female; Floxuridine; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Mastectomy, Radical; Medroxyprogesterone Acetate; Middle Aged; Mitoxantrone; Ovariectomy	1994
Tamoxifen versus medroxyprogesterone acetate for metastatic breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Volume: 12, Issue:11 Topics: Breast Neoplasms; Eligibility Determination; Female; Humans; Medroxyprogesterone Acetate; Randomized Controlled Trials as Topic; Tamoxifen	1994
Megestrol acetate in advanced breast carcinoma. Oncology, 1994, Volume: 51 Suppl 1 Topics: Aminoglutethimide; Breast Neoplasms; Carcinoma; Clinical Trials as Topic; Cross-Over Studies; Female; Humans; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Postmenopause; Prospective Studies; Randomized Controlled Trials as Topic; Tamoxifen; Treatment Outcome	1994
Modulation of adriamycin resistance in human breast carcinoma MCF-7 cells in vitro and in vivo by medroxyprogesterone acetate. Japanese journal of cancer research : Gann, 1994, Volume: 85, Issue:5 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Doxorubicin; Drug Resistance; Humans; Male; Medroxyprogesterone Acetate; Mice; Mice, Nude; Time Factors; Tumor Cells, Cultured; Verapamil	1994
[A case of inflammatory breast cancer successfully treated with 5'-DFUR and MPA]. Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:12 Topics: Administration, Oral; Aged; Antineoplastic Agents; Breast Neoplasms; Female; Floxuridine; Humans; Mastectomy, Extended Radical; Mastitis; Medroxyprogesterone Acetate	1994
Retraction of cultured endothelial cell monolayer by human breast cancer cells, MCF-7. Cell biology international, 1993, Volume: 17, Issue:12 Topics: Breast Neoplasms; Cell Adhesion; Cell Communication; Cell Line; Culture Media, Conditioned; Endothelium, Vascular; Estradiol; Glycopeptides; Glycoproteins; Humans; Leucine; Medroxyprogesterone Acetate; Metalloendopeptidases; Microscopy, Phase-Contrast; Progesterone; Protease Inhibitors; Receptors, Progesterone; Tamoxifen; Tissue Inhibitor of Metalloproteinases; Trypsin; Tumor Cells, Cultured	1993
[Clinical pharmacokinetics and practical consequences of optimal use of medroxyprogesterone acetate]. Bulletin du cancer, 1993, Volume: 80, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Treatment Outcome	1993
[Plasma concentrations of non-esterified fatty acids and lipids in high-dose medroxyprogesterone therapy of metastatic breast cancer]. Zentralblatt fur Gynakologie, 1993, Volume: 115, Issue:11 Topics: Blood Glucose; Breast Neoplasms; Cholesterol; Fatty Acids, Nonesterified; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Phospholipids; Prospective Studies; Reference Values; Triglycerides	1993
[Advanced breast cancer with remarkable response to the combination therapy of mitoxantrone (MIT) and medroxyprogesteron acetate (MPA) after failure of anthracycline therapy: a case report]. Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Doxorubicin; Drug Administration Schedule; Drug Resistance; Female; Humans; Medroxyprogesterone Acetate; Mitoxantrone	1994
Medroxyprogesterone acetate inhibits the proliferation of estrogen- and progesterone-receptor negative MFM-223 human mammary cancer cells via the androgen receptor. Breast cancer research and treatment, 1993, Volume: 25, Issue:3 Topics: Androgen Receptor Antagonists; Breast Neoplasms; Cell Division; Dexamethasone; Dihydrotestosterone; Female; Humans; Medroxyprogesterone Acetate; Tumor Cells, Cultured	1993
Androgen receptor-mediated stimulation of 17 beta-hydroxysteroid dehydrogenase activity by dihydrotestosterone and medroxyprogesterone acetate in ZR-75-1 human breast cancer cells. Endocrinology, 1993, Volume: 132, Issue:1 Topics: 17-Hydroxysteroid Dehydrogenases; Breast Neoplasms; Dexamethasone; Dihydrotestosterone; Estradiol; Estrone; Flutamide; Humans; Kinetics; Medroxyprogesterone Acetate; Receptors, Androgen; Tumor Cells, Cultured	1993
The relationship between affinity of progestins and antiprogestins for the progesterone receptor in breast cancer cells (ZR-PR-LT) and ability to down-regulate the receptor: evidence for heterospecific receptor modulation via the glucocorticoid receptor. European journal of cancer (Oxford, England : 1990), 1993, Volume: 29A, Issue:12 Topics: Binding, Competitive; Breast Neoplasms; Dexamethasone; Down-Regulation; Female; Gonanes; Humans; Medroxyprogesterone Acetate; Mifepristone; Mitosis; Pregnenediones; Progesterone Congeners; Progestins; Receptors, Glucocorticoid; Receptors, Progesterone; Tumor Cells, Cultured	1993
[A case of breast cancer with multiple organ metastases in which single low dose administration of 5'-DFUR proved effective]. Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:2 Topics: Antineoplastic Agents; Breast Neoplasms; Drug Administration Schedule; Female; Floxuridine; Humans; Lymphatic Metastasis; Mastectomy, Radical; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Prognosis; Quality of Life; Tamoxifen	1993
Response to third-line endocrine treatment for advanced breast cancer. European journal of cancer (Oxford, England : 1990), 1993, Volume: 29A, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Staging; Retrospective Studies; Treatment Outcome	1993
[Follow-up of tumor markers in evaluating the effectiveness of chemo- or hormone therapy in metastatic breast cancer]. Geburtshilfe und Frauenheilkunde, 1993, Volume: 53, Issue:1 Topics: Antigens, Tumor-Associated, Carbohydrate; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Carcinoembryonic Antigen; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Medroxyprogesterone Acetate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent	1993
[A case of breast cancer with thrombosis during treatment of lung metastasis]. Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:4 Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Epirubicin; Female; Humans; Infusions, Intravenous; Lentinan; Lung Neoplasms; Medroxyprogesterone Acetate; Pulmonary Embolism; Radiography; Tamoxifen; Tegafur; Thrombophlebitis; Uracil	1993
[Effect of medroxyprogesterone acetate on the anticellular activity of 5-fluorouracil against human breast and stomach cancer cells]. Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:5 Topics: Breast Neoplasms; Cell Division; Drug Synergism; Estrogens; Female; Fluorouracil; Humans; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Receptors, Estrogen; Receptors, Progesterone; Stomach Neoplasms; Tumor Cells, Cultured	1993
[Effects of combined hormone therapy on the coagulation-fibrinolytic systems in patients with advanced breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:7 Topics: Aged; Blood Coagulation; Breast Neoplasms; Drug Therapy, Combination; Female; Fibrinolysis; Humans; Medroxyprogesterone Acetate; Middle Aged; Tamoxifen	1993
Effect of onapristone and medroxyprogesterone acetate on the proliferation and hormone receptor concentration of human breast cancer cells. The Journal of steroid biochemistry and molecular biology, 1993, Volume: 45, Issue:4 Topics: Breast Neoplasms; Cell Cycle; Cell Division; DNA, Neoplasm; Flow Cytometry; Gonanes; Humans; Medroxyprogesterone Acetate; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Progesterone; Receptors, Steroid; Tumor Cells, Cultured	1993
Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: I. MCF-7 cell lines. The Journal of steroid biochemistry and molecular biology, 1995, Volume: 55, Issue:3-4 Topics: Adenocarcinoma; Breast Neoplasms; Cell Division; Desogestrel; Estradiol; Estrogen Antagonists; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Models, Statistical; Nandrolone; Norethindrone; Norpregnenes; Pregnanes; Pregnenediones; Progesterone; Promegestone; Receptors, Androgen; Receptors, Estrogen; Receptors, Progesterone; Tumor Cells, Cultured	1995
Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: II. T47D cell lines. The Journal of steroid biochemistry and molecular biology, 1995, Volume: 55, Issue:3-4 Topics: Breast Neoplasms; Carcinoma; Cell Division; Desogestrel; Dose-Response Relationship, Drug; Estradiol; Estrenes; Estrogen Antagonists; Female; Furans; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Mifepristone; Nandrolone; Norethindrone; Norpregnenes; Pregnanes; Pregnenediones; Progesterone; Promegestone; Tumor Cells, Cultured	1995
[A case of breast cancer with metastasis of multiple organs showing marked efficacy of medroxyprogesterone acetate (MPA)]. Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:5 Topics: Antineoplastic Agents, Hormonal; Bone Neoplasms; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Medroxyprogesterone Acetate; Middle Aged; Pleural Neoplasms; Remission Induction	1996
[A case of recurrent breast cancer responding to long-term treatment with 5'-DFUR combined with MPA]. Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:9 Topics: Adenocarcinoma, Scirrhous; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Female; Floxuridine; Humans; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local	1996
Effects of sex- and glucocorticoid steroids on breast cancer cells grown as either multicellular tumor spheroids or monolayers. The Journal of steroid biochemistry and molecular biology, 1996, Volume: 58, Issue:1 Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Division; Dexamethasone; Dihydrotestosterone; Estradiol; Estrogen Antagonists; Humans; Medroxyprogesterone Acetate; Mifepristone; Spheroids, Cellular; Steroids; Tamoxifen; Tumor Cells, Cultured	1996
Progestogen-only oral contraceptives and risk of breast cancer in New Zealand. Cancer causes & control : CCC, 1996, Volume: 7, Issue:5 Topics: Adult; Breast Neoplasms; Case-Control Studies; Confidence Intervals; Contraceptives, Oral, Hormonal; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; New Zealand; Population Surveillance; Pregnancy; Progesterone Congeners; Progestins; Reproductive History; Risk Factors; Time Factors	1996
Medroxyprogesterone acetate treatment reduces serum interleukin-6 levels in patients with metastatic breast carcinoma. Cancer, 1996, Dec-01, Volume: 78, Issue:11 Topics: Administration, Oral; Adult; Aged; Breast Neoplasms; Female; Humans; Interleukin-6; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Proteins; Progesterone Congeners; Prospective Studies	1996
The effects of cyclosporin A, tamoxifen, and medroxyprogesterone acetate on the enhancement of adriamycin cytotoxicity in primary cultures of human breast epithelial cells. Breast cancer research and treatment, 1996, Volume: 41, Issue:2 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Cyclosporine; Doxorubicin; Drug Resistance, Multiple; Drug Synergism; Epithelium; Humans; Medroxyprogesterone Acetate; Receptors, Estrogen; Tamoxifen; Tumor Cells, Cultured	1996
[Treatment results of brain metastasis from breast cancer: course of the disease and radiation therapy]. Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica, 1997, Volume: 57, Issue:1 Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Brain Neoplasms; Breast Neoplasms; Combined Modality Therapy; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Prognosis; Radiotherapy Dosage; Survival Analysis; Tamoxifen	1997
[Does interferon-alpha enhance the effect of tamoxifen-medroxyprogesterone acetate and hydroxyflutamide on in vitro tumor cells?]. Zentralblatt fur Gynakologie, 1996, Volume: 118, Issue:11 Topics: Androgen Antagonists; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Division; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Female; Flutamide; Humans; Interferon-alpha; Medroxyprogesterone Acetate; Ovarian Neoplasms; Tamoxifen; Tumor Cells, Cultured; Tumor Stem Cell Assay	1996
L-histidine/medroxyprogesterone acetate interaction modulates human breast cancer cell growth and progestin receptor expression in vitro. Pharmacological research, 1997, Volume: 35, Issue:2 Topics: Breast Neoplasms; Cell Count; Cell Division; Drug Synergism; Histidine; Humans; Kinetics; Medroxyprogesterone Acetate; Progesterone Congeners; Receptors, Estrogen; Receptors, Progesterone; Thymidine; Tritium; Tumor Cells, Cultured	1997
Natural interferon-alpha activity in hormone-sensitive, hormone-resistant and autonomous human breast-cancer cell lines. International journal of cancer, 1997, Jun-11, Volume: 71, Issue:6 Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Drug Resistance, Neoplasm; Humans; Interferon-alpha; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Tamoxifen; Tumor Cells, Cultured	1997
[A case of advanced breast cancer receiving combination therapy with 5'-DFUR and MPA with remarkable results]. Gan to kagaku ryoho. Cancer & chemotherapy, 1997, Volume: 24, Issue:9 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Papillary; Combined Modality Therapy; Drug Administration Schedule; Female; Floxuridine; Humans; Lymph Node Excision; Lymphatic Metastasis; Medroxyprogesterone Acetate	1997
Medroxyprogesterone acetate induced Cushing's syndrome. British journal of clinical pharmacology, 1997, Volume: 44, Issue:3 Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Cushing Syndrome; Female; Humans; Medroxyprogesterone Acetate; Middle Aged	1997
Progestin regulation of vascular endothelial growth factor in human breast cancer cells. Cancer research, 1998, Feb-01, Volume: 58, Issue:3 Topics: Breast Neoplasms; Endometrial Neoplasms; Endothelial Growth Factors; Female; Gene Expression Regulation, Neoplastic; Humans; Lymphokines; Medroxyprogesterone Acetate; Megestrol Acetate; Mifepristone; Neoplasm Proteins; Neovascularization, Pathologic; Norethindrone; Norethynodrel; Norgestrel; Progesterone; Progestins; Receptors, Progesterone; Stimulation, Chemical; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors	1998
[A case report of advanced breast cancer with remarkable response to chemoendocrine therapy (CTF + MPA)]. Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:5 Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Medroxyprogesterone Acetate; Middle Aged	1998
Pharmacokinetic study of low- versus high-dose medroxyprogesterone acetate (MPA) in women. Cancer chemotherapy and pharmacology, 1998, Volume: 42, Issue:1 Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Breast Neoplasms; Chromatography, High Pressure Liquid; Clinical Trials as Topic; Drug Administration Schedule; Drug Interactions; Female; Humans; Linear Models; Liver Function Tests; Medroxyprogesterone Acetate; Middle Aged; Statistics, Nonparametric	1998
Combined effect of navelbine with medroxyprogesterone acetate against human breast carcinoma MCF-7 cells in vitro. British journal of cancer, 1998, Volume: 77, Issue:11 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Cycle; Cell Division; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Female; Humans; Medroxyprogesterone Acetate; Phosphorylation; Retinoblastoma Protein; Tumor Cells, Cultured; Vinblastine; Vinorelbine	1998
Multidrug-resistant recurrent breast cancer which responded to medroxyprogesterone acetate showing a remarkable improvement in the quality of life: report of a case and the role of team medical care. Surgery today, 1998, Volume: 28, Issue:9 Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Fluorouracil; Humans; Medroxyprogesterone Acetate; Neoplasm Recurrence, Local; Palliative Care; Patient Care Team; Quality of Life	1998
[A case of stage IV breast cancer showing long-term complete response to combination therapy with 5'-DFUR and MPA]. Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:13 Topics: Adenocarcinoma, Scirrhous; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Combined Modality Therapy; Female; Floxuridine; Humans; Lymphatic Metastasis; Mastectomy; Medroxyprogesterone Acetate; Middle Aged; Remission Induction	1998
Applying k-sample tests to conditional probabilities for competing risks in a clinical trial. Biometrics, 1998, Volume: 54, Issue:4 Topics: Antineoplastic Agents, Hormonal; Biometry; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Medroxyprogesterone Acetate; Probability; Prognosis; Randomized Controlled Trials as Topic; Receptors, Estrogen; Recurrence; Risk Factors; Tamoxifen; Treatment Failure	1998
Medroxyprogesterone acetate inhibits interleukin 6 secretion from KPL-4 human breast cancer cells both in vitro and in vivo: a possible mechanism of the anticachectic effect. British journal of cancer, 1999, Volume: 79, Issue:3-4 Topics: Animals; Antineoplastic Agents, Hormonal; Body Weight; Breast Neoplasms; Cachexia; Female; Humans; Injections, Intramuscular; Interleukin-6; Medroxyprogesterone Acetate; Mice; Mice, Nude; Neoplasm Transplantation; Tumor Cells, Cultured	1999
[Effective chemo-endocrine combination therapy for obstructive-jaundice caused by multiple liver metastasis of recurrent breast cancer--a case report]. Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:7 Topics: Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cholestasis; Cyclophosphamide; Doxorubicin; Drainage; Female; Floxuridine; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Mastectomy, Radical; Medroxyprogesterone Acetate; Tamoxifen; Tegafur; Toremifene; Uracil	1999
[A case of breast cancer with liver metastases responding remarkably to combination therapy of mitoxantrone (MIT), doxifluridine (5'-DFUR) and medroxyprogesterone acetate (MPA)]. Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:8 Topics: Administration, Oral; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Drug Resistance, Neoplasm; Epirubicin; Female; Floxuridine; Fluorouracil; Humans; Liver Neoplasms; Medroxyprogesterone Acetate; Middle Aged; Mitoxantrone; Tamoxifen	1999
Multiple liver metastases of breast cancer: report of a case successfully treated with hormone-cytokine-chemotherapy. Japanese journal of clinical oncology, 1999, Volume: 29, Issue:8 Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Papillary; Combined Modality Therapy; Female; Humans; Infusions, Intra-Arterial; Interferon-alpha; Liver Neoplasms; Medroxyprogesterone Acetate; Tumor Necrosis Factor-alpha	1999
Androgen receptor agonist activity of the synthetic progestin, medroxyprogesterone acetate, in human breast cancer cells. Molecular and cellular endocrinology, 1999, Aug-20, Volume: 154, Issue:1-2 Topics: Androgen Antagonists; Androgens; Antineoplastic Agents; Binding, Competitive; Breast Neoplasms; Cell Division; Cytosol; Female; Gene Expression Regulation; Humans; Imidazoles; Imidazolidines; Medroxyprogesterone Acetate; Progestins; Receptors, Androgen; Transcription, Genetic; Tritium; Tumor Cells, Cultured	1999
Suppression of parathyroid hormone-related protein messenger RNA expression by medroxyprogesterone acetate in breast cancer tissues. Breast cancer research and treatment, 1999, Volume: 56, Issue:1 Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Estradiol; Female; Gene Expression Regulation, Neoplastic; Humans; Medroxyprogesterone Acetate; Parathyroid Hormone-Related Protein; Polymerase Chain Reaction; Protein Biosynthesis; Receptors, Progesterone; RNA, Messenger; Tamoxifen; Tumor Cells, Cultured	1999
[Successful treatment of pleuritis carcinomatosa using combination therapy of 5'-DFUR, MPA and CPA as maintenance therapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:13 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Drug Administration Schedule; Female; Floxuridine; Humans; Medroxyprogesterone Acetate; Middle Aged; Pleurisy	1999
Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast. The Journal of clinical endocrinology and metabolism, 1999, Volume: 84, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Biopsy; Breast; Breast Neoplasms; Cell Division; Cross-Sectional Studies; Epithelial Cells; Estrogen Replacement Therapy; Female; Humans; Ki-67 Antigen; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Proliferating Cell Nuclear Antigen; Receptors, Estrogen; Receptors, Progesterone; Risk Factors	1999
Risk of breast cancer in relation to the use of injectable progestogen contraceptives and combined estrogen/progestogen contraceptives. American journal of epidemiology, 2000, Feb-15, Volume: 151, Issue:4 Topics: Adult; Black or African American; Black People; Breast Neoplasms; Case-Control Studies; Contraceptives, Oral, Combined; Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Middle Aged; Progesterone Congeners; Risk Factors; South Africa	2000
[Improved QOL with cancer chemotherapy in two patients with breast cancer suffering form carcinomatous pleurisy and carcinomatous peritonitis]. Gan to kagaku ryoho. Cancer & chemotherapy, 2000, Volume: 27, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Humans; Medroxyprogesterone Acetate; Middle Aged; Peritonitis; Pleurisy; Quality of Life; Tegafur; Uracil	2000
[Pain relief with alendronate therapy in a breast cancer patient with bone metastasis]. Gan to kagaku ryoho. Cancer & chemotherapy, 2000, Volume: 27, Issue:4 Topics: Aged; Alendronate; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Bone Neoplasms; Breast Neoplasms; Female; Floxuridine; Humans; Medroxyprogesterone Acetate; Pain; Sternum	2000
Progestin regulation of 11beta-hydroxysteroid dehydrogenase expression in T-47D human breast cancer cells. The Journal of steroid biochemistry and molecular biology, 2000, Volume: 72, Issue:5 Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Breast Neoplasms; Carcinoma; Corticosterone; Dose-Response Relationship, Drug; Estradiol; Estrone; Female; Gene Expression Regulation, Enzymologic; Humans; Hydroxysteroid Dehydrogenases; Medroxyprogesterone Acetate; Mifepristone; NAD; Progesterone Congeners; Progestins; RNA, Messenger; Tumor Cells, Cultured	2000
[A case of advanced breast cancer associated with humoral hypercalcemia that responded to medroxyprogesterone acetate and docetaxel]. Gan to kagaku ryoho. Cancer & chemotherapy, 2000, Volume: 27, Issue:7 Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Docetaxel; Drug Administration Schedule; Female; Humans; Hypercalcemia; Lymph Nodes; Lymphatic Metastasis; Medroxyprogesterone Acetate; Neoplasm Invasiveness; Paclitaxel; Taxoids	2000
[Chemotherapy with mitoxantrone for the treatment of recurrent breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2000, Volume: 27, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Drug Administration Schedule; Female; Floxuridine; Humans; Lung Neoplasms; Medroxyprogesterone Acetate; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Vincristine	2000
[A case of effective bisphosphonate therapy of sequential pamidronate and incadronate for bone metastases from breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2000, Volume: 27, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Drug Administration Schedule; Female; Floxuridine; Humans; Medroxyprogesterone Acetate; Middle Aged; Pamidronate	2000
Paradoxical hormone responses of KPL-1 breast cancer cells in vivo: a significant role of angiogenesis in tumor growth. Oncology, 2000, Volume: 59, Issue:2 Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Hormonal; Apoptosis; Breast Neoplasms; Cell Division; Cyclohexanes; Endothelial Growth Factors; Female; Humans; Lymphokines; Medroxyprogesterone Acetate; Mitotic Index; Neovascularization, Pathologic; O-(Chloroacetylcarbamoyl)fumagillol; RNA, Messenger; Sesquiterpenes; Transfection; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors	2000
An analysis of serum interleukin-6 levels to predict benefits of medroxyprogesterone acetate in advanced or recurrent breast cancer. Oncology, 2000, Volume: 59, Issue:2 Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Breast Neoplasms; Female; Humans; Interleukin-6; Medroxyprogesterone Acetate; Middle Aged; Outcome Assessment, Health Care; Recurrence	2000
[A case of advanced breast cancer that responded remarkably to chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2000, Volume: 27, Issue:13 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Floxuridine; Fluorouracil; Humans; Medroxyprogesterone Acetate; Middle Aged	2000
Biphasic effect of medroxyprogesterone-acetate (MPA) treatment on proliferation and cyclin D1 gene transcription in T47D breast cancer cells. Breast cancer research and treatment, 2000, Volume: 63, Issue:3 Topics: Antineoplastic Agents, Hormonal; Blotting, Western; Breast Neoplasms; Cell Division; Cyclin D1; Female; Humans; Medroxyprogesterone Acetate; Promoter Regions, Genetic; Transcription, Genetic; Tumor Cells, Cultured	2000
[A case of breast cancer with multiple organ metastases responding remarkably to combination therapy of CAF (cyclophosphamide, adriamycin and 5-FU), 5'-DFUR and MPA (medroxyprogesterone acetate)]. Gan to kagaku ryoho. Cancer & chemotherapy, 2000, Volume: 27, Issue:14 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Floxuridine; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Mastectomy; Medroxyprogesterone Acetate; Middle Aged; Remission Induction	2000
[A case of breast cancer with multiple metastases successfully treated by medroxyprogesterone acetate with intermittent intra-arterial infusion low-dose chemotherapy to hepatic metastasis]. Gan to kagaku ryoho. Cancer & chemotherapy, 2000, Volume: 27, Issue:14 Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Drug Administration Schedule; Female; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local; Pleural Neoplasms; Tamoxifen; Tegafur; Uracil	2000
Pharmacological and endogenous progestins induce vascular endothelial growth factor expression in human breast cancer cells. International journal of cancer, 2001, May-15, Volume: 92, Issue:4 Topics: Alternative Splicing; Antimetabolites, Antineoplastic; Blotting, Northern; Breast Neoplasms; Culture Media; Dactinomycin; Dose-Response Relationship, Drug; Endothelial Growth Factors; Enzyme-Linked Immunosorbent Assay; Estrogens; Glucocorticoids; Hormone Antagonists; Humans; Lymphokines; Medroxyprogesterone Acetate; Mifepristone; Progesterone; Progestins; Protein Isoforms; Protein Synthesis Inhibitors; Puromycin; Receptors, Progesterone; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors	2001
[A patient with recurrent breast cancer whose liver metastasis regressed following combined use of weekly docetaxel and MPA.5'-DFUR]. Gan to kagaku ryoho. Cancer & chemotherapy, 2001, Volume: 28, Issue:10 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Docetaxel; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Floxuridine; Humans; Liver Neoplasms; Medroxyprogesterone Acetate; Paclitaxel; Taxoids	2001
Apoptosis inhibition mediated by medroxyprogesterone acetate treatment of breast cancer cell lines. Breast cancer research and treatment, 2001, Volume: 68, Issue:3 Topics: Antineoplastic Agents, Hormonal; Apoptosis; Breast Neoplasms; Cell Division; DNA Primers; Female; Gene Expression; Genes, bcl-2; Humans; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Receptors, Progesterone; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured	2001
The effect of medroxyprogesterone acetate and norethisterone on the estradiol stimulated proliferation in MCF-7 cells: comparison of continuous combined versus sequential combined estradiol/progestin treatment. European journal of gynaecological oncology, 2001, Volume: 22, Issue:5 Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma; Estradiol; Estrogen Replacement Therapy; Female; Humans; In Vitro Techniques; Medroxyprogesterone Acetate; Norethindrone; Progesterone Congeners; Progestins; Tumor Cells, Cultured	2001
Successful management of breast cancer with liver metastases with medroxyprogesterone acetate treatment. International journal of clinical oncology, 2001, Volume: 6, Issue:6 Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Liver Neoplasms; Mastectomy, Radical; Medroxyprogesterone Acetate; Tomography, X-Ray Computed; Treatment Outcome	2001
Comparison of the effects of continuous combined and sequential combined medroxyprogesterone acetate-estradiol treatment on the proliferation of MCF-7 cells. Climacteric : the journal of the International Menopause Society, 2000, Volume: 3, Issue:4 Topics: Breast Neoplasms; Cell Division; Drug Administration Schedule; Estradiol; Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Tumor Cells, Cultured	2000
[Successful treatment of advanced recurent breast cancer using DMpC therapy as maintenance therapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2002, Volume: 29, Issue:3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Drug Administration Schedule; Female; Floxuridine; Humans; Medroxyprogesterone Acetate; Neoplasm Recurrence, Local	2002
Progestogen-only contraceptives and cancer risk. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP), 2002, Volume: 11, Issue:2 Topics: Breast Neoplasms; Contraceptive Agents, Female; Female; Humans; Medroxyprogesterone Acetate; Progesterone Congeners; Risk Factors	2002
Progestin upregulates G-protein-coupled receptor 30 in breast cancer cells. European journal of biochemistry, 2002, Volume: 269, Issue:10 Topics: Breast Neoplasms; Cloning, Molecular; Gene Expression Profiling; GTP-Binding Proteins; Medroxyprogesterone Acetate; Receptors, Cell Surface; Receptors, Estrogen; Receptors, G-Protein-Coupled; Tumor Cells, Cultured; Up-Regulation	2002
[A case of breast cancer with multiple bone metastases that responded remarkably to doxifluridine (5'-DFUR), cyclophosphamide (CPA), medroxyprogesterone acetate (MPA) and pamidronate disodium therapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2002, Volume: 29, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Diphosphonates; Drug Administration Schedule; Female; Floxuridine; Humans; Medroxyprogesterone Acetate; Middle Aged; Pamidronate; Quality of Life	2002
The effect of endocrine therapy with medroxyprogesterone acetate, 4-hydroxyandrostenedione or tamoxifen on plasma concentrations of insulin-like growth factor (IGF)-I, IGF-II and IGFBP-1 in women with advanced breast cancer. International journal of cancer, 1992, Sep-09, Volume: 52, Issue:2 Topics: Aged; Androstenedione; Breast Neoplasms; Carrier Proteins; Female; Humans; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Tamoxifen	1992
Contraceptives and cancer--looking for the evidence. The Central African journal of medicine, 1992, Volume: 38, Issue:2 Topics: Adult; Breast Neoplasms; Contraceptive Agents, Female; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Risk Factors; Time Factors; World Health Organization	1992
[A case of inflammatory breast cancer treated with medroxyprogesterone acetate (MPA) in combination with intra-arterial infusion chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:11 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Doxorubicin; Female; Humans; Inflammation; Infusions, Intra-Arterial; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged	1992
[A case of phlebothrombosis of lower extremity and pulmonary embolism due to progesterone]. Kokyu to junkan. Respiration & circulation, 1992, Volume: 40, Issue:8 Topics: Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local; Pulmonary Embolism; Tamoxifen; Thrombophlebitis	1992
[A case of jejunal vein thrombosis due to medroxyprogesterone acetate]. Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:13 Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Gastrointestinal Hemorrhage; Humans; Jejunum; Medroxyprogesterone Acetate; Thrombosis; Veins	1992
Regulation of c-jun and jun-B by progestins in T-47D human breast cancer cells. Molecular endocrinology (Baltimore, Md.), 1992, Volume: 6, Issue:10 Topics: beta-Galactosidase; Blotting, Northern; Blotting, Western; Breast Neoplasms; Chloramphenicol O-Acetyltransferase; Cycloheximide; Dose-Response Relationship, Drug; Female; Gene Expression Regulation, Neoplastic; Genes, jun; Humans; Kinetics; Medroxyprogesterone Acetate; Multigene Family; Proto-Oncogene Proteins c-jun; Recombinant Proteins; RNA, Messenger; Transcription, Genetic; Transfection; Tumor Cells, Cultured	1992
[The use of Provera (medroxyprogesterone acetate) for treating malignant tumors]. Terapevticheskii arkhiv, 1992, Volume: 64, Issue:10 Topics: Adult; Aged; Breast Neoplasms; Combined Modality Therapy; Drug Evaluation; Female; Humans; Kidney Neoplasms; Male; Medroxyprogesterone Acetate; Middle Aged; Tablets; Uterine Neoplasms	1992
[Successful treatment of disseminated breast cancer with combination therapy of 5'-deoxy-5'-fluorouridine (5'-DFUR), medroxyprogesterone acetate (MPA) and cyclophosphamide (CPA)]. Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Papillary; Cyclophosphamide; Drug Administration Schedule; Female; Floxuridine; Humans; Liver Neoplasms; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Pleural Neoplasms; Soft Tissue Neoplasms	1992
Update on Depo-Provera. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1992, May-02, Volume: 81, Issue:9 Topics: Breast Neoplasms; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate	1992
Antiproliferative effect of leuprorelin acetate, alone or combined with tamoxifen or medroxyprogesterone acetate, on human breast cancer cell lines. Clinical therapeutics, 1992, Volume: 14 Suppl A Topics: Antineoplastic Agents; Breast Neoplasms; Cell Division; Cell Line; Delayed-Action Preparations; Estradiol; Female; Humans; Leuprolide; Medroxyprogesterone; Medroxyprogesterone Acetate; Tamoxifen; Tumor Cells, Cultured	1992
Pharmacokinetics and pharmacodynamics of medroxyprogesterone acetate in advanced breast cancer patients. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1992, Volume: 10, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Breast Neoplasms; Chromatography, High Pressure Liquid; Female; Humans; Liver Function Tests; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Treatment Outcome	1992
Depo-Provera. Controversial contraceptive wins approval from FDA panel. Science (New York, N.Y.), 1992, Jun-26, Volume: 256, Issue:5065 Topics: Adult; Breast Neoplasms; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Humans; Legislation, Drug; Medroxyprogesterone; Medroxyprogesterone Acetate; Osteoporosis; United States; United States Food and Drug Administration; Uterine Neoplasms	1992
[Combination of transarterial chemoembolization and endocrine therapy for liver metastases of breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1991, Volume: 18, Issue:11 Topics: Adult; Aged; Breast Neoplasms; Doxorubicin; Drug Therapy, Combination; Embolization, Therapeutic; Female; Humans; Infusions, Intra-Arterial; Iodized Oil; Liver Neoplasms; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged	1991
DMPA and breast cancer: the dog has had its day. Lancet (London, England), 1991, Oct-05, Volume: 338, Issue:8771 Topics: Adult; Animals; Breast Neoplasms; Contraceptive Agents, Female; Developing Countries; Disease Models, Animal; Dogs; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Product Surveillance, Postmarketing	1991
Safety of depot medroxyprogesterone acetate. Lancet (London, England), 1991, Oct-12, Volume: 338, Issue:8772 Topics: Adolescent; Adult; Breast Neoplasms; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Humans; Life Expectancy; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged	1991
Safety of DMPA. Lancet (London, England), 1991, Nov-02, Volume: 338, Issue:8775 Topics: Age Factors; Antineoplastic Agents; Breast Neoplasms; Endometrial Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Risk Factors	1991
Longterm remission of multiple brain metastases with tamoxifen. Journal of neuro-oncology, 1991, Volume: 10, Issue:2 Topics: Activities of Daily Living; Aged; Antineoplastic Agents; Brain Neoplasms; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Combined Modality Therapy; Estrogens; Female; Humans; Mastectomy, Radical; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Palliative Care; Psychomotor Disorders; Tamoxifen	1991
[5'-deoxy-5-fluorouridine (5'-DFUR), mitomycin C (MMC), etoposide and medroxy progesterone acetate (MPA) in a previously treated patient with advanced breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1991, Volume: 18, Issue:1 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Etoposide; Female; Floxuridine; Humans; Liver Neoplasms; Lymphatic Metastasis; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Mitomycin; Mitomycins; Remission Induction	1991
Adrenal failure in patients with breast carcinoma after long-term treatment of cyclic alternating oestrogen progesterone. British journal of cancer, 1991, Volume: 63, Issue:3 Topics: Adrenal Glands; Adrenal Insufficiency; Adult; Aged; Breast Neoplasms; Carcinoma; Drug Administration Schedule; Estradiol; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged	1991
Depo Provera and breast cancer. The New Zealand medical journal, 1991, Jan-23, Volume: 104, Issue:904 Topics: Adult; Breast Neoplasms; Contraceptive Agents, Female; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Risk	1991
[The elevation of serum iron level with oral administration of medroxyprogesterone acetate (MPA) in patients with breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1991, Volume: 18, Issue:6 Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Iron; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Retrospective Studies; Tegafur; Uracil	1991
Changes in hematologic parameters during treatment with medroxyprogesterone acetate for breast cancer. Japanese journal of cancer research : Gann, 1991, Volume: 82, Issue:4 Topics: Adult; Aged; Antineoplastic Agents; Blood Coagulation; Blood Coagulation Factors; Breast Neoplasms; Female; Fibrinolysis; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Partial Thromboplastin Time; Plasminogen; Prothrombin Time; Thromboembolism	1991
Differential regulation of c-myc by progestins and antiestrogens in T-47D human breast cancer cells. The Journal of steroid biochemistry and molecular biology, 1991, Volume: 39, Issue:1 Topics: Breast Neoplasms; Cell Line; Cell Transformation, Neoplastic; Estrogen Antagonists; Female; Gene Expression Regulation, Neoplastic; Genes, myc; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Progestins; Proto-Oncogene Proteins c-myc; RNA, Messenger; Tamoxifen; Tumor Cells, Cultured	1991
Growth stimulation and differential regulation of transforming growth factor-beta 1 (TGF beta 1), TGF beta 2, and TGF beta 3 messenger RNA levels by norethindrone in MCF-7 human breast cancer cells. Molecular endocrinology (Baltimore, Md.), 1991, Volume: 5, Issue:8 Topics: Breast Neoplasms; Cell Division; Estradiol; Gene Expression Regulation; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Promegestone; Receptors, Estrogen; Receptors, Progesterone; RNA, Messenger; Tamoxifen; Transforming Growth Factor beta; Tumor Cells, Cultured	1991
[Plasma lipoprotein fractions in high-dose medroxyprogesterone acetate therapy in metastatic breast cancer]. Gynakologische Rundschau, 1991, Volume: 31, Issue:4 Topics: Antineoplastic Agents; Breast Neoplasms; Dose-Response Relationship, Drug; Female; Humans; Lipoproteins; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Prospective Studies	1991
[Reflexions on hormone therapy of cancer of the breast]. Bulletin du cancer, 1991, Volume: 78, Issue:11 Suppl Topics: Aminoglutethimide; Androgens; Breast Neoplasms; Estrogens; Female; Humans; Medroxyprogesterone Acetate; Menopause; Neoplasm Metastasis; Ovariectomy; Tamoxifen	1991
Mechanisms involved in the evolution of progestin resistance in human breast cancer cells. Cancer research, 1991, Apr-15, Volume: 51, Issue:8 Topics: Antineoplastic Agents; Breast Neoplasms; Cell Division; Drug Resistance; Gene Expression Regulation, Neoplastic; Growth Substances; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Phenotype; Progestins; Receptors, Cell Surface; Receptors, Estrogen; Receptors, Progesterone; Tumor Cells, Cultured	1991
Influence of hormones on proliferation of ER-positive cells and ER-negative cells of human breast cancer (MCF-7). Oncology, 1990, Volume: 47, Issue:1 Topics: Animals; Autoradiography; Breast Neoplasms; Female; Humans; Immunohistochemistry; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Receptors, Estrogen; Tamoxifen; Thymidine; Tumor Cells, Cultured	1990
Inability of medroxyprogesterone acetate to down regulate estrogen receptor level in human breast cancer. Cancer, 1990, Mar-15, Volume: 65, Issue:6 Topics: Antineoplastic Agents; Breast Neoplasms; Down-Regulation; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Receptors, Estrogen; Receptors, Progesterone	1990
Hormone and cytotoxic drug responsiveness of cultured human breast cancer cells resistant to specific hormones. International journal of cancer, 1990, Apr-15, Volume: 45, Issue:4 Topics: Breast Neoplasms; Cell Division; Dexamethasone; Drug Resistance; Estradiol; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Methotrexate; Pyrrolidines; Tamoxifen; Thiophenes; Tumor Cells, Cultured; Vincristine	1990
High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions. British journal of cancer, 1990, Volume: 61, Issue:4 Topics: Antineoplastic Agents; Breast Neoplasms; Cell Division; Cell Line; Contraceptive Agents, Female; Culture Media; Estradiol; Estrogen Antagonists; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Receptors, Progesterone; Tamoxifen; Tumor Cells, Cultured	1990
Medroxyprogesterone (Depo Provera) and breast cancer. The New Zealand medical journal, 1990, May-09, Volume: 103, Issue:889 Topics: Adult; Breast Neoplasms; Contraceptive Agents, Female; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Risk Factors	1990
[Combination therapy with 5'DFUR and MPA as a second line treatment for advanced/recurrent breast cancer]. Nihon Gan Chiryo Gakkai shi, 1990, Mar-20, Volume: 25, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Floxuridine; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local	1990
[Male transsexualism and hormonal therapy: radiologic pictures of the breast]. Archivio italiano di urologia, nefrologia, andrologia : organo ufficiale dell'Associazione per la ricerca in urologia = Urological, nephrological, and andrological sciences, 1990, Volume: 62, Issue:1 Topics: Adult; Breast Neoplasms; Cyproterone; Cyproterone Acetate; Estrogens; Fibrocystic Breast Disease; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Radiography; Transsexualism	1990
Depot medroxyprogesterone and breast cancer. The New Zealand medical journal, 1990, Jul-11, Volume: 103, Issue:893 Topics: Antineoplastic Agents; Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Research Design; Risk Factors	1990
Interactions between estrogens, androgens, progestins, and glucocorticoids in ZR-75-1 human breast cancer cells. Annals of the New York Academy of Sciences, 1990, Volume: 595 Topics: Androgens; Androstenediol; Apolipoproteins; Apolipoproteins D; Breast Neoplasms; Carrier Proteins; Cell Division; Dihydrotestosterone; Estrogens; Gene Expression; Glucocorticoids; Glycoproteins; Humans; In Vitro Techniques; Insulin; Medroxyprogesterone; Medroxyprogesterone Acetate; Membrane Transport Proteins; Neoplasm Proteins; Piperidines; Raloxifene Hydrochloride; Receptors, Estrogen; Receptors, Progesterone; RNA, Messenger; Tumor Cells, Cultured	1990
Analysis by DNA polymerase alpha activity of human breast tumour proliferation and the effect of endocrine therapy. British journal of cancer, 1990, Volume: 62, Issue:2 Topics: Androstenedione; Antineoplastic Agents; Biopsy; Breast Neoplasms; DNA Polymerase II; Estrogens; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Receptors, Estrogen	1990
[A case of disseminated breast cancer successfully treated with medroxyprogesterone acetate]. Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:8 Pt 1 Topics: Adenocarcinoma; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Receptors, Estrogen; Remission Induction	1990
[Hormonal control of disseminated breast cancer]. Sovetskaia meditsina, 1990, Issue:6 Topics: Aminoglutethimide; Antineoplastic Agents; Breast Neoplasms; Delayed-Action Preparations; Estrogen Antagonists; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Neoplasm Metastasis; Tamoxifen	1990
[Effect of medroxyprogesterone acetate on the cell kinetics in primary breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:10 Topics: Antineoplastic Agents; Breast Neoplasms; Cell Cycle; DNA, Neoplasm; Female; Flow Cytometry; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Pituitary Hormones, Anterior; Receptors, Estrogen; Receptors, Progesterone	1990
Influence of aminoglutethimide on plasma levels of medroxyprogesterone acetate. Medical oncology and tumor pharmacotherapy, 1990, Volume: 7, Issue:4 Topics: Adult; Aged; Aminoglutethimide; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Drug Interactions; Drug Resistance; Female; Humans; Hydrocortisone; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Survival Rate	1990
Effect of tamoxifen and high-dose medroxyprogesterone acetate (MPA) on cell-mediated immune functions in breast cancer patients. Methods and findings in experimental and clinical pharmacology, 1990, Volume: 12, Issue:10 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Breast Neoplasms; Cell Migration Inhibition; Female; Humans; Immunity, Cellular; Interferon Type I; Interleukin-2; Lymphocyte Subsets; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Prospective Studies; Tamoxifen; Tumor Necrosis Factor-alpha	1990
[Clinical efficacy of ifosfamide for liver metastasis of breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:4 Pt 1 Topics: Antineoplastic Combined Chemotherapy Protocols; Bicarbonates; Breast Neoplasms; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Humans; Ifosfamide; Liver Neoplasms; Medroxyprogesterone; Medroxyprogesterone Acetate; Mitomycin; Mitomycins; Sodium; Sodium Bicarbonate	1990
Immunocytochemical assay for estrogen receptor in patients with breast cancer: relationship to a biochemical assay and to outcome of therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1986, Volume: 4, Issue:8 Topics: Aminoglutethimide; Antibodies, Monoclonal; Breast Neoplasms; Combined Modality Therapy; Dextrans; Female; Histocytochemistry; Humans; Immunoenzyme Techniques; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Prognosis; Receptors, Estrogen; Staining and Labeling; Tamoxifen	1986
[Complete remission, obtained by multidisciplinary treatment of recurrent breast cancer with carcinomatous pleuritis, and cervical lymph node and diver metastasis]. Gan no rinsho. Japan journal of cancer clinics, 1989, Volume: 35, Issue:1 Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Combined Modality Therapy; Doxorubicin; Drug Administration Schedule; Female; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Lymphatic Metastasis; Medroxyprogesterone; Medroxyprogesterone Acetate; Pleurisy; Remission Induction	1989
Actions of medroxyprogesterone acetate on the efficacy of cytotoxic drugs: studies with human breast cancer cells in culture. International journal of cancer, 1989, Mar-15, Volume: 43, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Interactions; Drug Screening Assays, Antitumor; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Methotrexate; Tumor Cells, Cultured; Vincristine	1989
High-dose medroxyprogesterone acetate in advanced breast cancer. Clinical and pharmacokinetic study with a combined oral and intramuscular regimen. Cancer, 1989, May-15, Volume: 63, Issue:10 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Humans; Injections, Intramuscular; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged	1989
Adriamycin action on human breast cancer cells: enhancement by medroxyprogesterone acetate. International journal of cancer, 1989, Apr-15, Volume: 43, Issue:4 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line; Dexamethasone; Dose-Response Relationship, Drug; Doxorubicin; Drug Evaluation, Preclinical; Drug Synergism; Estradiol; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Tumor Cells, Cultured	1989
Influence of tamoxifen-medroxyprogesterone sequential therapy on estrogen and progesterone receptor contents of breast cancer. Japanese journal of cancer research : Gann, 1989, Volume: 80, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Nucleus; Cytosol; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen	1989
Regulation of transforming growth factor alpha and transforming growth factor beta messenger ribonucleic acid abundance in T-47D, human breast cancer cells. Molecular endocrinology (Baltimore, Md.), 1989, Volume: 3, Issue:4 Topics: Antineoplastic Agents; Breast Neoplasms; Gene Expression Regulation; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Receptors, Steroid; RNA, Messenger; Transforming Growth Factors; Tumor Cells, Cultured	1989
[Combination therapy with medroxyprogesterone acetate and tegafur in tamoxifen- and adriamycin-resistant advanced breast cancers]. Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:5 Topics: Adult; Aged; Breast Neoplasms; Doxorubicin; Drug Evaluation; Drug Resistance; Drug Therapy, Combination; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Obesity; Receptors, Estrogen; Receptors, Progesterone; Remission Induction; Tamoxifen; Tegafur; Uterine Hemorrhage	1989
Androgen and glucocorticoid receptor-mediated inhibition of cell proliferation by medroxyprogesterone acetate in ZR-75-1 human breast cancer cells. Breast cancer research and treatment, 1989, Volume: 13, Issue:2 Topics: Breast Neoplasms; Cell Division; Cell Line; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Receptors, Adrenergic; Receptors, Glucocorticoid	1989
[Mammary gland carcinoma treated by large-dose medroxyprogesterone acetate of which pulmonary metastases disappeared and a selection of hormone, chemoimmunological treatment]. Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Combined Modality Therapy; Female; Humans; Lung Neoplasms; Mastectomy, Radical; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Remission Induction; Tamoxifen; Tegafur	1989
Sequential cyclic combined hormonal therapy for metastatic breast cancer. Cancer, 1989, Sep-01, Volume: 64, Issue:5 Topics: Adult; Aged; Breast Neoplasms; Ethinyl Estradiol; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Neoplasm Metastasis; Receptors, Estrogen; Receptors, Progesterone	1989
[Influence of endocrine therapy on the proliferation of estrogen (ER) positive cells and ER negative cells of human breast cancer (MCF-7)]. Nihon Geka Gakkai zasshi, 1989, Volume: 90, Issue:5 Topics: Animals; Antineoplastic Agents; Autoradiography; Breast Neoplasms; Cell Division; Estradiol; Female; Humans; Immunohistochemistry; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Receptors, Estrogen; Tamoxifen	1989
Depot medroxyprogesterone (Depo-Provera) and risk of breast cancer. BMJ (Clinical research ed.), 1989, Sep-23, Volume: 299, Issue:6702 Topics: Adult; Age Factors; Breast Neoplasms; Case-Control Studies; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Random Allocation; Risk Factors; Time Factors	1989
[Results of tamoxifen-medroxyprogesterone acetate sequential therapy in 22 patients with recurrent breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:11 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Humans; Lung Neoplasms; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Recurrence; Remission Induction; Soft Tissue Neoplasms; Tamoxifen; Weight Gain	1989
Sequential alternating medroxyprogesterone acetate and epirubicin in the treatment of advanced breast cancer. The Australian and New Zealand journal of surgery, 1989, Volume: 59, Issue:11 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Delayed-Action Preparations; Drug Evaluation; Epirubicin; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local	1989
Depot medroxyprogesterone and risk of breast cancer. BMJ (Clinical research ed.), 1989, Oct-28, Volume: 299, Issue:6707 Topics: Breast Neoplasms; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Risk Factors	1989
Oral high-dose progestins as treatment for advanced breast cancer. Acta oncologica (Stockholm, Sweden), 1989, Volume: 28, Issue:6 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Breast Neoplasms; Drug Administration Schedule; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Middle Aged; Receptors, Estrogen; Receptors, Progesterone; Remission Induction; Retrospective Studies	1989
The effects of sequential treatment with ethynyloestradiol and medroxyprogesterone acetate on oestrogen and progestogen receptors in breast cancer. Journal of steroid biochemistry, 1989, Volume: 34, Issue:1-6 Topics: Aged; Antineoplastic Agents; Biomarkers, Tumor; Breast Neoplasms; Drug Administration Schedule; Ethinyl Estradiol; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Receptors, Estrogen; Receptors, Progesterone	1989
The effect of medroxyprogesterone acetate on aromatase and DNA polymerase alpha activities in breast tumours. Journal of steroid biochemistry, 1989, Volume: 34, Issue:1-6 Topics: Aged; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Cell Division; DNA Polymerase II; Estrone; Female; Humans; Kinetics; Medroxyprogesterone; Medroxyprogesterone Acetate; Tumor Cells, Cultured	1989
Breast cancer and depot-medroxyprogesterone acetate. WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Bulletin of the World Health Organization, 1985, Volume: 63, Issue:3 Topics: Breast Neoplasms; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Humans; Kenya; Medroxyprogesterone; Medroxyprogesterone Acetate; Mexico; Risk; Thailand	1985
Hospitalizations among black women using contraceptives. American journal of obstetrics and gynecology, 1985, Oct-01, Volume: 153, Issue:3 Topics: Adolescent; Adult; Age Factors; Black or African American; Breast Neoplasms; Carcinoma in Situ; Cardiovascular Diseases; Child; Contraceptives, Oral; Female; Georgia; Hospitalization; Humans; Intrauterine Devices; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Pelvic Inflammatory Disease; Pregnancy; Pregnancy, Ectopic; Risk; Time Factors; Uterine Cervical Neoplasms	1985
[Hormone therapy of breast cancer-its role in the treatment of breast cancer]. Gan no rinsho. Japan journal of cancer clinics, 1985, Volume: 31, Issue:9 Suppl Topics: Breast Neoplasms; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Postoperative Care; Receptors, Estrogen; Tamoxifen; Tegafur	1985
Hormonal treatment of disseminated male breast cancer. Oncology, 1985, Volume: 42, Issue:6 Topics: Adult; Aminoglutethimide; Androgen Antagonists; Antineoplastic Agents; Breast Neoplasms; Castration; Cyproterone; Cyproterone Acetate; Estrogens; Hormones; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local; Tamoxifen; Time Factors	1985
[Selection of therapeutic procedures according to the clinicopathological features of breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1986, Volume: 13, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Combined Modality Therapy; Female; Humans; Lymph Node Excision; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasm Recurrence, Local; Receptors, Estrogen; Tamoxifen	1986
Analgesic activity of medroxyprogesterone acetate (MAP) in cancer patients: an antiinflammatory mediated activity? International journal of tissue reactions, 1985, Volume: 7, Issue:6 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Breast Neoplasms; Female; Humans; Kinetics; Medroxyprogesterone; Medroxyprogesterone Acetate; Pain; Rats; Rats, Inbred Strains	1985
Specific and sensitive determination of medroxyprogesterone acetate in human serum by gas chromatography-mass spectrometry. Journal of chromatography, 1985, Nov-29, Volume: 345, Issue:1 Topics: Biological Availability; Breast Neoplasms; Female; Gas Chromatography-Mass Spectrometry; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Radioimmunoassay	1985
Endocrine therapy testing of human breast cancers in the soft agar clonogenic assay. Breast cancer research and treatment, 1985, Volume: 6, Issue:3 Topics: Breast Neoplasms; Cell Line; Clone Cells; Colony-Forming Units Assay; Drug Resistance; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Neoplastic Stem Cells; Receptors, Estrogen; Tamoxifen; Tumor Stem Cell Assay	1985
[An analysis of treatments of recurrent breast cancer in relation to the lesion]. Gan no rinsho. Japan journal of cancer clinics, 1985, Volume: 31, Issue:15 Topics: Breast Neoplasms; Combined Modality Therapy; Doxorubicin; Female; Humans; Lymphatic Metastasis; Medroxyprogesterone; Medroxyprogesterone Acetate; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Prognosis; Receptors, Estrogen; Tamoxifen	1985
[Value of hormone therapy in metastasizing breast cancer]. Wiener medizinische Wochenschrift (1946), 1985, Dec-31, Volume: 135, Issue:23-24 Topics: Aminoglutethimide; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasm Metastasis; Ovariectomy; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen	1985
Hormonal therapies for breast cancer: can progestogens stimulate growth? Cancer letters, 1986, Volume: 30, Issue:2 Topics: Breast Neoplasms; Cell Division; Cell Line; Cells, Cultured; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Estradiol; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Polyamines; Progestins; Stimulation, Chemical; Tamoxifen; Time Factors	1986
[Cell cycle effects of antiestrogens and medroxyprogesterone acetate on the MCF-7 human breast cancer cell line]. Nihon Gan Chiryo Gakkai shi, 1985, Dec-20, Volume: 20, Issue:10 Topics: Breast Neoplasms; Cell Cycle; Cell Line; Cell Survival; DNA, Neoplasm; Estrogen Antagonists; Female; Flow Cytometry; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Tamoxifen	1985
Modalities and results of a combined anti-estrogenic therapy by means of tamoxifen and medroxyprogesterone in gynecologic cancerology. European journal of gynaecological oncology, 1986, Volume: 7, Issue:1 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Female; Humans; Lymphatic Metastasis; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Neoplasms, Hormone-Dependent; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Uterine Hemorrhage; Uterine Neoplasms	1986
Influence of steroids and retinoic acid on peanut-lectin binding of human breast cancer cells. Journal of steroid biochemistry, 1986, Volume: 24, Issue:1 Topics: Breast Neoplasms; Cell Line; Dexamethasone; Female; Fluorescein-5-isothiocyanate; Fluoresceins; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Receptors, Mitogen; Steroids; Thiocyanates; Tretinoin	1986
Oral plus intramuscular medroxyprogesterone acetate (high dose Farlutal) in advanced breast cancer. The Southeast Asian journal of tropical medicine and public health, 1985, Volume: 16, Issue:4 Topics: Administration, Oral; Aged; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Injections, Intramuscular; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged	1985
High-dose oral medroxyprogesterone acetate in heavily pretreated patients with metastatic breast cancer. Cancer treatment reports, 1986, Volume: 70, Issue:6 Topics: Adult; Aged; Breast Neoplasms; Edema; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Respiration Disorders	1986
Aminoglutethimide and medroxyprogesterone acetate in the treatment of patients with advanced breast cancer. A phase II study of the Association of Medical Oncology of the German Cancer Society (AIO). Cancer, 1986, Nov-01, Volume: 58, Issue:9 Topics: Adult; Aged; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Drug Evaluation; Drug Synergism; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Neoplasm Metastasis; Pain	1986
[Phase II study of medroxyprogesterone acetate in advanced breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1986, Volume: 13, Issue:11 Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Drug Administration Schedule; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged	1986
Phase II evaluation of megestrol acetate in previously treated patients with advanced breast cancer: relationship of response to previous treatment. European journal of cancer & clinical oncology, 1986, Volume: 22, Issue:9 Topics: Adult; Aged; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Drug Evaluation; Female; Hormones; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Middle Aged	1986
Effect of oral high-dose progestins on the disposition of antipyrine, digitoxin, and warfarin in patients with advanced breast cancer. Cancer chemotherapy and pharmacology, 1986, Volume: 18, Issue:3 Topics: Administration, Oral; Aged; Aged, 80 and over; Antipyrine; Breast Neoplasms; Digitoxin; Female; Humans; Kinetics; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Middle Aged; Progesterone Congeners; Warfarin	1986
Pharmacoclinical data on high dose medroxyprogesterone acetate in advanced breast cancer. Breast cancer research and treatment, 1986, Volume: 8, Issue:2 Topics: Aged; Aged, 80 and over; Breast Neoplasms; Female; Humans; Kinetics; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Prognosis; Receptors, Estrogen	1986
The effects of low and high dose medroxyprogesterone acetate on sex steroids and sex hormone binding globulin in postmenopausal breast cancer patients. British journal of cancer, 1987, Volume: 55, Issue:3 Topics: Androstenedione; Antineoplastic Agents; Breast Neoplasms; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol; Estrone; Female; Gonadal Steroid Hormones; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Sex Hormone-Binding Globulin; Testosterone	1987
Intensive short-term chemotherapy in patients with advanced breast cancer. Klinische Wochenschrift, 1987, Apr-01, Volume: 65, Issue:7 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dactinomycin; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Remission Induction; Vincristine	1987
High-dose medroxyprogesterone acetate in combination with vindesine in advanced breast cancer. European journal of cancer & clinical oncology, 1986, Volume: 22, Issue:12 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Evaluation; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Vindesine	1986
[Endocrine therapy of breast cancer]. Zentralblatt fur Gynakologie, 1987, Volume: 109, Issue:10 Topics: Aminoglutethimide; Antibodies, Monoclonal; Breast Neoplasms; Combined Modality Therapy; Female; Hormones; Humans; Lymphatic Metastasis; Medroxyprogesterone; Medroxyprogesterone Acetate; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen	1987
Phase II evaluation of oral medroxyprogesterone acetate in advanced breast cancer: a Northern California Oncology Group Study. Cancer treatment reports, 1987, Volume: 71, Issue:10 Topics: Adult; Aged; Breast Neoplasms; Drug Evaluation; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged	1987
[Sequential therapy with antiestrogens and progestational drugs in carcinoma of the breast in an advanced stage]. Chirurgia italiana, 1987, Volume: 39, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Female; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Staging; Tamoxifen	1987
Effects of serum type on steroid receptor binding sites and response to progestin of cultured human breast cancer cells. European journal of cancer & clinical oncology, 1987, Volume: 23, Issue:5 Topics: Binding Sites; Blood; Breast Neoplasms; Cells, Cultured; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Receptors, Steroid	1987
Actions of a progestogen on human breast cancer cells: mechanisms of growth stimulation and inhibition. European journal of cancer & clinical oncology, 1987, Volume: 23, Issue:5 Topics: Antineoplastic Agents; Breast Neoplasms; Cell Division; Cells, Cultured; Dexamethasone; Drug Interactions; Estradiol; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Polyamines; Receptors, Steroid	1987
[Hormone therapy in metastasized breast cancer. Criteria for establishing indications and implementing high-dose medroxyprogesterone acetate therapy]. Fortschritte der Medizin, 1987, Jul-30, Volume: 105, Issue:22 Topics: Antineoplastic Agents; Breast Neoplasms; Dose-Response Relationship, Drug; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasm Metastasis; Prognosis	1987
[Hormone therapy--recent advances]. Gan to kagaku ryoho. Cancer & chemotherapy, 1987, Volume: 14, Issue:10 Topics: Breast Neoplasms; Female; Gonadotropin-Releasing Hormone; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Receptors, Androgen; Receptors, Estrogen; Tamoxifen; Uterine Neoplasms	1987
Sequential combination of tamoxifen and high dose medroxyprogesterone acetate: therapeutic and endocrine effects in postmenopausal advanced breast cancer patients. European journal of cancer & clinical oncology, 1987, Volume: 23, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Evaluation; Female; Hormones; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Prognosis; Tamoxifen	1987
A case-control study of breast cancer and hormonal contraception in Costa Rica. Journal of the National Cancer Institute, 1987, Volume: 79, Issue:6 Topics: Adult; Age Factors; Breast Neoplasms; Contraceptives, Oral; Costa Rica; Delayed-Action Preparations; Demography; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Registries; Risk Factors	1987
Progestin regulation of EGF-receptor mRNA accumulation in T-47D human breast cancer cells. Biochemical and biophysical research communications, 1988, Jan-15, Volume: 150, Issue:1 Topics: Antineoplastic Agents; Breast Neoplasms; DNA; ErbB Receptors; Gene Expression Regulation; Humans; Kinetics; Medroxyprogesterone; Medroxyprogesterone Acetate; Nucleic Acid Hybridization; RNA, Messenger; Transcription, Genetic; Tumor Cells, Cultured	1988
On the role of additive hormone monotherapy with tamoxifen, medroxyprogesterone acetate and aminoglutethimide, in advanced breast cancer. Klinische Wochenschrift, 1987, Oct-15, Volume: 65, Issue:20 Topics: Aminoglutethimide; Antineoplastic Agents; Breast Neoplasms; Combined Modality Therapy; Dose-Response Relationship, Drug; Follow-Up Studies; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Tamoxifen	1987
No effect of high-dose medroxyprogesterone acetate on the frequency of sister chromatid exchange in lymphocytes of cancer patients. Oncology, 1988, Volume: 45, Issue:1 Topics: Breast Neoplasms; Dose-Response Relationship, Drug; Female; Humans; Kidney Neoplasms; Lymphocyte Activation; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Sister Chromatid Exchange	1988
Medroxyprogesterone acetate at very high doses in postmenopausal advanced breast cancer patients. Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1987, Volume: 6, Issue:6 Topics: Adult; Aged; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Remission Induction	1987
Induction of progesterone receptor with tamoxifen in human breast cancer with special reference to its behavior over time. Cancer, 1988, Apr-01, Volume: 61, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation; Preoperative Care; Receptors, Estrogen; Receptors, Progesterone; Stimulation, Chemical; Tamoxifen; Time Factors	1988
[Effects of high-dose medroxyprogesterone acetate in advanced breast cancer, with special reference to prior endocrine therapy and hormone receptors]. Gan to kagaku ryoho. Cancer & chemotherapy, 1988, Volume: 15, Issue:3 Topics: Administration, Oral; Aged; Breast Neoplasms; Estrogen Antagonists; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen	1988
[Effects of estrogen and endocrine therapeutic agents on the estrogen receptor, progesterone receptor and DNA synthesis in MCF-7 human breast cancer cells using the whole cell uptake method]. Nihon Naibunpi Gakkai zasshi, 1987, Nov-20, Volume: 63, Issue:11 Topics: Breast Neoplasms; Cell Line; DNA, Neoplasm; Estradiol; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Norpregnadienes; Promegestone; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Tumor Cells, Cultured	1987
Plasma concentrations of medroxyprogesterone acetate and megesterol acetate during long-term follow-up in patients treated for metastatic breast cancer. Journal of cancer research and clinical oncology, 1988, Volume: 114, Issue:2 Topics: Aged; Breast Neoplasms; Female; Follow-Up Studies; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Radioimmunoassay	1988
[Combination chemotherapy using low-dose epirubicin and vindesine in patients with metastatic breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1988, Volume: 15, Issue:4 Pt 1 Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local; Tamoxifen; Tegafur; Uracil; Vindesine	1988
Clinical trial of high-dose oral medroxyprogesterone acetate in the treatment of metastatic breast cancer and review of the literature. Cancer, 1988, Jun-01, Volume: 61, Issue:11 Topics: Administration, Oral; Breast Neoplasms; Dose-Response Relationship, Drug; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasm Metastasis; Prospective Studies; Time Factors	1988
Effects of antiestrogen and progestin on immune functions in breast cancer patients. Cancer, 1988, Jun-01, Volume: 61, Issue:11 Topics: Antigens, Differentiation, T-Lymphocyte; Breast Neoplasms; Concanavalin A; Female; Humans; Immunity; In Vitro Techniques; Interleukin-2; Leukocyte Count; Lymphocyte Activation; Medroxyprogesterone; Medroxyprogesterone Acetate; Phytohemagglutinins; Tamoxifen; Time Factors	1988
Effect of medroxyprogesterone acetate on proliferation and cell cycle kinetics of human mammary carcinoma cells. Cancer research, 1988, Sep-15, Volume: 48, Issue:18 Topics: Breast Neoplasms; Cell Cycle; Cell Division; Cell Line; Estradiol; Female; Flow Cytometry; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Receptors, Progesterone	1988
[Which hormone therapy should be used in advanced breast carcinoma in males?]. Deutsche medizinische Wochenschrift (1946), 1988, Sep-02, Volume: 113, Issue:35 Topics: Adenocarcinoma; Aged; Aminoglutethimide; Axilla; Breast Neoplasms; Dexamethasone; Drug Evaluation; Humans; Lymphatic Metastasis; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Tamoxifen; Testolactone; Testosterone Congeners	1988
The pharmacokinetics of medroxyprogesterone acetate following two different loading dose schedules in advanced carcinoma of the breast. British journal of cancer, 1988, Volume: 58, Issue:1 Topics: Antineoplastic Agents; Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Time Factors	1988
Pharmacokinetics and metabolism of medroxyprogesterone acetate in patients with advanced breast cancer. Journal of steroid biochemistry, 1988, Volume: 31, Issue:4A Topics: Administration, Oral; Breast Neoplasms; Female; Glucuronates; Half-Life; Humans; Injections, Intravenous; Medroxyprogesterone; Medroxyprogesterone Acetate; Metabolic Clearance Rate; Radioimmunoassay; Tissue Distribution	1988
[Chemo-endocrine therapy of advanced breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1988, Volume: 15, Issue:12 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Ovariectomy; Tamoxifen	1988
Prostacyclin and thromboxane in breast cancer: relationship between steroid receptor status and medroxyprogesterone acetate. British journal of cancer, 1985, Volume: 51, Issue:5 Topics: 6-Ketoprostaglandin F1 alpha; Aged; Antineoplastic Agents; Breast Diseases; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Epoprostenol; Female; Humans; In Vitro Techniques; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Receptors, Steroid; Thromboxane A2; Thromboxane B2; Thromboxanes	1985
Regulation of growth hormone and epidermal growth factor receptors by progestins in breast cancer cells. Biochemical and biophysical research communications, 1985, Sep-16, Volume: 131, Issue:2 Topics: Breast Neoplasms; Cell Line; Epidermal Growth Factor; ErbB Receptors; Female; Growth Hormone; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Pregnenediones; Progesterone; Progestins; Promegestone; Receptors, Cell Surface; Receptors, Somatotropin	1985
Modulation of lactogenic receptors by progestins in cultured human breast cancer cells. The Journal of clinical endocrinology and metabolism, 1986, Volume: 62, Issue:2 Topics: Breast Neoplasms; Cell Line; Cycloheximide; Estradiol; Female; Growth Hormone; Hormones; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Progestins; Receptors, Cell Surface; Receptors, Peptide; Receptors, Progesterone; Receptors, Somatotropin	1986
Progestational agents in advanced breast cancer: an overview. Seminars in oncology, 1986, Volume: 13, Issue:4 Suppl 4 Topics: Antineoplastic Agents; Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Menopause; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Hormone-Dependent; Prognosis; Receptors, Cell Surface; Tamoxifen	1986
Influence of aminoglutethimide on plasma levels of medroxyprogesterone acetate: its correlation with serum cortisol. Cancer treatment reports, 1985, Volume: 69, Issue:1 Topics: Aminoglutethimide; Breast Neoplasms; Drug Therapy, Combination; Female; Humans; Hydrocortisone; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Neoplasm Metastasis; Pilot Projects	1985
Lack of correlations between plasma concentration of medroxyprogesterone acetate, hypothalamic-pituitary function, and tumour response in patients with advanced breast cancer. Cancer chemotherapy and pharmacology, 1985, Volume: 14, Issue:2 Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Female; Follicle Stimulating Hormone; Humans; Hypothalamo-Hypophyseal System; Liver Function Tests; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Prolactin; Radioimmunoassay	1985
Medroxyprogesterone acetate versus tamoxifen in the therapy of advanced breast cancer. Neoplasma, 1985, Volume: 32, Issue:1 Topics: Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Receptors, Estrogen; Tamoxifen	1985
[Effects of antiestrogens and medroxyprogesterone acetate on the clonogenic growth of tamoxifen-sensitive and resistant human breast cancer cells]. Gan to kagaku ryoho. Cancer & chemotherapy, 1985, Volume: 12, Issue:4 Topics: Breast Neoplasms; Cell Division; Cell Line; Cells, Cultured; Drug Resistance; Estrogen Antagonists; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Nafoxidine; Tamoxifen	1985
Medroxyprogesterone acetate (MAP) and tamoxifen (TMX) plasma levels after simultaneous treatment with 'low' TMX and 'high' MAP doses. Cancer chemotherapy and pharmacology, 1985, Volume: 14, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Tamoxifen	1985
[Changes in serum lipoproteins under hormonal therapy of breast carcinoma and other endocrine-dependent tumors]. Onkologie, 1985, Volume: 8, Issue:2 Topics: Aminoglutethimide; Breast Neoplasms; Cholesterol; Cortisone; Drug Therapy, Combination; Female; Humans; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Triglycerides	1985
[Therapeutic effects of medroxyprogesterone acetate in recurrent or advanced breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1985, Volume: 12, Issue:3 Pt 1 Topics: Administration, Oral; Adult; Aged; Body Weight; Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Neoplasm Recurrence, Local	1985
Prolactin levels and hormonal profile in postmenopausal patients with advanced breast cancer during endocrine treatments. Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1985, Volume: 4, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bromocriptine; Delayed-Action Preparations; Estradiol; Female; Gonadotropins, Pituitary; Hormones; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Prolactin; Tamoxifen; Testosterone; Thyroid Hormones	1985
Mechanism of adrenal suppression by high-dose medroxyprogesterone acetate in breast cancer patients. Cancer chemotherapy and pharmacology, 1985, Volume: 15, Issue:2 Topics: 17-alpha-Hydroxyprogesterone; Adrenal Insufficiency; Aged; Androstenedione; Breast Neoplasms; Cosyntropin; Female; Humans; Hydrocortisone; Hydroxyprogesterones; Medroxyprogesterone; Medroxyprogesterone Acetate; Metyrapone; Middle Aged	1985
Oral medroxyprogesterone acetate in the treatment of metastatic breast cancer. Breast cancer research and treatment, 1985, Volume: 5, Issue:3 Topics: Administration, Oral; Adult; Aged; Breast Neoplasms; Female; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Receptors, Estrogen; Receptors, Progesterone	1985